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Abstract 
Resting energy expenditure (REE) can be reduced in situations of Low Energy 
Availability (LEA) in athletes, providing both a diagnostic sign of LEA and a potent risk 
factor for illness, injury and sub-optimal health. Current protocols regarding pre-measurement 
standardisation for REE are based on non-athlete populations, often following stringent rest 
and fasting protocols that would not be practical in a high performance environment. 
Furthermore, the reliability of measurements derived from these protocols has often been 
assessed in general and clinical populations and is unknown in an athlete population.  
Characteristics of the test protocol which alter an athlete's presentation (e.g. the location of the 
test, the duration of recovery from the last exercise bout) and changes in the athlete's own 
characteristics (changes in intramuscular solute and water content) were identified as 
variables that could affect the reliability of measurement of REE. This thesis presents a series 
of distinct but related studies which examine the how these variables affect the measurement 
and interpretation of REE in athletes.  
Study 1 examined the effect of testing location on REE in 32 elite and sub-elite 
athletes. REE was measured either at their bedside upon waking (inpatient) and as an 
outpatient (laboratory) protocol in a cross-over design following 8 h overnight fasts prior to 
each measurement.  The day to day variation and reliability of each protocol was also 
assessed.  There was no difference in REE when measured under the inpatient or outpatient 
protocols (7302 ± 1272 and 7216 ± 1119 kJ/d respectively).  Both protocols showed good day 
to day reliability (inpatient 96%, outpatient 97%), however, the outpatient protocol was found 
to have a greater typical error (TE) (478 kJ/d) and to be less sensitive to changes in REE than 
the inpatient protocol (336kJ/d).  
Study 2 was a pilot study that investigated the effect of acute exercise on REE.  A 
cross-over intervention was used in ten male athletes. Measurements were undertaken 
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following training sessions in the morning and afternoon to determine REE approximately 12, 
24, 36 and 48 h post exercise. There was a trend for REE to decrease with increasing rest time 
from exercise, with REE measured 48 h post exercise being significantly lower than REE 
measured at 12 h.  However, the difference of 375 kJ/d was within the typical error 
determined in Study 1.   
Study 3 focused on the reliability of DXA estimates of lean mass (LM), which is 
important in the interpretation of REE relative to fat free mass (FFM).  Intramuscular solutes 
and fluid were manipulated through a series of glycogen depletion, glycogen loading and 
creatine loading protocols in 18 male cyclists. Main outcome measures were total body and 
leg LM measured by dual x-ray absorptiometry (DXA), and total body water (TBW) 
measured by bioelectrical impedance spectroscopy (BIS).  Changes in the mean were 
considered substantial if they reached the threshold for the smallest worthwhile effect of the 
treatment. There were substantial increases in TBW (2.3 and 2.5%), total body (2.1 and 3.0%) 
and leg LM (2.6 and 3.1%) following glycogen loading and the combined glycogen-creatine 
loading protocols respectively.  Glycogen depletion caused a substantial decrease in leg LM (-
1.4%) and trivial decrease in total body LM (-1.3%).  Creatine loading resulted in substantial 
increases in TBW and in trivial increases in LM measures.   
Study 4 addressed the potential development of a practical method to determine an 
athlete's glycogen stores in combination with DXA-derived estimates of LM by investigating 
the validity of measuring muscle glycogen via a non-invasive ultrasound technique. The same 
cohort and design involved in Study 2 was used in this investigation, with the ultrasound 
derived estimates of muscle glycogen concentration and changes in glycogen concentration 
being compared with results derived from direct (biopsy-derived) measurements. Poor 
correlations and substantially large or unclear errors were determined for the ultrasound 
estimates of muscle glycogen compared to muscle biopsy.  Therefore, under the conditions 
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employed in the current study design, the ultrasound technique was unable to accurately 
predict either single measures of muscle glycogen or changes in muscle glycogen stores. 
 Study 5 applied the findings from Study 3 to investigate how changes in muscle 
glycogen influence the measurement and interpretation of REE in athletes, with particular 
interest in its effect on the sensitivity to detect changes in REE over time or as a result of an 
intervention. The investigation was undertaken within a larger study of the effect of 
adaptation to a low carbohydrate, high fat (LCHF) diet during a 21 day training camp for 
endurance athletes.  Nineteen elite male race-walkers participated in this study; ten were 
assigned to the control group (CHO) where they received a diet providing 60% of energy 
from carbohydrate while nine were in the intervention group in which carbohydrate was 
restricted to <50g per day and fat comprised >70% of their energy intake for this period.  
Before and after the dietary interventions, measurements were made of REE, body 
composition (DXA) and TBW (BIS).  Information derived from Study 3 to distinguish acute 
changes in TBW associated with changes in intramuscular glycogen and its bound water, 
from true (chronic) changes in muscle mass, was applied to the baseline and post-intervention 
measures of LM in all athletes. There was a significant decrease in FFM between Baseline 
and uncorrected Post-Intervention values FFM (-1.4; 95% CI -2.0, -0.80 kg). Using the 
uncorrected measures of FFM, we interpreted that no change in relative REE between 
baseline and post intervention occurred in either group.  However, when the correction factor 
was applied to FFM of the LCHF group, correcting for the artefact of reduced muscle 
glycogen levels associated with restricted carbohydrate intake, we detected a decrease in 
relative REE post intervention measurements compared to baseline.   
The conclusions from this series of studies are; 1) Inpatient and outpatient protocols 
should not be used interchangeably when tracking changes in REE over time.  2) An 8 h 
overnight fast has good day to day reliability for both inpatient and outpatient protocols. 3) 
Rest time from exercise should be kept consistent between measures of REE for longitudinal 
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monitoring. 4) Manipulations of muscle glycogen and creatine supplementation cause an 
artefact in the DXA which changes the estimate of LM accordingly. 5) Measurement of TBW 
via BIS is better suited to track changes in muscle glycogen than proprietary ultrasound 
technology. 6) A reduction in muscle glycogen stores, such as that achieved by the 
consumption of a LCHF diet, creates an artefact in the DXA-derived measurement of FFM, 
which could potentially alter the interpretation of relative REE.  This knowledge should be 
integrated into best practice guidelines for the measurement of REE in athletes to enhance the 
reliability and validity of measurement as well as the interpretation of the results.  
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1.0 Introduction and Overview 
Low energy availability (LEA) describes situations in which a mismatch between an 
individual’s energy intake and the energy cost of their exercise program leaves insufficient 
energy to support optimal function of many other body systems (Loucks et al., 2011). 
Operationally, energy availability can be calculated from information about energy intake and 
exercise energy expenditure, and is expressed relative to the body’s fat free mass (FFM).  
There is a growing literature on the association between LEA and an increased risk of illness 
and injury in athletes (Drew et al., 2017; Mountjoy et al., 2014).  These factors have been 
shown to increase the number of lost training days, creating a negative impact on athletic 
performance (Raysmith & Drew, 2016).  There is also evidence in female athletes that LEA 
directly impairs the response to training, leading to a reduction in performance gains 
(Vanheest et al., 2014). Therefore, early detection and management of LEA in males as well 
as females is important for not only maintaining the athlete’s health and well-being but also 
for achieving sporting success under Australia’s Winning Edge program.  
Resting metabolic rate can be supressed in situations of LEA and can be used as part 
of a spectrum of tools in the diagnosis of LEA (Melin et al., 2015).  This is convenient, since 
calculating energy availability for a free-living individual is laced with difficulties ranging 
from getting accurate information on energy intake from self-reported methods to defining 
what constitutes exercise and quantifying its energy expenditure. However, if measurements 
of resting metabolic rate (RMR) or daily resting energy expenditure (REE) are to be used as 
stand-alone tools in the assessment of energy availability, it is important that the protocols are 
practical to implement in the daily training environment, and that the measurements are 
reliable (sensitive enough to detect meaningful changes or differences) and valid (not being 
influenced by artefacts or variables that artificially alter the results).   
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The current best practice protocols for measuring REE in athletes are based on 
research on healthy sedentary individuals or clinically ill populations (Compher et al., 2006; 
Fullmer et al., 2015). Factors that could influence the variability or error of REE in these 
populations have been well investigated (Compher et al., 2006; Fullmer et al., 2015). 
However the same considerations have not been applied to athletes or some of the 
characteristics that define them. For example, REE is often expressed relative to FFM as it 
explains between 70-80% of the variability between individuals (Cunningham, 1991; Sparti et 
al., 1997). However, the validity and reliability of the tools used to assess body composition 
are not considered in the best practice protocols for REE assessment. Although it has been 
shown that DXA estimates of lean mass (LM) are influenced by recent food and fluid intake 
(Nana et al., 2012b), the effects of larger or longer term changes in body water content 
achieved through diet, exercise or supplements on DXA estimates of LM and consequent 
calculations of REE are largely unknown.  Since athletes can undertake extreme changes in 
dietary intake and exercise in the day/s preceding the measurement of REE, it is important to 
understand how these would influence the assessment or interpretation of REE.  Furthermore, 
in the case where it is not possible or practical to standardise these behaviours, it is of interest 
to develop tools that could correct for the potential measurement artefacts that they introduce.  
Meanwhile, the effect of other factors that need to be included in practical protocols for 
measurement of REE in free-living high performance athletes (e.g. testing location, period 
since the last exercise session, shorter fasting periods) have yet to be systematically studied.  
The implications of the current lack of clarity about the reliability and validity of REE 
measurements in high performance athletes include a failure to manage athlete preparation 
needs as well as to undertake research.  Problems may occur when a single measurement of 
REE is used to diagnose LEA, when serial measurements are used to track real life changes 
over time, or when there is investigation of whether an intervention poses a meaningful help 
or harm in the management of energy availability goals. Thus there is a need to develop or 
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validate protocols that are evidence based and athlete specific for use by sport 
science/medicine practitioners and researchers.  
The aim of this thesis was to investigate the reliability of protocols used to assess and 
interpret resting metabolism in an athletic population. The work presented in the following 
chapters consists of five independent but related studies that identify and examine key 
variables that influence the measurement and interpretation of metabolic rate in athletes. 
 Study 1:  Comparison of inpatient and outpatient protocols for measurement of resting 
energy expenditure in athletes (Chapter 4). Study 2: Investigation of the effect or prior 
exercise on measures of resting metabolic rate in trained men (Chapter 5). 
Study 3: Investigation of the effect of altering muscle solute and water content on 
DXA measurements of lean mass (Chapter 6).  
Study 4: Investigation of a practical and indirect method of assessment of muscle 
glycogen concentrations in athletes to allow changes to be considered in assessments of lean 
mass and REE. (Chapter 7).  
Study 5: Investigation of the significance of artefacts in DXA measurements of lean 
mass in assessment of REE in athletes (Chapter 8).  
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2.0 Literature review 
2.1 Introduction 
The concept and measurement of resting metabolic rate (RMR) is important in sports 
nutrition.  The management of energy intake and physique, which is important in athlete 
health and performance, requires an appreciation of basal metabolism within total energy 
expenditure. Indeed, in the case of elite athletes, values for each of these features may be 
found at each end of the normal continuum and require special expertise in measurement and 
interpretation of what is optimal.   
More importantly, over the past decade, there has been interest in sports nutrition 
research and practice in the concept of energy availability (EA), which represents a potential 
interrelationship between physique management and basal metabolism.  Energy availability is 
defined as the amount of energy that remains for body metabolic functions after accounting 
for the energy cost of exercise (Loucks et al., 2011).  Low energy availability (LEA), in which 
energy intake relative to the energy cost of exercise is inadequate to support optimal body 
function, can occur because energy intake is reduced and/or the exercise load is increased 
without adequate adjustment of dietary energy.  Since basal metabolism can be suppressed as 
a compensatory response to situations of low EA, it can therefore be used as a marker to 
support a diagnosis (Loucks et al., 1998).   
Functional outcomes of LEA and its metabolic and hormonal adjustments include 
menstrual dysfunction in female athletes, impairment of protein synthesis and bone 
metabolism and disruption to many other body systems (Mountjoy et al., 2014).  These 
factors can impair athletic performance by increasing the risk of illness and injury (therefore 
causing the loss of training days or interruption to full training loads), as well as by causing 
difficulties in maintaining ideal physique and decreasing the effectiveness of the response to a 
training stimulus (Vanheest et al., 2014).  While exercise is known to produce an acute 
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increase on RMR (Bullough et al., 1995; Dolezal et al., 2000; Sjodin et al., 1996; Tremblay et 
al., 1988), this is not well characterised in terms of the range of training or competition 
activities undertaken by well-trained athletes.  Furthermore, the time course of any chronic 
changes in RMR as a result of low EA or the restoration of a healthy EA in athletes has not 
been well studied, in isolation or as an interaction with the acute effects of the daily exercise 
load.  
When used as a marker of LEA, RMR can be interpreted by comparing absolute 
values in kilojoules per day (kJ/d), against predicted equations (De Souza et al., 2007) or 
against pre-determined criteria relative to fat free mass (kJ/kg FFM/d) (Loucks, 2003). 
However, current values used to classify someone with optimal, reduced and low energy 
availability are still debated, particularly when used with male athletes (Koehler et al., 2016) 
as the majority of research has been conducted in female athletes. The reliability and validity 
of the protocols used to measure/estimate FFM are equally vital as the introduction of error on 
an artefact may cause an over or underestimation of the true EA and relative RMR (Melin & 
Lundy, 2015).  Dual energy x-ray absorptiometry (DXA) has become the preferred tool for 
assessment and monitoring of body composition in athletes when conducted under 
standardised conditions such as the presentation of the subject in a fasted, rested and 
euhydrated state, and controlled placement on the scanning bed (Nana et al., 2015).  However, 
it is suspected that changes in muscle glycogen concentrations, due to manipulations of diet 
and/or exercise, may be interpreted by DXA scans as changes in lean mass (Rouillier et al., 
2015; Sherman et al., 1982) and may introduce an artefact in measurements of body 
composition.  Since this scenario is likely to occur in athletes, an ideal approach would be 
either to standardise muscle glycogen and total body water (TBW) content, or at least be able 
to assess any perturbations for consideration in the interpretation of body composition 
measurements. Currently, it is possible to assess TBW using bioelectrical impedance 
spectroscopy (BIS), (Kerr et al., 2015), however, the assessment of  muscle glycogen is either 
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very invasive (biopsy techniques) or expensive (magnetic resonance imaging) (Harris et al., 
1974; Nygren et al., 2001).  Ultrasound technology using proprietary software has been used 
to assess muscle glycogen, however this technology is still in its infancy and further 
independent validations have yet to occur (Hill & Millan, 2014; Nieman et al., 2015).    
This literature review will provide background information about the measurement, 
interpretation and manipulation of body composition and muscle glycogen in relation to basal 
metabolism in athletes.  It will include a summary of techniques and protocols, with insights 
in to the suitability of these techniques in athletic populations.  Furthermore, it will review the 
reciprocal relationship between RMR and athletic performance; how alterations in RMR may 
affect the outcome of the athlete’s goals for optimal health and performance while activities 
undertaken by an athlete in their sports pursuits may affect RMR.  To undertake this review, 
literature was sourced from Internet databases including but not limited to Medline via Ovid, 
Web of Knowledge, PubMed and Sports Discuss. Keywords used were BMR; RMR; REE; 
SMR; resting metabolic rate; resting energy expenditure; athlete/s; trained; sport; diet; TEM; 
exercise; male/s; injury; illness and performance. The Australian Catholic University (ACU) 
Library catalogue was also used to source reference texts on metabolism and injury.  Articles 
where limited to those written in the English language, abstracts and conference proceedings 
were excluded as were articles involving, clinical populations and weight loss interventions in 
obese individuals.  The last literature search was performed on 17 May 2017.  
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2.2 Overview of basal metabolism 
Basal metabolism is one of three components of total daily energy expenditure 
alongside the thermic effect of food (TEF; the energy cost of eating, digesting and absorbing 
food) and the thermic effect of activity (TEA; energy expended during planned physical 
activity and non-exercise activity (Burke & Deakin, 2009; Mahan & Escott-Stump, 2008; 
Mann & Truswell, 1998).  Basal metabolism is defined as the minimum energy required to 
perform metabolic and chemical processes when awake, in order for the body to function at 
its optimum (Institute of Medicine, 2005; Ravussin et al., 1986).  In a sedentary population, 
basal metabolism is the largest component of total daily energy expenditure (Mahan & Escott-
Stump, 2008; Mann & Truswell, 1998), while physical activity is the most variable 
component, ranging from 20-30% of total energy expenditure (2005; Ravussin et al., 1986).  
However, this is often not the case in elite athletes where the energy expenditure from 
exercise (EEE) is often larger than basal metabolism (Beidleman et al., 1995; Rontoyannis et 
al., 1989; Thompson et al., 1993). There are small intra-individual changes in basal 
metabolism however there are large inter-individual variations, mainly due to differences in 
body composition (Nelson et al., 1992; Ravussin et al., 1986). 
 
2.2.1 Terminology used to describe basal metabolism 
Although a number of terms are used, often interchangeably, to describe basal 
metabolism, there are differences in the definition of various metrics, according to the 
protocols used to collect measurements as well as units of measurement (Institute of 
Medicine, 2005). 
BMR (Basal metabolic rate): measured in kJ/min, quantifies a measurement of 
metabolic rate, taken from the bedside of a lying-supine individual who has just woken up and 
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has followed a 9-12 h fast (Institute of Medicine, 2005), abstained from alcohol and caffeine 
intake and in a thermoneutral environment (Institute of Medicine, 2005; Levine, 2005).  
RMR (Resting metabolic rate): measured in kJ/min, quantifies a measurement of 
metabolic rate when any one or more of the conditions listed under BMR are not met 
(Institute of Medicine, 2005; Levine, 2005).  
SMR (Sleeping metabolic rate): measured in kJ/min or kJ/h, quantifies the 
measurement of basal metabolism in a sleeping individual. It is reported to be 5-10% lower 
than BMR since it excludes the metabolic cost of arousal or being awake (Institute of 
Medicine, 2005).  There are differing protocols in the literature for monitoring SMR with the 
most common involving assessment over a continuous 60 min or 3 h period (Goldberg et al., 
1988; van Marken Lichtenbelt et al., 2001).   
BEE (Basal energy expenditure): measured in kJ/d, quantifies the extrapolation of 
BMR to a 24 h period 
REE (Resting Energy Expenditure): measured in kJ/d, quantifies the extrapolation 
of RMR to a 24 h period. 
SEE (Sleeping energy expenditure): measured kJ/d, quantifies the extrapolation of 
SMR to a 24 h period. 
 
2. 3 Methods to assess basal metabolism 
In its simplest terms, our metabolic rate is the amount of heat produced over a (set) time. 
Energy is not destroyed, but transformed from one form to another (Schutz, 1995). Chemical 
and mechanical energy in humans is released as heat, which allows us to quantify energy 
expenditure (Schutz, 1995); the science known as calorimetry.  Therefore, the heat released 
and measured when we are at complete rest represents our basal metabolism.   Heat loss can 
be difficult to measure and is often impractical, particularly in large groups (Compher et al., 
2006).  Although there are several different ways to measure or predict basal metabolism, the 
13 
 
proxy measurement of heat production, through indirect calorimetry, is the most common 
method used in both research and clinical settings (Compher et al., 2006; Mahan & Escott-
Stump, 2008; Mann & Truswell, 1998).  This section will review the different methods for 
quantifying basal metabolism.  
 
2.3.1 Direct calorimetry 
Direct calorimetry is the gold-standard technique of measuring metabolic rate and 
quantifies the basic principle of measurement of heat dissipated over a 24 h period (Mann & 
Truswell, 1998). Energy expenditure is calculated from the difference in heat stored compared 
to heat lost through mechanical work and evaporation, convection and radiation (Mann & 
Truswell, 1998). Direct calorimetry requires a specialist room-sized chamber that is able to 
detect the heat loss. Such chambers are expensive to construct and operate, require a high 
degree of technical expertise to ensure precision of measurement and are not universally 
available.  Furthermore, energy expenditure is not able to be measured in real time due to the 
time lag between heat production and measurement by the chamber. They also impose a high 
participant and investigator burden as participants have to be in the chamber for at least 24 h 
while being constantly monitored (Mahan & Escott-Stump, 2008; Mann & Truswell, 1998). If 
exercise ergometers are placed in the chamber, they also produce heat when used, which 
needs to be accounted for in subsequent analysis.  In addition, as only heat is measured, it is 
not possible to obtain substrate oxidation rates. Due to these disadvantages direct calorimetry 
is rarely used to measure basal metabolism in both research and clinical settings.  Indirect 
calorimetry, when performed under stringent conditions, is considered the criterion method 
for measuring energy expenditure in real-life settings (Henry et al., 2003; Leonard, 2012; 
Levine, 2005). 
2.3.2 Indirect calorimetry 
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The principle of indirect calorimetry is that knowledge of respiratory gas exchange 
can be used to accurately estimate heat production, and hence, energy expenditure. The 
measurement of the gas exchange requires the collection of respiratory gas (pulmonary 
ventilation), and analysis of the volumes, flow rates and composition of the gas, when 
standardised for ambient temperature and pressure, saturated with water vapour (ATPS) 
conditions. Specifically, the consumption of oxygen (O2) and production of carbon dioxide 
(CO2) is measured and the respiratory quotient (RQ) and energy expenditure are calculated 
using formulae, such as the Haldane Transformation (Haldane, 1918). Although most 
techniques for indirect calorimetry capture the respiratory gases from subjects through 
mouthpieces or ventilation hoods, the construction of respiration chambers has allowed 
measurements of metabolic rate to be undertaken on sleeping subjects without being 
interrupted by the gas collection process  (Rising et al., 2015) 
 
The traditional method of indirect calorimetry undertook collection of expired 
pulmonary gases into large polyvinyl chloride ‘Douglas’ bags (Douglass 1911). While this 
method is very laborious, it is inexpensive, highly robust (<3% ‘small’ error; (Levine, 2005)) 
and is still considered the most accurate method for respiratory gas collection under steady-
state conditions (Roecker et al., 2005). To address the earlier absence of a commercially 
available alternative, the Australian Institute of Sport custom-built a fully automated version 
of this system (Russell et al., 2002).  It continues to use this system since it provides complete 
control of the algorithms used to calculate oxygen consumption (Gore et al., 2013).  A large 
range of metabolic carts are now available for purchase, with some showing more reliable and 
valid results than others. These typically involve breath-by-breath and mixing-chamber 
systems.  
 
2.3.3 Activity monitors 
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Activity monitors estimate energy expenditure via algorithms which use data from a 
variety and combination of sources, including heart rate, movement patterns and other 
biological factors (King et al., 2004; Koehler et al., 2013b; Welk et al., 2007).  While early 
activity monitors used single inputs, more recent technology has produced more sophisticated 
units that integrate data from multiple sources.  For example, SenseWear (SWA) is a 
multisensory monitor that is claimed to have improved accuracy in estimating energy 
expenditure from multiple factors such as heat flux, skin temperature, galvanic skin response 
and tri-axel accelerometer (Liden et al., 2002).  The SWA monitor is worn on the upper left 
arm and is transportable, practical and reported to be of little discomfort when being worn 
(Fruin & Rankin, 2004).   It is therefore particularly suited for use in free-living populations 
for collecting field measures, and presents another option for measuring SMR since it can be 
worn by the individual while they are sleeping.  
 
Energy expenditure derived from SWA has been compared with RMR measured by 
indirect calorimetry with mixed results (El Ghoch et al., 2012; Elbelt et al., 2012; Malavolti et 
al., 2007).  In healthy untrained individuals, the resting energy expenditure measured by the 
SWA correlated well (r= 0.86, p < 0.0001) with RMR measured by indirect calorimetry 
(Malavolti et al., 2007). In contrast, SWA overestimated RMR compared to indirect 
calorimetry in anorexia nervosa populations (El Ghoch et al., 2012; Elbelt et al., 2015). 
Meanwhile, in obese individuals, Papazaoglu et al. (2006) reported that SWA had a good 
correlation (r=0.88, p<0.0001) with indirect calorimetry but tended to underestimate RMR, 
with errors increasing in magnitude with the increase in RMR.  Elbelt et al. (2012) compared 
overnight measurements of sleeping energy expenditure (SEE) via SWA to the RMR 
measured by indirect calorimetry in 20 healthy individuals and 61 patients who were either 
obese or diagnosed win fatty liver syndrome.  Although SEE is generally regarded as being 5-
10% lower than RMR, the SWA-derived SEE was found to be 7% higher than the measured 
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RMR (Elbelt et al., 2012; 2005).  However, all these studies used an older version of the 
SWA monitor, based on a 2-axel accelerometer and older firmware (El Ghoch et al., 2012; 
Papazoglou et al., 2006).  It would be of interest to see if these errors persist with the updated 
3-axel accelerometer and when applied to athletic populations.    
 
2.3.2 Prediction equations 
A number of prediction equations have been developed to calculate basal energy 
expenditure of individuals in the absence of the equipment, expertise or opportunity to 
undertake measurements. These equations have typically been derived via regression analysis 
from studies of RMR in sedentary populations, with input factors including age, body mass, 
height and fat-free mass (FFM) (Cunningham, 1980; Harris & Benedict, 1918). The most 
widely used equation for predicting RMR in normal populations comes from the work of 
Harris and Benedict (1918), while other popular algorithms are provided by Cunningham et 
al. (1980), Westerterp et al. (1995) and Mifflin et al. (1990). Prediction equations derived 
from athletic populations include the work of De Lorenzo and colleagues (De Lorenzo et al., 
1999).  Whereas, the equations of Harris-Benedict, Mifflin-St Jeor and De Lorenzo use body 
mass and height to predict RMR with different equations for men and women, the Westerterp 
equation takes into account both fat-free mass (FFM) and fat mass (FM) (Westerterp et al., 
1995) while Cunningham only accounts for FFM (Cunningham, 1980).   Thomas and Manore 
(1996) investigated the accuracy of applying commonly used prediction equations to athletic 
populations, finding that they generally underestimate RMR in an athletic population, 
particularly if athletes have a high FFM.  According to their work, the Cunningham equation 
was the most accurate in predicting RMR in well-trained individuals (Thompson & Manore, 
1996).    
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As well as providing an estimate of RMR for clinical use, it has been proposed that 
prediction equations could be used to assess the “normality” of measurements of basal 
metabolism within athletic populations. Here, the comparison of measured RMR to expected 
RMR could be used to classify an individual into categories of “normal” or “suppressed” 
basal metabolism for further investigation (De Souza et al., 2007).  Of course, this assumption 
requires an understanding of the accuracy or bias of various prediction equations, as well as 
the use of valid and reliable protocols for measuring basal metabolism. Therefore, techniques 
for measuring RMR, particularly the most commonly available method of indirect 
calorimetry, should be systematically investigated in high performance athletes to assess 
measurement variability and to refine protocols to minimise avoidable errors.  
 
2.4 Sources of variability measurements of basal metabolism in athletes 
As summarised in section 2.3.2, indirect calorimetry involves the measurement of 
RMR from respiratory gases collected from a resting individual. Sources of error or 
variability in the measurement of basal metabolism can be divided into three main categories: 
those that derive from the instruments used to collect data, those associated with the 
conditions under which the subject is assessed, and inherent biological variability within the 
individual.  
 
2.4.1 Technical 
Technical error may be associated with any of the processes involved in collecting 
respiratory gases and then analysing the composition, volume and flow rate of these gases. 
 
Ventilation hoods vs mouthpieces 
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 There are three main apparatuses used for the collection of respiratory gases: nose 
clip and mouthpiece (mouthpiece), facemask and ventilation hood. In the first two cases, the 
individual is required to breathe into a device that is either attached directly to the Douglas 
Bag or metabolic cart or connected through a short hose of known volume (Haugen et al., 
2007).  The ventilation hood consists of a transparent bubble, placed over the face, attached to 
a fabric skirt that gets tucked in around the participant to create a tight seal. Room air enters 
the hood through a one-way valve while air is extracted via a pump into the mixing chamber 
for analysis as an air-tight seal is often difficult to achieve (Isbell et al., 1991).   An error 
could be added to RMR measurements if there is any physical cost (e.g. body movement or 
breathing effort) involved with the use of any of these apparatuses; particularly the 
mouthpiece or facemask. 
 
Several studies have measured the variability of RMR measurements between and 
within the different protocols of collecting respiratory gases. Roffey and colleagues (Roffey et 
al., 2006) measured the daily variation in gases collected via nosepiece-mouthpiece and 
ventilation hood protocols in ten sedentary individuals. The volume of oxygen consumption 
(V̇O2), and hence RMR was significantly higher when the mouthpiece system was used 
compared with the ventilation hood (Roffey et al., 2006). However, different types of gas 
analysers were used in conjunction with these protocols; therefore, it is unknown how much 
the gas collection method contributed to the error (Roffey et al., 2006).  Conversely, Isbell et 
al. (1991) reported no difference in mean RMR over a three-day measurement period in 30 
females.  In this study, resting expirate was collected using a Hans Rudolph mouthpiece 
(Hans Rudolph, Inc, Kansas City, MO), a facemask (Concord Laboratories, Inc., Keane, NH) 
and a ventilated hood (Medical Graphics Corporation, Minneapolis, MN), but were analysed 
using a standardised calibrated Medical Graphics Critical Care Monitor (CCM), (Medical 
Graphics Corporation, Minneapolis, MN). However, confounding methodological parameters 
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were identified; the relatively short periods of time required for fasting (5 h) and post-exercise 
rest (5 h) and exposure to external noise (participants were permitted to listen to classical 
music). Therefore, future studies are needed to better understand the effect of different types 
of gas collection equipment on RMR measurements, when confounding factors are 
standardised.  
 
Gas analysis systems 
Under ideal practices, the validation of a gas analysis system should be compared 
against the criterion technique; the Douglas bag method. Under resting conditions, as 
performed with RMR testing, it is common for one gas analysis system to be compared with 
another in a randomised crossover research design where the participants have their RMR 
measured using each of the apparatuses (Ashcraft & Frankenfield, 2014; Blond et al., 2011; 
Cooper et al., 2009; Haugen et al., 2007; Macfarlane & Wu, 2013).   
 
Although the Deltatrac (Sensormedics, Yorba Linda, CA) metabolic cart (Ashcraft & 
Frankenfield, 2014; Blond et al., 2011) is no longer commercially available, two studies were 
conducted comparing energy expenditure measured using this device with that of the Quark 
metabolic cart (Cosmed, Rome, Italy) and found that there was no difference between 
measures of V̇O2, V̇CO2 and RMR.  Kistorp et al (1999) compared the Medigraphics CCM 
System (Medical Graphics, Minneapolis, USA) to a respiration chamber and concluded that 
RMR measured under the ventilated hood was consistently lower by 13%. (Kistorp et al., 
1999). However, there was no clear reason stated that could help explain these differences.   
 
A number of other confounding variables have been identified among the available 
studies of commercial metabolic carts, making it difficult to make clear interpretations of the 
validity of specific systems.  Such limitations include low sample sizes (n=1, (Ashcraft & 
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Frankenfield, 2014)); the engagement of participants in passive activities (reading, watching 
movies (Blond et al., 2011)); measurements performed in a non-randomised order (Kistorp et 
al., 1999); and the lack of uniform standardisation of the pre-test period(Ashcraft & 
Frankenfield, 2014; Bassett et al., 2001; Blond et al., 2011; Cooper et al., 2009; Macfarlane & 
Wu, 2013). As such, future studies, comparing the different gas analysis systems against the 
criterion, are warranted.  
 
2.4.2 Subject preparation 
Across all related studies, there are large variations in the practices included in the pre-
test preparation of subjects that could affect the RMR assessment. Although some practices 
are generally controlled or standardised (e.g., subjects are rested and fasted according to a 
standard protocol believed to achieve a resting steady-state (Compher et al., 2006; 2005; 
Matarese, 1997), the protocols for achieving these conditions vary between studies (Compher 
et al., 2006).  A summary of the variations in protocols can be found in Table 2.1 and will be 
discussed further below.  These have been considered in a review written by Compher and 
colleagues (Compher et al., 2006) and recently updated by the Academy of Nutrition and 
Dietetics (Fullmer et al., 2015) to provide Guidelines for Best Practice in undertaking RMR 
measurements in healthy and non-critically ill individuals; special considerations for elite 
athletes or well-trained individuals have not received such attention.    
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Table 2.1. Standardisation of RMR protocols used in studies for measurement of RMR in an athletic, trained or exercising population. 
Study Population 
Standardisation of Participant Standardisation of measurement technique & technician 
  Time 
Rested – 
exercise 
Time 
fasted 
Body 
Composition -
Assessment 
Positioning Lab 
Temp 
Gas – 
analysis 
system 
Expirate 
collection 
device 
Rest 
upon 
arrival 
Data 
collection 
time 
Time of 
day 
Equation for 
conversion to 
EE 
Burleson 
et al 1998 
15 M 
resistance 
trained 
NS NS NS Supine NS Metabolic 
Cart 
NS 30 min 3 x 5 min NS NS 
Binzen et 
al 2001 
10 F – 
resistance 
trained.  
48h 4-5 Skinfolds – 7 
sites 
Reclining 25-
27°C 
Metabolic 
Cart 
FMK 20 min 20 min Througho
ut day 
Weir 
Bullough 
et al 1995 
8 M trained 
–type NS 
*First 
measure – 
NS 
12 h Hydrostatic 
weighing 
Supine 23°C Metabolic 
Cart 
V 15 min 30 min 6.30am Weir 
Carlsohn 
et al 2011 
8 M and 9 F 
– rowing 
and canoe 
internationa
l 
24 h* 
vigorous 
only, low 
intensity 
training 
allowed 
NS - 
O/N 
Skinfolds – 10 
sites 
Supine 22-
25°C 
Metabolic 
Cart 
FM 10 min 
– 
sitting 
30 min Morning Weir 
De 
Lorenzo et 
al 1999 
51 M – 
water polo, 
judokas, 
karatekas 
36 h no 
training 
10-12 h DXA Supine 23-
26°C 
Metabolic 
Cart 
V 30 30 min NS Weir 
De Souza  24 h 12 h DXA Supine 20-
24°C 
Metabolic 
Cart 
V 45 30 min 8.30-
11.00am 
Weir 
Doyle et 
al 2010 
15 F 
professional 
dancers  
24h 
Vigorous 
exercise 
10-12 h DXA NS NS Metabolic 
Cart 
V 10 min 45 min 6.30am NS 
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Study Population 
Standardisation of Participant Standardisation of measurement technique & technician 
  Time 
Rested – 
exercise 
Time 
fasted 
Body 
Composition -
Assessment 
Positioning Lab 
Temp 
Gas – 
analysis 
system 
Expirate 
collection 
device 
Rest 
upon 
arrival 
Data 
collection 
time 
Time of 
day 
Equation for 
conversion to 
EE 
Freedman-
Akabas et 
al. 1985 
N=12 
highly 
active 
24 h 4 h Weight only NS 25°C Metabolic 
Cart 
MP 30 min 12 min Mid-
morning/
mid-day 
NS 
Guebels et 
al 2014 
17 F  - 
endurance 
trained 
19 h 
(range 11-
24h) 
8 h DXA Supine NS Metabolic 
Cart 
V 20-30 
min 
8-10 min Morning Weir 
Herring et 
al. 1992 
9 F – highly 
trained 
runners 
15 h 10-12 h Hydrostatic 
weighing 
Own home – 
prior to 
getting up 
Variabl
e 
Kofranyi-
Michaelis 
gasometer – 
rubber 
bladder 
MP Done 
in 
subject
s own 
home 
15-20 min Morning NS 
LaForgia 
et al. 1999 
16 M: 
various –
trained 
36 h 12 h 2,3,4 
Compartment 
models 
Supine 24.0±0.
5°C 
DB MP 50 m 2 x 10 min  7.20am Elia & Livesey 
Lebensted
t et al. 
1999 
33 F – 
regional 
track and 
field 
24 h O/N BIA Supine NS Metabolic 
Cart 
V 20 min 20 min 7.30 am Weir 
Melin et 
al. 2014 
40 F – 
endurance – 
teams/ club 
level 
60 h* 
Hard 
prolonged 
O/N DXA 
 
NS NS Metabolic 
Cart 
V 15 min 35 min 7-8.30an Weir 
Myerson 
et al. 1991 
27 F 
Competitive 
runners 
O/N 12 h Hydrostatic 
weighing 
Seated 21-
24°C 
DB MP 30 min 2 x 6 min 8.00am Weir 
O’Donnell 
et al.  
14 F – 
recreational 
NS NS DXA Supine NS Metabolic 
Cart 
V 45 min 30 min 8.30-
11.00am 
Weir 
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Study Population 
Standardisation of Participant Standardisation of measurement technique & technician 
  Time 
Rested – 
exercise 
Time 
fasted 
Body 
Composition -
Assessment 
Positioning Lab 
Temp 
Gas – 
analysis 
system 
Expirate 
collection 
device 
Rest 
upon 
arrival 
Data 
collection 
time 
Time of 
day 
Equation for 
conversion to 
EE 
Paoli et al. 
2012  
18 M 
resistance 
trained 
O/N N/S SF – 9 sites, 
bone breadths 
4 sites, girths 2 
sites 
Seated 24°C computerise
d 
spirometer 
N/S 15 min 30 min 7-8.00am Weir 
Poehlman 
1988 – 
DIT 
9 M 
endurance 
runners 
24 h 12 h Hydrostatic 
weighing 
Supine 24°C  Metabolic 
cart 
V 30 min 30 min 0630 Weir 
Ribeyre et 
al. 2000 
15 M and 
11 F 
adolescents 
NS 10 h Skinfolds 4 
sites 
Supine N/S Respiratory 
Chamber^ 
NA N/A 1 h 7-8am Weir 
Schmidt et 
al. 1993 
25 M – 
collegiate 
wrestlers 
12 h 10 h Hydrostatic 
weighing 
Skinfolds – 6 
sites 
Supine 24-
25°C 
 Metabolic 
Cart 
V 15 min 30 min 6-9.00am Weir 
Schuenke 
et al. 2002 
7 M – 
resistance 
trained 
Baseline: 
4 d 
Baselin
e N/s 
others 4 
h 
N/S Supine N/S Metabolic 
Cart 
FMK 30 Min  30 Min Baseline 
– 7.00am 
N/S 
Short & 
Sedlock 
1997 
7 M and 5 
F, 
competitive 
running, 
cycling, 
swimming 
Replicate
d 
12 h H & W only Seated 22.4± 
0.9°C 
 Metabolic 
cart 
MP 15 min 15 min 6:30-7am N/S 
Ten Haaf 
& Weijs 
2014 
103 M & F 
recreational  
12 h (non 
vigorous) 
4 h BodPod Supine N/S Metabolic 
Cart 
V 30 min 30 min N/S Manufacturer 
Software 
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Study Population 
Standardisation of Participant Standardisation of measurement technique & technician 
  Time 
Rested – 
exercise 
Time 
fasted 
Body 
Composition -
Assessment 
Positioning Lab 
Temp 
Gas – 
analysis 
system 
Expirate 
collection 
device 
Rest 
upon 
arrival 
Data 
collection 
time 
Time of 
day 
Equation for 
conversion to 
EE 
Thomson 
& Manore 
1996 
24 M and 
13 W 
12 h 12 h Hydrostatic 
weighing 
NS NS  Metabolic 
cart 
V 30 min 30 min 6-8am Weir 
Thomson 
et al. 1993 
24 M 
runners, tri 
or bi 
athletes  
12 h 12 h Hydrostatic 
weighing 
NS NS Metabolic 
Cart 
V 30 min 30 min 5-8am Weir 
Thomson 
et al. 1995 
10 M 
endurance 
12 h 12  h Hydrostatic 
weighing 
N/S N/S  Metabolic 
cart^ 
V 30  k  30 min Morning Weir 
Tremblay 
et al. 
1987S 
8 M – 
endurance 
runners and 
x-country 
skiers 
15-18h 
>72 h 
12 h Hydrostatic 
Weighing 
Reclined N/S Metabolic 
Cart 
V 30 Min 15 min Morning Weir 
Vanheest 
et al. 2014 
10 F 
swimmers 
(15-17 y) 
NS NS – 
assume 
ON 
Skinfolds – 4 
sites *DXA 
considered 
impractical and 
not safe 
NS 22.2-
23.3°C 
Metabolic 
Cart 
V 45 min 30 min 
 (min 20 
min used 
for 
assessment
) 
NS Weir 
Westrate 
et al. 
1990* 
9 – M 
recreational  
10-12h +* 12-14h Hydrostatic 
weighing 
Supine 24°C Metabolic 
Cart 
V 30 min 1 h 8-9.00am Jéqueir 
V=ventilation hood, FMK=Face mask, ON=overnight, M=male, F=female; NS=not stated; DB=Douglas Bag; MP=mouthpiece and nose clip; BIA=Bioelectrical Impedance Analysis; MC=metabolic cart;  
DXA=dual energy x-ray absorptiometry;  
*Participants exercised on cycle ergo at either 25-35% or 60-7-% VO2max after dinner, were not allowed to eat anything until after RMR measure next day – allowed to watch a video during measure. 
^=BMR measurement.  
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Inpatient vs outpatient (RMR vs BMR) 
As previously mentioned, the defining difference between BMR and RMR is the 
circumstance under which the measurement of metabolic rate is made: in particular, whether 
the test is conducted at the bed in which the participant has slept overnight, or whether the 
participant has reported to the laboratory with minimal arousal possible after waking at home 
(2005).  It is of interest to understand the differences in magnitude and variability between 
measurements of BMR (hereafter referred to as “inpatient”) and RMR (hereafter referred to as 
“outpatient”), particularly in athletic populations when measured under the criterion Douglas 
Bag method.  In one study, Berke et al. (Berke et al.) reported that outpatient RMR 
measurements were 8% higher than BMR in elderly subjects, although there was no attempt 
to identify the factors that explained this difference (Berke et al., 1992).  
 
More recent studies have failed to determine any statistical difference between RMR 
measured simulating the outpatient/inpatient method (Bullough & Melby, 1993; Turley et al., 
1993). Bullough & Melby (1993) studied nine recreationally active males, which may offer 
greater application to a high performance athlete population compared with Berke et al. 
(1992), who conducted their study on elderly patients.  Bullough & Melby (1993) repeated the 
evening meal prior to the overnight fast that preceded testing both inpatient and outpatient 
settings, and compared this to an outpatient setting where participants were allowed to self-
select another meal.  Again there were no differences detected in RMR brought about by the 
different meal selection (Bullough & Melby, 1993). Interestingly, in this study participants 
were chauffeured from their home to the laboratory with a travel time of 5 min. Furthermore, 
participants were permitted to rise, void and had their height and body mass measured before 
returning to the bed they slept in for the inpatient RMR (Bullough & Melby, 1993).  It is 
unknown if the lack of difference would have remained if the participants had transported 
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themselves (Bullough & Melby, 1993) or if they had remained in their beds until after the 
measurement.    At sports institutes or clinics with dormitories nearby, the effect of a short 
walk on RMR is of interest.  Furthermore, exposure to varying outdoor ambient temperature 
due to the required transfer to the laboratory may also affect athletes who are measured using 
an outpatient protocol.  Indeed, Kashiwazaki et al. (1990) reported that RMR was 6-7% 
higher after a 10-min outdoor walk in winter compared to summer. This suggests that the time 
of year when measures are undertaken should be considered for longitudinal monitoring of 
RMR.  
 
Length of fast  
The typical increase in metabolic rate following food ingestion is termed the thermic 
effect of food (TEF) or the thermic effect of a meal (TEM) (hereafter referred to as TEM) 
(Institute of Medicine, 2005; Manore & Thompson, 2009).  In sedentary individuals this 
accounts for up to 10% of daily energy expenditure.  The time to peak of the TEM is reported 
to occur 1-3 hours following the consumption of a meal, with obese and older-adults peaking 
later than non-obese adults and younger people (Compher et al., 2006).  
 
Poehlman and colleagues (Poehlman et al., 1988) demonstrated the TEM in trained 
individuals was lower than untrained individuals, but the TEM was still elevated above 
resting levels at the end of the measurement phase (3 h post-prandial)(Poehlman et al., 1988).  
Thompson et al. (1993) reported similar findings with TEM peaking 1 h post-prandial in male 
endurance athletes. In contrast, Reed et al. (1996) reported that energy expenditure was still 
elevated 9% above resting levels 5 h after food was ingested (Reed & Hill, 1996).  Kinabo 
and Durnin (1990) reiterated these findings, reporting that metabolic rate had not returned to 
resting levels after 5 h of measurement.  The TEM typically lasts 4-8 h and is dependent on 
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the size of the meal. Therefore, it appears that RMR testing within 5 h of a meal, as suggested 
by Compher et al. (2006), will not accurately reflect resting metabolism.  D’alessio and 
colleagues (D'Alessio et al., 1988) reported that by 8 h the TEM has dissipated in lean and 
obese men, except when they ate at energy intakes as high as 133 kJ/kg FFM.  Twelve hours 
of fasting is typically used in studies involving RMR measurements. However, a 12 h fast 
may be impractical for high performance athletes, due to their high-energy intake 
requirements and frequent training demands.  
 
Prior exercise 
It is generally accepted that exercise temporarily increases RMR (Compher et al., 
2006) and is primarily due to the excessive post-exercise oxygen consumption (EPOC) and 
increased metabolic cost of repairing and resynthesising muscle (Manore & Thompson, 
2009). The effect of exercise on metabolic rate post-exercise has been extensively studied in 
both trained and untrained individuals (Herring et al., 1992; Hunter et al., 2006; Hunter et al., 
2003; Kelly et al., 2013; Knab et al., 2011; Lee et al., 2009; Melby et al., 1993; Osterberg & 
Melby, 2000; Paoli et al., 2012; Pratley et al., 1994; Schuenke et al., 2002; Tremblay et al., 
1988; Williamson & Kirwan, 1997).  However, there is currently no consensus on the amount 
of rest time following an exercise session that is sufficient before a valid RMR can be 
measured, as the majority of studies only measure EPOC for up to 3 h (Binzen et al., 2001; 
Freedman-Akabas et al., 1985; Short & Sedlock, 1997). A subset of studies has looked at the 
effect of exercise up to 72 h later (Bullough et al., 1995; Dolezal et al., 2000; Hunter et al., 
2006; Tremblay et al., 1988; Williamson & Kirwan, 1997), however, we question the 
practicality of this in elite athletes, as it is highly likely that a subsequent training session will 
fall within that period. It is estimated that the longest rest period for an elite athlete might be 
18-36 h (Burke, L; 2014-personal communication).   
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Studies investigating EPOC indicate that energy expenditure returns to baseline 40-60 
min following aerobic-based exercise involving 20-30 min at ~70% V̇O2peak, regardless of 
training status (Freedman-Akabas et al., 1985; Short & Sedlock, 1997). Meanwhile, another 
study which compared the effect of steady state, resistance and high intensity intermittent 
training sessions on measurements of RMR taken 12 and 21 h post exercise (Greer et al., 
2015) found that both resistance and high intensity sessions increased RMR above baseline at 
each time point (Greer et al., 2015).  Indeed, a number of studies have shown a sustained (14-
38 h) and elevated (16-22% over 24 h) EPOC following an acute bout of high-intensity 
resistance exercise in trained men (Gillette et al., 1994; Paoli et al., 2012; Schuenke et al., 
2002).  Investigations by Gillette et al (Gillette et al., 1994), Paoli et al (2012) and Schuenke 
et al (2002), who used resistance training protocols of varying reps , sets, percent of maximal 
effort and number of exercises, determined that  RMR was higher for 14-, 22- and 38 h, 
respectively, post exercise compared to a non-exercise baseline RMR. Conversely, Abboud et 
al. (2013), reported no increase in RMR above baseline for up to 48 h following resistance 
exercise in eight trained men, however, only a 4 h fasting period was used prior to RMR.  
While these studies have looked at RMR in response to an exercise protocol, only two studies 
have investigated the effect of the cessation of exercise in chronically trained individuals 
(Herring et al., 1992; Tremblay et al., 1988).   RMR was lower by 6-8% in both male and 
female athletes following three days without exercise (Herring et al., 1992; Tremblay et al., 
1988), compared to the morning after a 90 min aerobic exercise bout. No study has 
systematically investigated the combination of the type of exercise and the period of recovery 
from exercise on RMR in highly trained individuals.  
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It is difficult to find common ground in the methodologies of studies of the effect of 
prior exercise on RMR.  There are differences in study populations (athletes vs non-athletes), 
the techniques of undertaking RMR measurements (e.g. equipment and protocols), and the 
conditions of pre-measurement standardisation. Furthermore, even among the studies of 
athletes, there are different criteria for defining the participants as ‘well-trained’: whereas one 
study required a training history of six months (Schuenke et al., 2002), in another, the 
minimum commitment was at least two years (Dolezal et al., 2000). These factors make it 
difficult to apply the results of the current literature to a high performance environment where 
athletes train 6-8 h per day for 5-6 days per week, year-round.  Further work is needed to 
identify standards for the rest period between the last exercise session and an RMR test which 
will allow a meaningful measurement to be collected. 
 
2.4.3 Measurement of Body composition 
Although measurements of RMR and REE are typically assessed in absolute terms 
(kJ/min or kJ/d respectively), REE is often expressed relative to FFM (kJ/kg FFM/d). Fat Free 
Mass (FFM) can be determined by a range of protocols including anthropometry (skin folds), 
hydrostatic (underwater) weighing, air displacement plethysmography (BodPod), body mass 
index (BMI), bioelectrical-impedance and dual energy x-ray absorptiometry (DXA) (Kelly et 
al., 2013; Knab et al., 2011; Lee et al., 2009; Melby et al., 1993; Osterberg & Melby, 2000; 
Paoli et al., 2012).  In the athletic population, the validity of some of these measures has come 
under scrutiny, with doubly indirect methods such as skinfolds and bioelectrical impedance 
being deemed unsuitable for the assessment of FFM (Ackland et al., 2012).  Whole body 
DXA measurements have been validated as a measure of body composition in athletes when 
undertaken according to a standardised protocol (Nana et al., 2012b; Nana et al., 2016; Nana 
et al., 2015). Lean mass and bone mineral content are the components that comprise FFM 
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when assessed by DXA. Obviously, there is a risk of inaccurate measurement and 
misinterpretation of relative RMR if there are errors in the assessment of the components of 
FFM due to either a lower precision technique or measurement error (Korth et al., 2007).   
The timing of the assessment of body composition used in the calculation of relative 
RMR is important; indeed, the measurement of FFM should be undertaken as close as is 
practical to the assessment of RMR, especially in well-trained and/or adolescent athletes who 
can experience changes in lean mass over short periods of (Garthe et al., 2011; Kerr & 
Ackland, 2010).  Changes in measurements of lean mass can occur due to real changes in 
muscle mass (which would be expected to change RMR), but can also reflect acute 
fluctuations in intra-muscular substrate and associated fluid storage which can add variability 
to assessments of FFM (without affecting RMR) (Nygren et al., 2001). For example, an 
investigation using Magnetic Resonance Imaging (MRI) showed increases in muscle cross-
sectional muscle area following dietary-based carbohydrate loading (Nygren et al., 2001). 
Furthermore, carbohydrate loading was reported to increase DXA estimates of lean mass in 
healthy untrained men (Rouillier et al., 2015; Toomey et al., 2017). There is also another 
report of lean mass change induced by a 10-day creatine monohydrate loading protocol, when 
measured by DXA in 12 untrained men (Safdar et al., 2008).  Since changes in muscle 
glycogen would be a common occurrence in this population as part of their daily training and 
competition regime, it is of interest to see how much error they add to assessments of FFM 
and how this may alter an assessment and interpretation of RMR relative to FFM. 
 
Assessment of muscle glycogen 
Current techniques to assess intramuscular substrates involve either the invasive 
muscle biopsy technique (Harris et al., 1974) or use of expensive and non-portable equipment 
(MRI) (Nygren et al., 2001) both of which require trained personal to conduct.   Recently, a 
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non-invasive protocol to measure muscle glycogen via ultrasound technology has been 
developed (MuscleSound®) (Hill & Millan, 2014; Nieman et al., 2015), based on the 
hypothesis that measurement of the echo-intensity of the ultrasound image reflects the fluid 
bound with the storage of glycogen (Hill & Millan, 2014; Utter et al., 2010). Specifically, 
muscle glycogen is indirectly assessed and assigned an arbitrary score, via the use of a 
proprietary algorithm which assumes that the presence of muscle water makes the fluid darker 
or hypoechoic, representing “high glycogen” (Hill & Millan, 2014; Nieman et al., 2015), 
while the breakdown of glycogen and subsequent release of fluid results in a brighter or 
hyperechoic image (Nieman et al., 2015). Two validation studies, investigating muscle 
glycogen concentrations pre- and post-exercise, reported high correlations between the 
ultrasound-derived score and estimates derived from the gold standard muscle biopsy 
technique from rectus  (Hill & Millan, 2014)  and vastus lateralis (Nieman et al., 2015) 
respectively.  However, no analysis on the limits of agreement or Bland-Altman plots were 
reported and the statistical analysis used of student t-tests and Pearson’s correlation 
coefficients are deemed to be inappropriate for assessing validation (Watson & Petrie, 2010). 
Furthermore, the authors did not address potential confounders which may also cause changes 
in intramuscular fluid such as muscle damage, or changes in cellular metabolites such as 
creatine or carnitine.  Whether the ultrasound technology can detect changes in glycogen 
associated with carbohydrate loading has also yet to be explored.     
 
Using the same concept, the measurement of total body water may also be able to assess 
whether or not a change in muscle glycogen has occurred.  Bioelectrical impendence 
spectroscopy (BIS) has been validated for measuring total body water and distinguishing 
between the intracellular and extracellular fluid compartments against the criterion dilution 
method (Matias et al., 2016; Moon et al., 2010).  Bioelectrical impedance, has been used 
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assess changes in total body water following creatine supplementation (Brilla et al., 2003).  
However, its use for confirming a change in muscle glycogen, due to exercise depletion or 
dietary loading, has been achieved has yet to be explored.  
 
2.4.4 Biological variation 
Biological variation refers to errors or variability introduced due to innate 
characteristics of the participant and includes factors such as chronic exercise and training 
history, menstrual cycle and body composition (Compher et al., 2006).  
 
Body Composition 
The majority (70-80%) of the inter-individual variation in RMR measurements can be 
explained by FFM (Cunningham, 1991; Gibney et al., 2002; Sparti et al., 1997).   An 
individual’s FFM is sum of the mass of organs, skeletal muscle, bone and fluid in the body; 
since these tissues have greater metabolic activity than FM, individuals with a higher skeletal 
muscle mass and FFM have a higher absolute RMR (Gibney et al., 2002; Ravussin et al., 
1982).  This has been reported in studies comparing males and females (Arciero et al., 1993; 
Buchholz et al., 2007) and young adults compared to elderly individuals (Bosy-Westphal et 
al., 2003; Poehlman et al., 1993).  For this reason RMR is often expressed relative to FFM 
(kJ/kg FFM/d), when interpreting results, especially when evaluating the impact of an 
intervention on RMR. 
 
Chronic training status 
It is commonly believed that athletes have a higher RMR than their sedentary 
counterparts.  The difference in RMR is attributed to the higher skeletal muscle mass relative 
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to body mass (Poehlman et al., 1988; Sjodin et al., 1996; Tremblay et al., 1986).  However 
Sjodin et al., (1996) reports that RMR remained significantly higher by 16% in trained 
individuals compared to untrained after adjusting for FFM.  Conversely, Broeder et al., (1992) 
report no difference in RMR when participants are matched for FFM.  The concept of energy 
flux, describing the combination of a high (or low) energy intake and exercise energy 
expenditure (EEE), has been used to explain the differences between the studies (Bullough et 
al., 1995).  In one study RMR was only higher in trained individuals after two to three days of 
a high energy intake and EEE.  There was no difference between trained and sedentary groups 
following a period of low EEE and low energy intake.  
 
Menstrual status 
There is conflicting evidence regarding the change in RMR during the different phases 
of the menstrual cycle (Bisdee et al., 1989; Henry et al., 2003; Piers et al., 1995; Solomon et 
al., 1982). Bisdee et al., (1989) reports that mean BMR was higher by 619 kJ/d during the late 
luteal phase compared with the late follicular phase, with six of the eight women in their study 
cohort showing differences between phases (Bisdee et al., 1989).  SMR was also significantly 
higher during the late luteal phase compared with the late follicular phase however, these 
differences appear to be minimal as they were not reflected in the total daily energy 
expenditure while in a respiratory chamber (Bisdee et al., 1989). These findings support those 
of Solomon and colleagues (Solomon et al., 1982) who also reported an increased RMR in the 
late luteal phase.  On the other hand, Piers et al. (1995) reported no change in RMR between 
the follicular and luteal phases in 13 women.  The individual data from this study were not 
reported and may be important to consider.  For example, Henry et al. (2003) noted the 
individuality of change in RMR over the menstrual cycle; of the 19 participants in this study, 
10 showed no variation while others exhibited a large variation over the cycle.   
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Altitude training  
Altitude training may influence metabolic rate, through a variety of reasons. RMR 
may decrease due to decreased appetite and decreased nutrient absorption resulting in a 
decreased energy intake and loss of FFM (Westerterp, 2001).  Alternatively, greater muscle 
catabolism at altitude could lead to an increase in RMR though increased muscle building and 
repair (Westerterp, 2001).  It is unknown if undertaking the collection of respiratory gases at 
different altitudes influences the results of RMR measurements; in such a case, a technical 
error would also be introduced. 
 
2.5 Energy availability and RMR in athletes 
Within the field of sports nutrition, there is a renewed interest in RMR as a marker of 
the “healthiness” versus “impairment” of an athlete’s metabolic function.  This interest has 
grown out of the need to explain, prevent and treat the apparently high incidence of 
amenorrhea in female athletes; a problem that was first recognised in the 1990s (Loucks, 
2003). The concept of energy availability (EA) was first hypothesised by Anne Loucks 
(Loucks et al., 1998) in an attempt to unify the theories that this phenomenon was caused by 
low levels of body fat or high training volumes.  Rather than focusing on energy balance (the 
difference between energy intake and energy expenditure), EA considers the role of energy 
intake in meeting the needs of the various physiological processes it must support within a 
biological system.  
 
The construct of EA was developed from the field of bioenergetics, where it is 
proposed that dietary energy used in one of the processes of thermoregulation, cell 
35 
 
 
maintenance, locomotion (exercise), growth, immunity and reproduction cannot be used for 
the others (Loucks et al., 2011). From an exercise physiology perspective, EA is defined as 
the energy available to support other physiological processes once the energy expenditure 
associated with exercise (EEE) has been deducted from energy intake (EI) (Loucks et al., 
2011).  Since fat mass has a much lower metabolic activity, Energy availability (EA) is 
expressed relative to Fat Free Mass (FFM).  Therefore: 
EA = (EI – EEE)/FFM 
An EA of 45 kcal/kg FFM/d (188 kJ/kg FFM/d) is considered to provide sufficient 
energy to maintain energy balance and physiological processes in healthy athletes (Loucks, 
2003).  However when energy balance is disturbed in scenarios in which dietary energy is less 
than total energy expenditure (TEE), the body can respond either by contributing its energy 
reserves (e.g. adipose tissue, body proteins) to meet the energy deficit and/or by reducing the 
energy expenditure involved with other body functions.  EA is not synonymous with energy 
balance, since a situation in which energy availability is reduced in the face of a chronic 
energy deficit (EI < TEE) leading to adaptations to reduce energy expenditure may return the 
body to a new situation of energy balance (EI = TEE). Although such energy conservation is 
an evolutionary adaptation favourable for survival, it comes at the cost of physiological 
processes such as growth, cellular maintenance, reproduction and thermoregulation (Loucks 
et al., 2011).  
 
Loucks proposed that in situations in which a female athlete either reduced energy 
intake and/or increased EEE to the extent that other physiological systems (e.g. the 
reproductive system) sensed low energy availability (LEA), there would be a reduction in 
expenditure and function by that system.  She and her colleagues then undertook a systematic 
series of studies, manipulating energy availability in stepwise changes via changes in dietary 
36 
 
 
intake and/or exercise energy expenditure, to determine the level of EA at which reproductive 
function was impaired (Loucks, 2006; Loucks & Thuma, 2003; Loucks & Verdun, 1998; 
Loucks et al., 1998). These studies identified an EA threshold of 30 kcal/kg FFM/d (126 kJ/ 
kg FFM/d) below which reproductive function in females is impaired, with the effect being 
independent of whether the reduction in EA was achieved by dietary restriction or a large 
volume of exercise (Loucks & Thuma, 2003).  It was later realised that this threshold of 30 
kcal/kg FFM/d corresponded to RMR in an athlete of mean body size (Loucks et al., 2011).   
 
This work coincided and contributed with the evolution of the understanding of the 
Female Athlete Triad (FAT), with changes to this concept including an expansion of the 
“dietary corner” of the Triad beyond its previous assumption of eating disorders to encompass 
any situation of reduced EA (Otis et al., 1997). Indeed, it was recognised that a number of 
scenarios in athletic populations can lead to inadequate energy intake (EI) and/or  high 
exercise energy expenditure and thus contribute to LEA (Loucks et al., 2011).  Disordered 
eating is often the underlying cause of low EI, especially given its prevalence in sports where 
a low body mass or body fat level is considered important (e.g. endurance sports, gymnastics). 
However, LEA can also occur due to mismanagement or excessive manipulation of diet 
and/or training when an athlete is trying to reduce body fat, or to the failure to sufficiently 
increase energy intake during a period of intensified training or competition (Burke, 2015; 
Mountjoy et al., 2014).  Indeed, these behaviours may be well-intentioned or unintentional 
rather than innately pathological, with the athlete being unaware of the negative health and 
performance consequences of allowing a mismatch between energy intake and exercise 
energy expenditure to occur.   At times, energy deficit and its accompanied reduction in EA is 
required/necessary for an athlete to optimise body composition. However, it is important that 
the athlete is monitored and provided with appropriate nutritional strategies to spare lean 
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muscle tissue and to create an energy deficit that maintains energy availability at a sufficient 
level to avoid overly negative effects on performance and physiological processes; typically 
an EA within the range of 30-45 kcal/kg FFM can be tolerated for modest periods (Loucks et 
al., 2011).    
 
Over the past decade, there has been a concentrated effort to measure the prevalence, 
causes and effects of LEA in athletic populations.  The practical direction of this work may 
have commenced with the assumption that tools could be found to measure EA accurately and 
that a universal threshold of EA exists above which athletes can maintain good health and 
performance (i.e. >30 kcal/kg FFM/d).  However, further studies have revealed some 
problems with these assumptions as well as other extensions of our knowledge regarding 
impaired basal metabolism in athletes.  These will now be briefly reviewed.  
 
2.5.1 Impairment of many body systems with low EA 
The primary work in the area of what has become known as the FAT focussed on the 
inter-related impairments of menstrual function and bone health in female athletes (Anderson 
et al., 2000; Manore et al., 2007; Nattiv et al., 2007). There is now strong evidence that LEA 
causes menstrual and reproductive dysfunction underpinned by disruption of the pituitary 
secretion of luteinizing hormone secondary to disruption of the pulsatile secretion of 
gonadotropin-releasing hormone (Loucks et al., 1994; Loucks & Thuma, 2003; Loucks et al., 
1998).  Although impairments of bone mineral density and architecture with FAT were first 
attributed to reduced oestrogen concentrations associated with menstrual dysfunction, later 
studies identified that LEA is an independent and additive factor in the deterioration of bone 
health.  Indeed, LEA has been shown to reduce bone formation via reduction in procollagen 
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type I C-terminal propeptide (PICP) and osteocalcin, as well as an increase in bone resorption 
(Ihle & Loucks, 2004).  
 
The recognition of the expanding range of metabolic systems that are impaired by low 
EA has led to a proposal to expand FAT into a wider syndrome termed RED-S (Relative 
Energy Deficiency in Sport) (Mountjoy et al., 2014).  Figure 2.1 and 2.2 taken from a review 
paper underpinning this proposal summarises that low EA can impair health and performance 
of athletes in a variety of ways. 
 
Figure 2.1. Health consequences of Relative Energy Deficiency in Sport (RED-S) 
(Mountjoy et al., 2014). 
 
Evidence for the range of additional indices of impaired health and optimal function 
now associated with low energy availability (Figure 2.1) includes the following observations:  
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 Hyperlipidaemia and endothelial dysfunction have both been reported in athletic 
females with amenorrhea (Rickenlund et al., 2005) increasing their risk of a 
cardiovascular event.   
 Metabolic deficiency indicated by low 3.5.3’-triiodothyronine (T3) suppressed RMR 
in females with an EA of <30kcal/kg FFM/d (Loucks & Heath, 1994; Melin et al., 
2015). 
 Attenuation of muscle protein synthesis at rest following 5 days at an EA of 30kcal/kg 
FFM/d compared with 45kcal/kg/FFM (Areta et al., 2014).   
 Type 1 immunity decreases in an energy deficiency state, making athletes more 
susceptible to viral infections (Hagmar et al., 2008). 
 
 
Figure 2.2. Potential performance effects of RED-S (Mountjoy et al., 2014). 
 
The potential for a direct impact of LEA on sports performance is of particular 
importance to athletes, and includes a range of issues identified in Figure 2.2. Evidence that 
LEA has a measureable effect on training adaptations and competition performance is 
emerging.  Indeed, Vanheest and colleagues (Vanheest et al., 2014)  recently reported that a 
sub-group of adolescent female swimmers with LEA, estimated from food and training diaries 
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and confirmed by direct measurement of ovarian hormones and RMR, showed no 
improvement in swimming performance following a 12 week training block while a cohort 
with adequate EA achieved a 8% improvement in 400 m swimming time over the same 
training program.  Of further interest to many athletes, this study observed that the swimmers 
with LEA had higher body fat levels, which remained static over the training, in comparison 
to the swimmers with healthier RMR and EA.  A range of mechanisms identified in Figure 
2.1 and 2.2 may contribute to the reduced ability to adapt to a training response.  
 
2.5.2 Extension to male athletes 
The negative physiological effects of relative energy deficiency are not confined 
solely to female athletes (Areta et al., 2014; Dolan et al., 2012; Hackney, 2008; Vogt et al., 
2005), since factors such as the pressure to be lean and light or the engagement in training and 
competition activities involving high energy expenditure also occur in male athletes and may 
lead to situations of LEA (Tenforde et al., 2015). Indeed, observational data in male cyclists 
have reported EA of as low as 8kcal/kg FFM per day (Vogt et al., 2005).  Although there have 
been fewer studies of the effect of LEA in male subjects, it is known that important growth 
hormones associated with bone formation such as testosterone and insulin growth factor-1 
(IGF-1) are down regulated in males with low energy intake (Dolan et al., 2012).  A reduction 
in resting levels of muscle protein synthesis and its response to protein intake was reported in 
male athletes when following a diet providing EA of 30kcal/kg FFM/d compared with 
45kcal/kg FFM/d. Meanwhile, Koehler et al. (Koehler et al., 2016), reported reductions in 
serum leptin and insulin when LEA of 15 kcal/kg FFM/d was induced with or without 
exercise in six healthy men. However, no changes in testosterone, IFG-1 and T3 were 
observed.   Although there has been some debate that the effects of LEA in male athletes may 
have a different outcome in the nature and severity of symptoms, there is clearly a case for 
41 
 
 
further research in male athletes (Koehler et al., 2016; Mountjoy et al., 2015; Tenforde et al., 
2015).  
 
2.5.3 Challenges to the use of EA as a diagnostic or assessment tool  
Although EA and the role of LEA in impaired health and performance of athletes are 
robust concepts, there are several issues that prevent the assessment of EA from being used as 
a diagnostic tool. 
 
Difficulties in accurate and reliable calculation of EA 
The calculation of EA requires accurate measurements of EI, EEE and FFM.  This is 
straightforward in short-term studies where a desired EA is devised as an intervention: in 
these situations there is the equipment and capability to measure each component of the EA 
equation and an opportunity to control the events that contribute to EI and EEE for a brief 
period (Burke, 2015).  However, the assessment of EA in free-living individuals is more 
problematic from several viewpoints.  First, there is no standard protocol for the time period 
over which it should be measured, as a reflection of the individual’s current EA status (Burke, 
2015).  Second, it involves the assessment of two metrics that are problematic (EI and EEE) 
and one that may require access to specialised equipment such as DXA technology to measure 
accurately (FFM).  Finally, the assessment of each of the components is time consuming. 
 
The collection of information on dietary intake via self-reported methods is challenged 
by issues of reliability and accuracy, with a particular bias to under-reporting in individuals 
who possess the characteristics that are likely to be associated with LEA (Loucks et al., 2011).  
There are also several challenges to the accuracy and reliability of measurements of EEE, 
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particularly during activities that involve high-intensity exercise, intermittent exercise or 
activities involving skills (King et al., 2004; Loucks et al., 2011); these are likely to contribute 
to the sporting activities of many athletes.   Furthermore, the definition of exercise in free-
living athletes is unclear: for example: should recreational or incidental activity (e.g. walking 
or cycling for transport) be included as well as the athlete’s primary training or competition 
activities (Burke, 2015).  It is important for a standardised protocol to be developed for the 
assessment of each parameter otherwise it will lead to different calculations and 
interpretations of EA (Burke, 2015). 
 
Lack of universal threshold of LEA at 30 kcal/kg FFM 
The pioneering work undertaken by Loucks and colleagues studies suggested a dose-
response between EA and impairment of menstrual reproductive function, in which function 
was maintained until a threshold at 30 kcal/kg FFM/d beyond which there was a rapid decline 
(Loucks et al., 1994; Loucks et al., 1998). However, further investigations involving step-wise 
changes in EA have identified differences in the response of other systems to LEA in terms of 
the absence of a threshold and different rates of decline in relation to the reduction in EA 
(Hilton & Loucks, 2000; Ihle & Loucks, 2004).  This issue has been elegantly summarised by 
Loucks in Figure 2.3 which plots the impairment of a number of important metabolic 
hormones in response to difference degrees of reduced energy availability.  While it is of 
interest to gain such understandings with other parameters of body function, the current 
message from this work is that it is impossible to set universally “safe” levels of reduced EA 
or to expect uniformity around the reduction in health and performance that might accompany 
a specific level of LEA.  Rather than assuming or predicting a reduction in function associated 
with a certain reduction in EA, it remains more prudent to collect direct measurements of the 
altered function.   
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Figure 2.3. Dose-response effects of energy availability on LH pulse frequency 
(f_LH), plasma glucose (Glu), markers of bone protein synthesis (PICP) and 
mineralisation (OC), and anabolic hormones that regulate bone formation (insulin, leptin, 
tri-iodothyronine [T3], and insulin-like growth factor-1 [IGF-1]). Created by Loucks – 
Clinical Sports Nutrition- (2015) from data in (Ihle & Loucks, 2004; Loucks & Thuma, 
2003). 
 
Lack of scaling of low EA to RMR 
A further impediment to the use of EA as an indicator of the risk of impaired function 
is the lack of linear scaling of EA and RMR.  Although the cut-off for impaired reproductive 
function at an EA of ~ 30kcal/kg FFM/d was found to be equivalent to RMR in an athlete of 
average body mass, this relationship does not exist across the spectrum of BM which athletes 
may span.  As body size changes, there is also a change in the relative proportion of vital 
organs with high metabolic rate (e.g. liver and brain) to total FFM.  As shown by Loucks 
(Figure 2.4), the relationship between measured sleeping energy expenditure and FFM 
observed by Westerterp (2003) fails to track EA, with the line of identify for an EA of ~ 30 
kcal/kg FFM/d resulting in an underestimation of SMR in smaller individuals and an 
overestimation in athletes with greater FFM (Loucks et al., 2011; Westerterp, 2003).   
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Figure 2.4. by Loucks et al (Loucks et al., 2011). Sleeping metabolic rate plotted as a 
function of fat-free mass (FFM). • = females; (○ = males. The solid regression line has a 
significant non-zero intercept. The dashed line is 30 kcal.kg FFM−1.day−1. Figure modified 
from Westerterp (2003).  
 
2.5.4 Direct measurement of supressed RMR to confirm or diagnose LEA 
Several studies of the FAT have reported the lack of association between 
measurements of LEA, impaired menstrual function and poor bone health (Koehler et al., 
2013a; Reed et al., 2013) confirming that the correlation or inter-relatedness is more 
complicated than originally thought and/or that there is a lack of precision in the 
measurements of these indices.  Therefore, it is of interest to find additional ways to measure 
or confirm the presence of problematic levels of EA in athletes which are practical to achieve 
and reliable in outcome and interpretation.  The direct measurement of RMR as evidence of 
energy conservation that is likely to signal a reduction in metabolic function is one such 
strategy.    
 
In support of the value of an impaired RMR as a signal of reduced activity in 
important body systems, there is evidence that measured reductions in RMR are associated 
with impaired health and function in athletes (Melin et al., 2015; Vanheest et al., 2014).  A 
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cross-sectional study in well-trained female runners found that those with menstrual 
deficiency and LEA also had a 7% lower RMR compared with runners who were 
eumenorrheic and had optimal EA (Melin et al., 2015).  Total cholesterol was also higher and 
concentrations of fasting glucose and luteal hormones lower in the group with the lower 
RMR.  Vanheest (Vanheest et al., 2014) and colleagues also found that the adolescent 
swimmers with low EA and ovarian suppression also had a supressed RMR.  
 
In order for RMR to be used as a diagnostic tool for LEA in athletes, it must be able to 
be measured with sufficient accuracy and reliability such that changes in RMR that are be 
linked with functional outcomes can be detected. This literature review has identified a 
variety of sources of variability in the measurement of RMR, including factors that are either 
likely to be controllable and/or to contribute to substantial error.  Furthermore, there is a 
paucity of work on LEA on male athletes.  The goal of this body of work is to better identify 
and quantify the influence of these factors, towards the development of a reliable standardised 
protocol for assessment of RMR in both female and male athletes that optimises the 
practicality of measurement and the utility of the results.  This will provide a useful diagnostic 
tool for those working to optimise the health and performance of athletes as well as aid future 
research into the role of energy availability in achieving such goals. 
 
2.6 Determining reliability and validity 
In order to have confidence that measurements of RMR are reflective of a true 
metabolic rate it is important to have an understanding of measurement error and reliability; 
particularly as this can affect the ability to make a valid judgement about a single 
measurement, or detect the difference or change between two measurements, in the same or 
different individual, respectively.  Measurement error causes the observed or tested value to 
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deviate from the true value (Hopkins, 2000).  If the deviation from the true value is large then 
the test is said to have poor validity or low precision (Hopkins, 2000). While, large variations 
in the score when the same test is repeated indicate poor reliability.  There are multiple 
sources of error categorised into technical or instrumental, biological variability, tester error 
and participant error.  
Reliability has important implications when monitoring a change in a variable over 
time.  It enables researchers, practitioners and coaches to determine if a change from the 
previous test is a “real” change rather than the error inherent in the test or measurement.  If a 
test or protocol has poor reliability, a larger magnitude of change is required to be confident 
of detecting a “true” change.  In turn, tighter reliability is able to identify changes of smaller 
magnitude (Hopkins, 2000). The reliability compares the variability within the same 
participants to the variability between participants from repeated measurements of the same 
test (Hopkins, 2000; Peat & Barton, 2014).  It is possible to decrease the error of 
measurement and increase the reliability by standardising certain aspects of the testing 
procedure to increase repeatability between tests.  
 
Reliability is grouped into different categories: intra-tester (within one’s self); inter-
tester (consistency between different testers); or test-retest reliability (of the measurement 
itself regardless of tester) (Peat & Barton, 2014).  In sport science the focus is often on test-
retest reliability, which can be determined using several different statistical methods 
(Atkinson & Nevill, 1998; Hopkins, 2000; Weir, 2005).  It is outside the scope of this thesis 
to provide an in depth review of each method, rather an overview of four common methods 
will be provided; the intra-class correlation coefficient (ICC), the typical error (also known as 
the standard error of measurement), the Bland-Altman assessment and the change in the mean 
(Atkinson & Nevill, 1998; Hopkins, 2000; Weir, 2005).   
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2.6.1 Intra-class correlation coefficient  
The ICC is a ratio calculated from the between participant variance to the between and 
within participant variance.  Its values range from 0 to 1, and is presented with a 95% 
confidence interval. A value of one (e.g. ICC = 1.0) indicates no within-participant variance, 
meaning any difference in scores is due to a true change and not measurement error. An ICC 
of >0.90 indicates good reliability (Hopkins, 2000).  The ICC is a relative measure of 
reliability dependent on the amount of difference between repeated measures and also the 
reliability of the sample. Therefore, a 1-way or 2-way analysis of variance (ANOVA) model 
is used with either fixed or random effects (Weir, 2005). The chosen ANOVA model will 
indicate if the results from that specific study are generalisable to other populations. 
Therefore, it should always be stipulated in the written description of the statistical 
methodology of an article.   
 
2.6.2 Typical error 
The typical error (TE) is a measure of within-subject variation, and is also known as 
the standard error of measurement.  The TE is expressed in the units of the measurement and 
is thus an indicator of absolute reliability (Atkinson & Nevill, 1998). The use of the within-
subject standard deviation as the TE removes susceptibility to sample size but permits 
susceptibility to sample heteroscedasticity (Atkinson & Nevill, 1998); a phenomenon 
commonly seen in sports science where the TE of a measurement increases as the mean value 
increases (Hopkins, 2000).  However, expressing the TE as a percentage or the coefficient of 
variation (CV) nullifies this phenomenon (Hopkins, 2000).  The TE and CV can then be used 
to determine effect sizes for the Magnitude Based Inference statistical approach and also 
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calculation of  the smallest worthwhile effect which can be used to monitor an individual or 
estimate individual differences (Hopkins, 2000).  
 
2.6.3 Bland-Altman and Limits of Agreement 
The Bland-Altman method calculates that there is 95% probability that the difference 
between two tests in an individual lie within specific values or limits of agreement (LOA) 
(Atkinson & Nevill, 1998).  This is visualised by plotting the individual participant test mean 
against the corresponding difference between two tests (Atkinson & Nevill, 1998).  The limits 
of agreement are the standard deviation of the differences between the test multiplied by 1.96, 
which provides the 95% probability range (Atkinson & Nevill, 1998; Hopkins, 2000). Bland-
Altman deals with heteroscedasticity by using a natural log transformation prior to calculating 
the limits of agreement. The significance of the LOA can be dependent on the sample size and 
there is disagreement whether 95% limits are applicable to all measures (Hopkins, 2000).   
 
2.6.4 Change in the mean 
The change in the mean value between two or more tests is the simplest measure of 
reliability, however, it should not be used as the sole measure of reliability (Atkinson & 
Nevill, 1998; Hopkins, 2000).  A change in the mean is more commonly used to determine if 
any systematic bias has occurred (Atkinson & Nevill, 1998).  For example, a learning effect 
may be indicated by the second test value being significantly lower or higher than the first 
(Atkinson & Nevill, 1998; Hopkins, 2000).  In the case of RMR, a participant may 
hyperventilate on a first test because they are not familiar with the breathing apparatus.  This 
would cause them to “blow off” CO2 which decreases V̇CO2 and increases V̇O2 thus inflating 
RER above the RQ at the cell. This results in an inflated energy value per litre of oxygen 
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(McClave & Snider, 1992). Bias can be assessed by conducting a paired t-test or ANOVA to 
test the null hypothesis that there is no change in the mean between tests. (Atkinson & Nevill, 
1998).  
 
2.7 Conclusions 
The measurement of RMR has the potential to become a widespread diagnostic tool in 
research and servicing activities of sports nutrition and sports science. Currently there is no 
consensus on a variety of features that should be included in a standardised protocol for 
measuring RMR in athletes via indirect calorimetry: these include the duration of the period 
since the last exercise session and the value of inpatient vs outpatient measurement scenarios. 
Since, the measurement of FFM is included in the assessment of RMR, it is also important to 
continue previous activities of our research group to improve the precision of measurement 
via DXA techniques by understanding the effects of changes in glycogen concentrations in the 
muscle and the liver.  Further evidence is also required to assess the reliability and validity of 
novel software to non-invasively measure muscle glycogen at the time of body composition 
assessment.  The studies presented in this thesis will directly address these gaps in the 
literature. 
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3.0 Methodology and Design 
The following chapter expands on the methodology and study design presented in the 
forthcoming study chapters. It provides further detail beyond what has been provided in the 
manuscripts for publication.   
3.1 Resting energy expenditure  
All RMR measures were conducted in the morning between 05:00 and 08:00 h, 
following an 8 h overnight fast and overnight rest from exercise.  Participant standardisation 
prior to RMR has been detailed in the methods section of chapters four, five and eight 
respectively.  
Resting metabolic rate was measured using open circuit indirect calorimetry.  
Participants wore a two-way valve mouthpiece (series 2700, Hans Rudolph Inc, Shawnee, KS, 
USA) and nose clip during expirate collection.  Expired air was collected into 120 L foil 
Douglas Bag (Scholle, Edinburgh North, SA, AUS) for 10 min in duplicate.  
For Studies 1 and 5 the mouthpiece was connected directly to one Douglas Bag 
modified with a tap and sampling line (Figure 3.1). 
 
Figure 3.1. Douglas Bag. 
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For study 2, the mouthpiece was connected by a plastic hose to an in-house designed 
four-way tap apparatus known as “The Bob” (Figure 3.2).   
 
Figure 3.2. Four way tap “The Bob” front (A) and side (B) on views.  
 
The hose was connected to the back valve of The Bob while two Douglas Bags were 
connected to valve 1 and 2 respectively (Figure 3.3).  Three towels were used to support the 
hose or mouthpiece plus the Douglas Bag.  
 
Figure 3.3. Douglas Bag with Bob. Front (A) and side (B) views with the hose attached. 
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Following collection, the gas fraction of the expirate was analysed first followed by 
the bag volume. The Douglas Bag was connected to Ametek O2 and CO2 analysers (Ametek 
Inc, PA, USA) via a silicone hose which was connected to calcium chloride crystals (Unilab, 
Ajax Fredman, NSW, Australia) to dry the expirate.  Oxygen and CO2 was recorded after 1 
min which was deemed appropriate time for the gases to stabilise throughout the analysers. 
The flow rate was recorded alongside laboratory pressure (mmHg), temperature (˚C) and 
relative humidity (%).   
Volume was measured using a 350 L Tissot Spirometer (Warren Collins, Braintree, 
MA, USA). The starting value of on the Tissot Spirometer was recorded to the nearest 0.1cm. 
A hose connected the tank to a pump and the Douglas Bag.  Once connected the tank was 
opened, the pump turned on and the bag opened in this sequence. The expirate was pumped 
into the tank and any excess air in the Douglas Bag was rolled out using a solid plastic pipe. 
The final value of the Tissot was then recorded.  The volume of the expired air (VE) was 
calculated by multiplying the Tissot scaling factor of 3.244 which is the cross-sectional area 
of the tank. This gives the Tissot tank a precision of volume to the nearest 300 ml. The same 
process was repeated for the second bag.  
The gas fractions, Tissot displacement and environmental conditions were placed into 
a spreadsheet where the Haldane equation was used to determine V̇O2 and V̇CO2, V̇E.   The 
Weir (Weir, 1949) equation was used to determine energy expenditure in kJ/min for RMR  
and extrapolated to 24 h to provide REE.  
3.1.1 Calibration 
The Ametek analysers were calibrated prior to gas analysis each morning. The flow 
meter was turned on for a minimum of 30 min prior to calibration until the O2 analyser 
temperature was 6.790 ± 0.05 ˚C.  Calcium chloride crystals were replaced with fresh ones 
each morning. For Study 1 two known gases with the following concentrations were used; 
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14.56% O2 and 2.50% CO2; and 16.01% O2 and 4.00% CO2.  For Studies 2 and 5 three known 
gases with the concentrations of O2 14.63% and CO2 2.56%; O2 16.17% and CO2 3.99%; and 
O2 15.30 and CO2 3.38 were used.  The analysers were calibrated within 0.03% of the gas 
concentrations. The system was checked for leaks prior to calibration.  
 
3.2 Body composition 
All body composition assessments were completed using dual energy x-ray 
absorptiometry (DXA). For Studies 1 and 4 a GE Lunar Prodigy was used to capture the 
scans, with the images analysed using GE enCore v12.30 software. For Studies 2 and 5 a GE 
Lunar iDXA was used with images analysed using enCore v16.0 software (GE, Madison, WI, 
USA).  Both versions of the software use the reference population database Lunar-Geelong 
for bone mineral density and body composition (Pasco et al., 2012). 
The DXA was calibrated the morning of each body composition assessment according 
to manufacturer instructions.  The Quality Assurance process calibrates and checks the 
functionality, accuracy and precision of the DXA (GE Healthcare Lunar, 2015). A black 
block consisting of three bone simulating chambers of know bone mineral content and tissue 
equivalent material is used for the Quality Assurance process (GE Healthcare Lunar, 2015).  
A Spine phantom with BMD of 1.252 ± 0.03 g/m2 was then scanned for quality control to 
monitor drift.  
 
A pre-DXA questionnaire (Appendix: 11.6-A) was completed by all participants prior 
to measurement.  This collected descriptive information as well as enquired about recent 
radiation exposure within the previous 12 months, their ability to lie still for 10 min and if 
they had any metal or prosthesis, as per radiation safety requirements of Australian Radiation 
Protection and Nuclear Safety Agency. 
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Participants presented for DXA following an overnight fast and without exercising 
prior to arrival (Nana et al., 2015).  Participants voided their bladder and were then weighed 
in their underwear (underwear or boxer shorts for men and underwear and non-wired crop top 
for women).  Participants then lay supine on the scanner bed with their head towards the head 
of the scanner. Custom made positioning aids to standardise feet width separation at 15cm 
and hand separation of 3 cm from the body were used (Appendix 11.7).  All scans were run 
on standard mode which provides a surface radiation dose of 3µGy per scan. The enCore 
software automatically generates regions of interest (ROIs) to separate the arms, legs and 
trunk (left and right). The ROIs were checked by a qualified and experienced DXA 
technician.  Two DXA technicians were used. One completed all the scans in Studies 1 and 5, 
while another completed all the scans for Studies 2 and 3.  
 
The technical error of measurement for the Lunar Prodigy was ~ 0.1% for total mass, 
0.4% for total lean, 1.9% for total fat and 0.7% for total bone mineral content (Nana et al., 
2012a). The test-retest technical error of measurement for the iDXA was determined during 
the pilot study in Chapter 4.  Participants were scanned once, and then they got up from the 
bed and were re-positioned and scanned once again.  The technical error of measurement for 
the iDXA was, 0.1% for total mass, 0.4% for lean mass, 1.6% for fat mass and 0.4% for bone 
mass.  
 
Hydration status was assessed by urine specific gravity (USG).  Participants collected 
a mid-stream urine sample from their first morning void (Nana et al., 2012a). One drop of 
urine was placed on the refractometer (UG-a, Atago Refractomer, Japan) and USG recorded 
to the nearest 0.001 g/L.  
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3.3 Total Body Water 
Total body water and the fluid compartments were estimated using Bioelectrical 
Impedance Spectroscopy (BIS).  All measures were conducted using an IMP SFB7 
(ImpediMed Limited, Queensland, Australia) and analysed using BioImp Analysis 5.4.0 
Software (ImpediMed Limited, Queensland, Australia). BIS measures were taken while 
participants lay in a supine position with arms at 30 degree angle from the torso and legs 
separated at 30 degree angle.  Participants were required to rest in this position for 10-15 min 
prior to measurement in order to allow body water to stabilise prior to measurement (Moon et 
al., 2008).  Part of this rest time was made up of the DXA scan.  Dual-tab electrodes (L-Dex, 
(ImpediMed Limited, Queensland, Australia) were placed on the dorsal surface of the left 
wrist at the site of the styloid and on the left ankle at the medial and lateral malleoli (IMP 
SFB7, Instructions for use, ImpediMed, QLD, Australia).  The sites were prepared by 
cleaning with alcohol swabs and shaving if necessary prior to placing the electrode tabs.  Site 
preparation and placement of electrodes was done during the 15 min rest period.  Prior to 
measurement, the four leads of the BIS were calibrated/tested as per manufacturer 
instructions.  The BIS measures were then taken in triplicate, with the mean of the values used 
for analysis.  The values in litres and percent for total body water (TBW), extra cellular fluid 
(ECF) and intracellular fluid (ICF) were recorded. 
  
3.4 SenseWear 
The SenseWear Mini-arm band is a multi-sensory activity monitor (Liden et al., 
2002).  The monitor was worn on the mid left triceps.  Monitors were pre-programmed with 
the participant’s date of birth, height (in cm), weight (in kg), sex, dominant hand and smoking 
status prior to wearing the monitor. Participants were advised to wear the monitor at all times 
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except when showering or swimming (Liden et al., 2002).  Following the study completion 
the SWA data were downloaded using SenseWear Professional (version 8, Body media). 
SenseWear estimates energy expenditure via a proprietary algorithm that combines what it 
directly measures (heat flux, skin temperature skin galvanic response and accelerometry data) 
with the individual age, height, weight, sex, dominant hand and smoking status.  The raw data 
which included the measured variables and those derived from it (laying down time, sleep 
time, energy expenditure and METs) were then exported into a Microsoft Excel file. Data is 
provided in one minute intervals.  Energy expenditure was determined by selecting the 
required date and time using the filter feature in Microsoft Excel (2010, Redmond, WA, USA) 
and summing the energy expenditure within the specified time frame.   
 
3.5 Muscle Biopsy 
All Muscle biopsies were taken from the vastus lateralis of either the left or right leg 
by registered medical professionals. The site was anesthetised with 1% xylocaine and once it 
was numb (participant reported no response to sharp test), the area was sterilised using Iodine 
(povidone-iodine, Betadine antiseptic solutions, Sanofi-aventis Consumer Healthcare, QLD, 
AUS) prior to an incision being made with a scalpel through the dermal layer and facia of the 
leg. A 5 mm Bergstrom needle modified with suction was then inserted into the vastus 
lateralis.  The muscle tissue was frozen immediately in liquid nitrogen and stored at -80°C 
until analysis.  
3.5.1 Muscle Glycogen Analysis 
Muscle glycogen was hydrolysed to glycosyl units prior to using enzymatic analysis to 
determine glycogen concentrations (Churchley et al., 2007).  Approximately 20g of freeze-
dried muscle was powdered and cleaned of connective tissue and blood prior to the addition 
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of 500 µL of hydrochloric acid.  The sample was then heated to 100°C for 2 h to hydrolyse 
the glycogen to glycosyl units.  1.5 mL of 0.67 M sodium hydroxide was then used to 
neutralise the sample prior to determing glycogen concentrations with fluorometric detection 
(Jasco FP-750 spectrofluorometer, Easton, MD) at excitation 365 nm/emission 455 nm 
(Tomcik, 2016).   
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Pre-face to Chapter 4 
Chapter 2 identified and reviewed aspects of RMR measurement protocols that have 
the potential to increase the error and reduce the reliability of the measurement of RMR in an 
athlete population.  The following chapter (Study 1) investigates the effect of testing location 
and day to day variability while taking into consideration aspects of an athlete’s life that 
would make controlled laboratory protocols for measurement of metabolic rate impractical for 
the routine assessment of RMR in exercising individuals.  Reliability is assessed using the 
intra-correlation coefficient and the typical error. The TE is expressed in units and as a 
coefficient of variation in order to be comparable with the current literature.  
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4.0 Study 1: No difference in young adult athletes resting energy 
expenditure when measured under inpatient or outpatient 
conditions.   
 
This chapter is comprised of the following paper which has been accepted and is in 
Press in International Journal of Sports Nutrition and Exercise Metabolism: 
 
Bone, J L, & Burke, L M. (2017). No difference in young adult athletes resting energy 
expenditure when measured under inpatient or outpatient conditions. Int. J. Sport Nutr. Exerc. 
Metab. In Press. 
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4.1 Abstract 
Low energy availability can place athletes at increased risk of injury and illness and 
can be detected by a low metabolic rate.  The lowest metabolic rate is captured at the bedside, 
after an overnight fast and termed inpatient REE.  Measurements done in a laboratory with a 
shorter overnight fast are termed outpatient REE.  Although important to know what the 
lowest energy expenditure is, a bedside measure and/or 12 h fast is not always practical or 
logistically possible particularly when you take into account an athlete’s training schedule.  
The aim of this investigation was to compare a bedside measure of resting metabolism to a 
laboratory measure in athletes following an 8 h fast.  Thirty-two athletes (24 females, 8 males) 
underwent measures of resting metabolism using indirect calorimetry once at their bedside 
(inpatient) and once in a simulated laboratory setting (outpatient).  Paired T-Test was used to 
compare the mean (± standard deviation) differences between the two protocols.  Inpatient 
REE was 7302 (±1272) kJ/d and outpatient REE was 7216 (± 1119) kJ/d (p=0.448).  Thirteen 
participants repeated the outpatient protocol and 17 repeated the inpatient protocol to assess 
the day to day variation. Reliability was assessed using the intra-correlation coefficient and 
typical error. The inpatient-protocol variability was 96% with a typical error of 336 kJ/. For 
the outpatient-protocol the ICC and typical error were 87% and 478 kJ/d respectively. Results 
indicate no difference in REE when measured under inpatient and outpatient conditions; 
however the inpatient protocol has greater reliability.  
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4.2 Introduction 
The measurement of basal metabolism, the lowest amount of energy required for the 
body to function, is of interest to athletes due to its potential as a diagnostic tool to detect low 
energy availability (Mountjoy et al., 2015). The terms basal energy expenditure (BEE) and 
resting energy expenditure (REE) are used interchangeably, however, this is not appropriate 
as they reflect difference in the protocols under which measurements were obtained.  BEE is a 
measurement of metabolic rate, extrapolated to 24 h, taken from the bedside of a supine 
individual who has just woken up  following a 12 h fast and abstinence from alcohol and 
caffeine intake (Institute of Medicine, 2005).  Protocols that deviate from one or more of these 
conditions are deemed to measure REE. The most common deviations are the collection of 
data from time-points other than “on waking” (i.e. bedside measurement) and shorter fasting 
periods.  Indeed, in real-life, it is usually most practical to measure REE in a patient who 
reports to the laboratory in fasted, rested condition and further undertake a standardised 
period of rest (outpatient protocol) (Fullmer et al., 2015).  Although ideal, a 12 h overnight 
fast is not always practical and considerations on the reliability of REE following a shorter 
overnight fast are yet to be done.  
An outpatient REE is considered to be higher than inpatient REE (which would be 
closer to BEE) (D'Alessio et al., 1988). However, investigations in healthy and elderly 
populations which directly compared inpatient and outpatient REE have found conflicting 
results (Berke et al., 1992; Bullough & Melby, 1993; Turley et al., 1993).  Furthermore, no 
comparison has been done in an athlete population nor employed a more practical 8 h 
overnight fast.  This is of interest in athletes given they have a higher metabolic rate and 
different training and dietary habits that could impact on the variability of REE (Poehlman et 
al., 1988; Sjodin et al., 1996).  Therefore, the aims of this study are to, 1) investigate the 
variability in measurements of REE which results from a bedside versus outpatient protocol 
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following an 8 h overnight fast in athletes and 2) determine the daily variability and reliability 
of each protocol.   
 
4.3 Methods 
Participants 
Twenty-four female and eight male athletes who compete at state or national level 
(Table 4.1) participated in this study after providing informed consent.  Participants were 
recruited from a convenient sample of athletes who visited the Australian Institute of Sport for 
training purposes.  Approval was granted by the Australian Institute of Sport and Australian 
Catholic University Ethics Committees.  
Table 4.1. Participant characteristics by sport and sex, presented as mean ± SD. 
Characteristic 
All 
Males Females 
Sport Gymnastics Cycling Athletics 
n 32 8 19 5 
Age (y) 23.6 ± 4.3 20.4 ± 2.14 24.5 ± 4.1 25.4 ± 5.05 
Weight (kg) 58.2 ± 6.9 63.3 ± 6.95 57.9 ± 5.6 51.0 ± 4.6 
Height (cm) 166.8 ± 6.6 165.4 ± 7.84 167.0 ± 6.7 168.6 ± 4.1 
Fat free mass (kg) 49.4 ± 7.6 59.2 ± 6.4 47.1 ± 4.6 42.6 ± 2.4 
Fat mass (kg) 9.2 ± 3.6 5.0 ± 0.8 11.1 ± 2.9 9.0 ± 2.6 
 
 
Study Design 
REE was measured for each participant under an inpatient and outpatient protocol in a 
cross-over study design.  The conditions were measured on separate days with 24-48 h 
between measurements and random allocation of protocol order. Participants stayed overnight 
at the AIS residences for the study duration.  
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Pre-testing standardisation:  
Participants were required to undertake a similar training load and macronutrient 
composition of their diet for the 24 h prior to each REE measurement.  REE was collected 
following an 8 h overnight fast (including caffeine) and a minimum 10 h after training for 
both protocols (Fullmer et al., 2015). Dietary intake was recorded using a written food diary 
with analysis completed by an accredited sports dietitian.  Training activities were recorded 
and SenseWear™ activity monitors (BodyMedia, Mini-MF) were worn to monitor 
compliance to training and to estimate total energy expenditure (BodyMedia, SenseWear 
Version 8).  
REE collection: 
Resting energy expenditure was measured using indirect calorimetry.  Measurements 
were collected at the same time each morning between 5-7am.  Participants wore a nose clip 
and breathed into a two-way valve mouth-piece (Hans Rudolph R2700). Their expired air was 
collected in 10 min duplicates into two 120 L gas-impermeable Douglas Bags (Haugen et al., 
2007; Woods et al., 2016). 
Intervention Protocols:  
Inpatient: Expired air was collected at the bedside after participants had been woken 
and without them rising from their bed.  Following 10 min of familiarization with the 
mouthpiece, the expirate was collected into the Douglas Bags.  
 Outpatient: To minimise the effect of potential confounding factors such as a 
different bed and laboratory sounds, the outpatient protocol was conducted in the same room 
as the inpatient protocol after the participant had slept overnight.  However, to simulate the 
situation of reporting to a laboratory, participants were required to wake themselves, dress and 
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walk a return distance of 500m back to their bed. They then lay supine for 25 min prior to 
connecting the Douglas Bags. The mouth-piece was provided 10 min into the rest period for 
familiarization.  
Determination of REE: 
A sample of air from the Douglas Bag was measured for the gas fractions of oxygen 
consumption (V̇O2) and carbon dioxide production (V̇CO2) using Ametek O2 and CO2 
analysers (Ametek Inc, Pennsylvania, USA) and the sampling duration and flow rate 
recorded. The analysers were calibrated against two known gases (14.56% O2, 2.501% CO2 
and 16.01% O2 and 4.001% CO2) prior to measurement.  Following the sample measurement 
the Douglas Bag was attached by hose to a water sealed 350 L Tissot Spirometer (Warren 
Collins, Braintree, MA, USA) to measure gas volume.  V̇O2 and V̇CO2 were determined using 
the Haldane transformation (Haldane, 1918) and converted to kJ/min based on the Weir 
equation (Weir, 1949). The process was repeated for the second Douglas Bag and the mean 
value of the duplicate bags was extrapolated to kJ/d and kJ/kg FFM/d.   
Body Composition:  
Body composition was assessed via a standardised protocol using a narrowed fan-
beam DXA (Lunar Prodigy, GE Healthcare, Madison, WI) with technical error of 
measurements  of ~ 0.1% for total mass and 0.4% for lean mass and 1.9% for fat mass (Nana 
et al., 2016).     
Reliability of protocols 
Thirty participants were randomised to complete a third REE measure under either the 
inpatient (n=17) or the outpatient (n=13) condition in order to determine the day to day 
variation and reliability for each protocol.  This assessment was completed no more than 48 h 
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after the last intervention protocol and was completed at the same time of the morning and 
following the same pre-testing standardisation protocols.   
Statistical Analysis: 
Energy intake, energy expenditure and REE data were all normally distributed for both 
protocols as assessed by Shapiro-Wilk’s test (p >0.05).  Paired t-tests were used to compare 
REE, energy intake and energy expenditure between inpatient and outpatient protocols, and 
between days for the same protocol.  Reliability and day to day variation for the inpatient and 
outpatient protocols was determined using a two-way random intra-correlation coefficient 
(ICC) using absolute agreements and the typical error (TE) (Hopkins, 2000; Weir, 2005).  
Paired t-test and ICC were determined using SPSS (Version 23 for Windows, SPSS Inc, 
Chicago, IL).  All values are mean ± standard deviation (SD) unless otherwise stated.   
4.4 Results 
Results were combined as there was no statistical difference in mean absolute REE 
between the male and female athletes.  There was no statistical difference in absolute REE 
(kJ/d) or relative REE (kJ/kg FFM/d) between the inpatient and outpatient protocols (Table 
4.2).  
Table 4.2. REE for inpatient and outpatient conditions for all participants (mean ± SD). 
 Inpatient 
(n=32) 
Outpatient 
(n=32) 
p-value 
REE (kJ/d) 7302 ± 1272 7216 ± 1116 0.448 
REE (kJ/kg/FFM/d) 148.5 ± 20.5 146.8 ± 17.2 0.459 
RER 0.86 ± 0.05 0.84 ± 0.04 0.009* 
*Significantly different between Inpatent and Outpatient conditions 
REE: resting energy expenditure; FFM: fat free mass; RER: respiratory exchange ratio. 
For kCal/d divide by 4.18 
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Reliability results are presented in Table 4.3.  Mean day to day variation in REE for 
the inpatient and outpatient protocol were 92 ± 456 kJ/d (p=0.417) and 382 ±716 kJ/d 
(p=0.107) respectively. The outpatient protocol had a lower ICC and a higher TE by 155 kJ/d. 
Table 4.3. Inter-day Reliability and Typical Error of Inpatient and Outpatient protocols. 
 Inpatient 
(n=17) 
Outpatient 
(n=13) 
ICC (95% CI) 0.96 ( 0.896, 0.986) 0.87 (0.58, 0.96) 
SEM (95% CI) (kJ/d)  323 (240, 491) 478 (342, 788) 
Typical error as CV (%) 4.9 (3.6, 7.6) 5.9 (4.2, 9.9) 
SD: Standard deviation; ICC: Intra-class correlation coefficient, SEM: Standard error of the 
mean; CI: 95% Confidence limits; CV: coefficient of variation 
ICC determined using two-way random model with absolute agreements.  SEM calculated 
mean squares from ANOVA For kCal/d divide by 4.18 
 
Three athletes failed to comply with diet and energy expenditure monitoring for the 24 
h preceding each REE measure and were excluded from this analysis. There was no 
significant difference in energy intake, macronutrient intake or total energy expenditure in the 
24 hours prior to measurement between protocols (Table 4.4), nor when the same protocol 
was repeated.    
Table 4.4. Energy intake, macronutrient intake and estimated total EE in the 2 4h preceding 
the REE measurement for inpatient and outpatient conditions, n=29 (mean ± SD). 
 Inpatient Outpatient p-value 
Total EE (kJ/d) 12109 ± 4419 12929 ±3733 0.557 
Energy Intake (kJ/d) 11022 ± 3100 10694 ± 2812 0.223 
Protein intake (g/d) 146 ± 47 140 ± 48 0.318 
Fat intake (g/d) 77 ±  33 76 ± 26 0.771 
Carbohydrate intake (g/d) 324 ± 115 313 ± 104 0.412 
EE: Energy expenditure. For kCal/d divide by 4.18 
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4.5 Discussion 
Our results indicate that there is no difference in REE when measured following either 
an inpatient or outpatient protocol, with this being the first investigation of this issue in 
athletes.  This is a useful finding since it means that practitioners and researchers can obtain a 
measure of metabolic rate in athletes under conditions that are more practical and economical 
to administer.  The further novelty of our work in determining the reliability of these 
measurement protocols indicates that there is greater noise associated with the outpatient 
protocol; thus it has reduced capacity to detect small but potentially important changes in 
REE when longitudinal measurements are taken on the same athlete.  Given the wide 
variation in the TE, the results indicate that multiple REE measures over consecutive days 
should be collected in order to determine an individual athlete’s TE, however this may not 
always be logistically possible.  
Previous work (Berke et al., 1992) reported an 8% higher REE following outpatient 
conditions compared with the inpatient conditions in elderly men and women. In contrast, 
other studies have found no differences in REE and BEE measurements in elderly populations 
(Fredrix et al., 1990)  or young active men  (Bullough & Melby, 1993); a cohort more similar 
to the current investigation.  More recently, REE was found to have returned to resting levels 
20 min after a 300m walk. However, the initial resting REE was not measured following an 
inpatient protocol (Frankenfield & Coleman, 2009).  One difference between these studies 
and the current investigation is our use of an 8 h overnight fasting period for both inpatient 
and outpatient protocols, which is shorter than the 12-14 h period which is often used to 
define a true fast (Institute of Medicine, 2005).  Others  (D'Alessio et al., 1988) have reported 
that metabolic rate increases associated with the thermic effect of food return to baseline by 8 
h in lean men.  Furthermore, updated guidelines for conducting indirect calorimetry by the 
Academy of Nutrition and Dietetics state that a minimum of 7 h of fasting is required prior to 
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measuring REE in general and clinical populations (Fullmer et al., 2015).  Given the 
impracticality of achieving a 12 h fast in athletic populations whose training schedules are 
often linked with food intake during the evening and early morning rising, an 8 h fast is 
considered by the authors as adequate to achieve non-absorptive conditions and a strength of 
the current investigation.    
The current investigation required athletes to undertake a 10 min walk protocol within 
their outpatient preparation, and contrasts with the conditions of other studies in which 
participants have been driven to the laboratory or used transport that has not been noted.  We 
note that REE is purported to be higher than BEE due to the energy costs for the activities of 
waking, dressing and the neural activation /mental activity required to get to the testing 
location.  Further research investigating the effect of different modes of transport (e.g. driving 
different distances, walking or taking public transport) would have application not only to 
athletes but to general populations. However, the procedures used in the current protocol 
represent the major activities involved in conducting research in an outpatient setting, and is 
deemed to be practical and representative of real-life. 
Having a reliable protocol for measuring REE in athletes is important for some of its 
practical applications, such as its use as a diagnostic tool for low energy availability (Melin et 
al., 2015).  Although the reliability of both protocols was high, the ICC of the outpatient 
protocol was lower and the TE higher than that of the inpatient protocol, indicating lower 
reliability. This difference may be of importance when monitoring REE over time or in 
response to an intervention to interpret if a real change in REE has occurred.  Further research 
should investigate changes in REE in response to other likely artefacts in the measurement 
protocols (e.g. environmental noise and temperature, effects of prolonged/intense exercise on 
the previous day) to determine real-life variability in measurement versus changes that 
indicate a physiological alteration in baseline metabolic health and function. 
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Limitations 
Participants were recruited from a convenience sample, therefore we were unable to 
schedule REE collection for the same phase of the menstrual cycle in female athletes. 
Furthermore, it was unknown if participants were in energy balance upon study 
commencement.  However, as the study was completed within 3-5 days it was presumed that 
there would be minimal changes in weight.  
 
4.6 Novelty and Practicality Statement: 
This study is the first to compare measurements of REE via inpatient and outpatient 
protocols in athletes, using protocols that represent conditions that are realistic or practical for 
the implementation of this measurement in athletic populations.  Although both protocols 
were shown to have high reliability, the inpatient protocol would provide greater sensitivity to 
monitor real changes that might occur in an athlete over time. Although not always possible 
logistically, obtaining multiple (two to three) REE measures should be conducted to establish 
an athlete’s individual TE.  
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Preface to Chapter Five 
The results from Chapter 4 (Study 1) indicate that the 8 h overnight fasted outpatient 
protocol is reliable for measuring REE in a young adult athletic population when 
measurements are taken on the morning after a training day.  However the validity of such 
measurements needs to be addressed since exercise has been previously shown to elevate REE 
for a period of 39- to 72 h after the session (Herring et al., 1992; Tremblay et al., 1988).   
Previous studies that have investigated the effect of exercise on REE have either used 
endurance or resistance trained participants who completed a standardised bout of exercise in 
their habitual exercise mode.  Whether the acute effect of exercise remains in conditions that 
better reflect the variety of exercises and athletes in the daily training environment has yet to 
be investigated.  In addition there have been few attempts to track this acute post-exercise 
effect in a stepwise fashion at specific time intervals following exercise.  Although Study 1 
was conducted on both male and female athletes, the majority of participants were female.  
There is a lack of literature in male athletes where REE has been used as a proxy for 
determining or diagnosing low EA. Therefore, this population should be targeted when 
conducting research in this area and that of REE reliability.  For this reason, the remaining 
studies of this thesis have solely used male athletes as participants. The following chapter 
summarises Study 2, an investigation of the acute effect of exercise on REE in a 
heterogeneous male athlete population.  
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5.0 Study 2: The effect of prior exercise on measures of resting 
metabolic rate in trained men.  
 
The following chapter consists of a pilot study and will not be submitted for 
publication.  However, the outcomes and limitations of this study are important to the central 
theme/aim of this thesis and thus worthy of inclusion.   
 This pilot study was funded in part by a grant from Sports Dietitians Australia 
awarded to myself, and the Australian Institute of Sport PhD Program Student Budget. 
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5.1 Abstract 
Background: 
The increase in resting energy expenditure (REE) following exercise has been reported 
to last up to 39 or 72 h in homogeneously trained populations.  The aim of this pilot study was 
to profile REE when measured at 12 h intervals up to 48 h post exercise in a heterogeneous 
group of athletes undertaking self-selected training sessions.  
Methods 
Ten trained males (age, 30.32 ± 6.15 y; weight 81.45 ± 11.64 kg; height, 187.82 ± 
6.94 cm) from a variety of sports participated in this study.  Participants undertook a standard 
training session of their choosing on Day 0, either in the morning or afternoon.  The next 
morning they presented for their 1st REE (post-exercise-day) and DXA with no exercise 
being permitted following the REE on Day 1.  Participants returned on Day 2 for their second 
REE (post-rest-day).  They then repeated this process the following week, however with the 
training session completed at the other time of day.  Participants were assigned to train either 
in morning or the afternoon in the first week and in the alternative time in the second week. 
This provided REE approximately 24 and 48 h post exercise following morning training 
session and 12 and 36 h post exercise following the afternoon training session.  The training 
session and diet was replicated from week to week.  Linear mixed modelling was used to 
determine the difference between the different time points. The typical error for REE is 478 
kJ / d. 
Results: 
There was a statistically significant decrease in REE of 345 kJ/d when measured 48 h 
post exercise compared to 12 h. There was a trend for REE to be lower with increasing rest 
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from exercise. All differences between time-points were within the typical error for the 
outpatient protocol.  
Conclusion: 
There was a trend for REE to decrease with increasing rest period from exercise.  
However, no clear effects of acute exercise on subsequent morning measures of REE could be 
detected in participants from a mixed sport population undertaking self-selected training 
sessions.  
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5.2 Introduction 
Resting energy expenditure (REE) is one tool that can be used to support the diagnosis 
of low energy availability (LEA).   However to accurately measure REE and to be able to 
detect  changes between measurements, it is important to investigate how certain variables 
may artificially increase the REE, potentially masking evidence of a supressed metabolic rate 
(Manore & Thompson, 2009). One such variable is exercise. 
It is well documented that oxygen consumption is increased acutely after exercise in 
what is termed excess post exercise oxygen consumption (EPOC) (Gore & Withers, 1990; 
Manore & Thompson, 2009).  The increase in oxygen consumption translates to a temporally 
elevated metabolic rate (Gore & Withers, 1990). Whether this elevated metabolic rate remains 
high for measurement of REE in athletes the following morning is inconclusive with reports 
ranging from a return in REE to resting levels by 3 h post exercise (Binzen et al., 2001; 
Freedman-Akabas et al., 1985; Short & Sedlock, 1997) to elevations in REE taking up to 72 
hours to return to normal (Dolezal et al., 2000; Tremblay et al., 1988).   
Furthermore, the majority of studies have been undertaken in untrained persons or 
populations with a short training history (6 month to 2 years) (Schuenke et al., 2002).  One 
study investigated elite cross-countries skiers and reported that REE was lower when 
measured three days after training compared to the morning after training (Tremblay et al., 
1988). However, REE was not measured in the mornings in between, so the time course of the 
return to baseline metabolic rate is unknown.   
It could also be argued that refraining from exercise for three days is not reflective of 
an athlete’s habitual lifestyle, and that undertaking REE the day after exercise would better 
reflect the athlete’s typical metabolic state. However, it is common for athletes to have 12-36 
h of rest between exercise sessions during a training cycle. Conducting an REE measurement 
within 12-24 h of a training session may cause the measurement to be made during a period of 
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elevated metabolic rate, either masking or diluting the apparent degree of suppression of 
metabolic rate in an athlete.  In turn, this would interfere with an appropriate diagnosis and 
management plan for cases in which true low energy availability was in effect outside these 
times of post-exercise metabolic elevation. (Melin & Lundy, 2015; Mountjoy et al., 2014).  
Although laboratory studies provide good control over the measurement of REE, it is 
important that any findings can be applied practically.   
Therefore, the aim of this pilot study was to determine if there is a difference in REE 
when measured the morning after an exercise day compared to the morning after a rest day 
and if the time of the exercise (morning or afternoon) plays a role in these differences.  We 
hypothesised that REE will be lower when measured at the period of longest recovery from 
exercise.   
 
5.3 Methods 
Participant characteristics:  
Male athletes (age, 30.3 ± 6.2 y; weight 81.5 ± 11.6 kg; height, 187.8 ± 6.9 cm) who 
trained a minimum of 10 hours per week in their respective sport were recruited for this pilot 
study.  Participants ranged from triathletes, cyclists, endurance runners, middle distance 
runners, Australian football players and swimmers. Written informed consent was provided 
prior to commencing the study which was approved by the ethics board of the Australian 
Catholic University.  
 
Study design: 
This study was conducted as a cross-over intervention. Participants had their REE 
measured on four occasions, over a nine day period (Figure 5.1). The time of the 
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training/exercise session was manipulated so that in the first week they trained in the morning 
(AM REE measurements) and in the second week they trained in the afternoon (PM REE 
measurements) or vice versa.  The AM session had to be completed by 1000 h, while the 
afternoon (PM) session started after 1600.  Within each week, REE was measured on two 
consecutive mornings.  The first measurement (REE-1) was taken the morning after the 
training day. The second measurement (REE-2) was taken the morning after REE-1 which 
was a rest day.  Following REE-1, participants were not permitted to exercise for the 
remainder of the day and were instructed to limit strenuous activity (e.g. running upstairs, 
riding to work).  This was repeated in week 2 for REE-3 and REE-4.  Therefore, REE 
measurements approximately 12-, 24-, 36- and 48 h post exercise were obtained.  
 
Figure 5.1 Cross over study design. Time of exercise sessions were assigned as either Week 
1: AM - Week 2 PM or Week 1 PM - Week 2 AM.   REE: resting energy expenditure 
 
Diet and Training standardisations: 
Participants were required to complete the same training session each week with the 
time of the session being the only manipulated variable.  Participants recorded their sessions 
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in a food and activity diary and were also required to wear SenseWear Armband (BodyMedia, 
Mini-MF) activity monitors over the measurement period (three days) each week.  
Participants wore the SWA during exercise and recorded exercise duration and intensity using 
a 20 point RPE scale (Borg, 1970).  Dietary intake for the 24 h prior to each REE 
measurement was recorded and participants were instructed to replicate this meal plan in 
week 2.  All diets were analysed using Foodworks (version 8, Xyris, Australia) by the same 
Accredited Sports Dietitian.  SenseWear data were analysed using Professional software 
version 8.1 and analysed for total energy expenditure, total exercise energy expenditure (> 3 
METs) and energy expenditure of moderate ( 3-6 METs), vigorous (6-9 METs) and very 
vigorous (> 9 METs) activity.  
 
REE Protocol: 
Resting energy expenditure was determined using indirect calorimetry as previously 
described in Chapter 3.1 (p. 50). Briefly, participants arrived at the lab for an outpatient 
measure of REE following an 8 h overnight fast (Bone & Burke, 2017).  Participants were 
required to lie supine for 25 min upon arrival to “rest” before collection of expirate into 
Douglas bags in 10 min duplicates.  After 10 minutes of this rest period, participants were 
given a Hans Rudolph (2700 series, country) mouthpiece for familiarisation.  Tests of REE 
commenced between 0530 – 0700 and were at the same time of the morning for each 
participant’s set of measures.  Laboratory conditions and patient behaviour (e.g. refraining 
from listening to music) were also kept consistent.  
 
Determination of energy expenditure: 
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Oxygen and carbon dioxide gas fractions were determined using Ametek analysers 
(Ametek Inc, Pennsylvania, USA) for a period of one min with the flow rate recorded.  Gas 
volume was determined using a Tissot Spirometer (Warren Collins, Braintree, MA, USA). 
Gas fractions and volumes were converted to energy expenditure based on the Weir equation 
(Weir, 1949). Bags were excluded if the respiratory exchange ratio was greater than 0.95 
(Compher et al., 2006; Fullmer et al., 2015). The mean of the duplicate bags was used to 
calculate energy expenditure, expressed as kJ/day and kJ /kg FFM/day.  
 
Body Composition 
As REE is commonly interpreted relative to fat free mass, participants underwent a 
total body composition assessment via dual x-ray absorptiometry (DXA, GE, Lunar iDXA, 
Wisconsin, IL) each week.  Scans were conducted following REE collection on the first 
morning of each week when participants were still rested and fasted (Nana et al., 2012a). 
Although the diets and training were replicated, differences in the period of recovery from the 
last exercise bout meant muscle glycogen may have replenished to different concentrations 
which could impact on the measurement of fat free mass (Bone et al., 2017).  One 
experienced DXA technician conducted and analysed all DXA scans.  The test-retest technical 
error of measurement for the iDXA is, 0.1% for total mass, 0.4% for lean mass, 1.6% for fat 
mass and 0.4% for bone mass.  
 
Statistical Analysis: 
Data were checked for normality and outliers prior to interpretation.  Data at all time 
points were normally distributed as per the Shapiro-Wilks test (p>0.05).  Repeated linear 
mixed models with pairwise comparisons were conducted for REE kJ/d, REE kJ kg FFM/d, 
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respiratory exchange ratio (RER), energy intake and total energy expenditure.  Paired t-tests 
were used to compare body composition between week 1 and week 2. Data are presented as 
mean ± standard deviation (SD). All data was analysed using SPSS (Version 23 for Windows, 
SPSS Inc, Chicago, IL, USA).  Graphs were constructed using GraphPad Prism (version 7.03, 
GraphPad Software, Inc, La Jolla, CA).    
 
5.4 Results 
The results of investigations on nine participants are presented below. One participant 
failed to comply with the resting/no vigorous activity protocol on the rest day and was 
therefore excluded from statistical analysis.  The exercises varied from long distance running, 
road cycling, swimming and high intensity interval sessions.  
 
Figure 5.2 shows the mean time course for absolute and relative REE.  Comparison of 
results at 48 h post exercise to 12 h post exercise showed a reduction in absolute REE by 345 
kJ/d, (p=0.015) while relative REE was lower by 5.7 kJ/kg FFM/d (p=0.012).   
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 Figure 5.2. Mean ± SD for absolute (A) and relative (B) REE measured after 12, 24, 36 and 
48 h post exercise. * indicates statistically significant difference between REE measured 12 h 
post exercise.  
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Figure 5.3 shows energy intake and total energy expenditure for the 24 h periods 
preceding each REE measurement.  Total energy expenditure was significantly lower on the 
rest day compared to measurements taken in the afternoon (p=0.023 and 0.013 for rest day 
after afternoon and morning training, respectively).  There was no difference in mean values 
for self-reported energy intake in the 24 h periods prior to each RMR measurement.  
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Figure 5.3. Mean ± SD energy intake (A) and total energy expenditure (B) in the 24 h 
preceding REE measurement.  PM-T, afternoon training day; AM-T, morning training day; 
PM-R, rest day following afternoon training; AM-R, rest day following morning training. * 
indicate statistically significant difference in total energy expenditure compared to PM-T. 
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There was no significant difference in RER between the different time points (Table 
5.1), nor was there a difference in body mass, lean mass, fat free mass and fat mass between 
weeks 1 and 2 of the study (Table 5.2). 
 
Table 5.1. Mean ± SD RER measured 12, 24, 36 and 48 h post exercise. 
Study Week 12 h 24 h 36 h 48 h 
RER 0.84 ± 0.04 0.83 ± 0.04 0.84 ± 0.04 0.86 ± 0.03 
RER: respiratory exchange ratio 
 
Table 5.2. Mean ± SD of body composition between weeks 1 and 2. 
Study Week Body mass (kg) Lean mass (kg) 
Fat Free mass 
(kg) Fat mass (kg) 
1 79.4 65.4 68.8 11.5 
2 79.5 65.4 68.8 11.4 
 
 
5.5 Discussion 
The results from the current investigation suggest that REE is lowest when the time 
interval from the last exercise session is at its greatest (~48 h post exercise).  It appeared that 
REE decreased in a stepwise fashion with each 12 h period from exercise, however, the 
differences in REE measured between 12-, 24- and 36 h were not significant. Although the 
difference in REE measured 48 h after exercise was statistically different to that measured 12 
h post exercise, the mean difference of 345 kJ/d was within the daily variation for the 
outpatient 8h fasting protocol (Bone & Burke, 2017).  The range in the difference in REE 
between 12 and 48 h was -90 to 785 kJ /d or -1.8 to 13.9 kJ/kg FFM/d, indicating that there 
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would be clinical implications for some individuals (i.e. a change in interpretation of the 
normalcy of a REE measurement according to the time that it was taken). Surprisingly, there 
was no difference in reported energy intake between training and non-training days.  As 
expected estimated total energy expenditure was significantly lower on rest days compared to 
exercise days confirming that participants complied with the study protocols.  There was no 
correlation between the magnitude of change in total daily energy expenditure and the RPE of 
the exercise session between 12 and 36 h and 24 and 48 h post exercise. 
 
It appears that total energy intake and expenditure can both have an impact on REE. 
Although no significant difference in REE was reported between 36 and 12 h post-exercise, it 
is possible that if energy intake had been lower on rest days it would have resulted in a 
decreased REE, as per the “energy flux” theory (Bullough et al., 1995).  This concept 
theorises that metabolic rate is highest when there is a high energy intake and high energy 
expenditure compared to when both energy intake and energy expenditure are low (Bullough 
et al., 1995).  However, in the current study, energy intake was not different between exercise 
and rest days and may be one reason why the magnitude of the difference in REE was not as 
large as previous studies.   
 
Previous studies have reported significant decreases in metabolic rate of 6.6% and 
8.8% following 72 h and 39 h rest from exercise in trained men and women respectively.  In 
the case of work from Tremblay et al. (Tremblay et al., 1988), the first measurement of REE 
did not occur until 72 h post exercise, therefore, the time course of the decrease in REE is 
unknown.  Meanwhile, Herring et al. (Herring et al., 1992) found that in women, REE had 
decreased ~39 h post exercise and remained low for up to 87 h post training. In the current 
study a significant decrease was observed ~48 h post exercise however, this was below the 
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typical error for the outpatient protocol as determined in Study 1 (Chapter 4) (Bone & Burke, 
2017).   The discrepancy in the magnitude of the differences reported in the previous studies 
and those from current investigation could reflect the greater consistency of the effects seen in 
the former studies which employed 12 h overnight fasting protocols and a homogenous 
(endurance trained) population who all completed the same mode of exercise (Herring et al., 
1992; Tremblay et al., 1988).  In the current investigation, greater variability in the effect of 
exercise on REE was expected, since study participants ranged from triathletes to Australian 
Rules Football players who undertook a range of exercise sessions.  Increased variability in 
the effects of REE on exercise may have reduced the ability to detect consistent differences at 
different time points.  This feature of the methodological design is not viewed as a limitation, 
since it provides the study with ecological validity in its goal of trying to identify a common 
point at which it is best to measure REE in a real world high performance environment.  In 
such a scenario, REE will be measured on a range of different athletes and it is unlikely that 
the clinician who is investigating REE will be able to limit or prescribe the exercise or 
training session that the athlete will undertake on the day prior to measurement.   Therefore, 
this study reflects the challenge of trying to incorporate an ideal testing point (i.e. period of 
rest from the previous exercise bout) or develop a correction factor that might be applied to 
the results of an REE measurements when an assessment of a potential situation of LEA is 
required.  
 
Although no attempt was made in this study to track indicators of potential 
mechanisms underpinning the spike and reduction in REE following an exercise session, 
several theories have been presented: these include differences in circulating catecholamines 
and cortisol, as well as the energy cost associated with inflammatory responses and protein 
synthesis.  In the case of catecholamines, elevations have been observed the morning after 
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strenuous exercise (Maron et al., 1977; Sagnol et al., 1989), while in other studies, a decrease 
in catecholamines coincided with a decrease in REE following cessation of exercise in female 
endurance athletes (Herring et al., 1992) and noradrenaline concentrations in male endurance 
athletes who were in a state of low energy flux (Bullough et al., 1995).   
 
Limitations:  
The small sample size and the lack of inclusion of elite athletes among the study 
participants prevented this pilot study from achieving its intended outcome of clearly 
quantifying the difference in REE when measured at different durations from exercise. The 
recruitment of high performance athletes who were willing to refrain from training (which 
often includes multiple sessions in a day) was not possible, and it was even difficult to find 
athletes at a lower level who were willing to interfere with their exercise routines. Therefore, 
even if a larger sample size had allowed the effects of exercise on REE in the current study to 
become clearly detected, we would have experienced some difficulty in applying the results to 
our population of interest.  The logistics of the study design (containing REE measurements 
to a two week period) prevented us from involving female athletes and adding the 
confounding variable of effects of the menstrual cycle on REE.  
 
In conclusion, this pilot study is the first to measure REE in a stepwise fashion over 
different periods of recovery from an exercise bout using the 8 h overnight outpatient 
protocol.  Future studies involving greater participant numbers and in elite athlete populations 
are required before the real life effects of exercise on REE can be clearly detected and 
factored into best practice protocols for the measurement of REE in clinical practice.  
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Preface to Chapter Six 
In the following chapter the focus moves from the reliability of athlete presentation protocols 
for assessment of REE via indirect calorimetry, to the reliability of the assessment of body 
composition by DXA.  One study has highlighted the difference in relative REE when 
different methods of body composition assessment such as DXA, BIA and surface 
anthropometry are used (Korth et al., 2007).  DXA has become a mainstream tool for the 
assessment of body composition in athletes, with standardised protocols now in place (Nana 
et al., 2016).  When using DXA to asses body composition FFM is composed of LM and bone 
mineral content.  LM estimates by DXA are susceptible to changes caused by fluid and food 
intake.  It stands to reason that changes in intramuscular solutes that change the fluid content 
of the cell, such as glycogen and creatine, would also cause changes in the LM component of 
FFM by DXA.   
One study has investigated the effect of acute high carbohydrate intake on LM 
estimates of DXA (Rouillier et al., 2015).  However, they did not have a depletion protocol, 
used a non-athlete population and used different statistical methods from recent DXA 
reliability studies (Nana et al., 2012a, 2012b, 2013).  Changes in muscle glycogen and 
creatine concentration influence the LM estimate by DXA would have implications not only 
for the longitudinal monitoring of body composition but also for resting energy expenditure.  
In order for Study 3 to be comparable with the literature on the reliability of DXA assessments 
of body composition in active populations, magnitude based inference statistics will be used 
to interpret the effects of creatine and glycogen manipulation on DXA estimates of LM.   
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6.0 Study Three: Manipulation of muscle creatine & glycogen 
changes DXA estimates of body composition 
 
This chapter is comprised of the following paper which has been published in 
Medicine & Science in Sports and Exercise: 
Bone, J L, Ross, M L, Tomcik, K A, Jeacocke, N A, Hopkins, W G, & Burke, L M. 
(2017). Manipulation of muscle creatine and glycogen changes dual x-ray absorptiometry 
estimates of body composition. Medicine and Science in Sports and Exercise, 49, 1029-1035.  
 
This study was funded by a grant from the Australian Catholic University Research 
Fund awarded to Prof Louise M Burke. 
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6.1 Abstract 
Standardising a dual x-ray absorptiometry (DXA) protocol is thought to provide a 
reliable measurement of body composition.  
Purpose: We investigated the effects of manipulating muscle glycogen and creatine 
content independently and additively on DXA estimates of lean mass.  
Method: Eighteen well-trained male cyclists undertook a parallel group application of 
creatine loading (n=9) (20 g/d for 5 d loading; 3 g/d maintenance) or placebo (n=9) with 
crossover application of glycogen loading (12 v 6 g/kg BM/d for 48 h) as part of a larger 
study involving a glycogen-depleting exercise protocol. Body composition, total body water, 
muscle glycogen and creatine content were assessed via DXA, bioelectrical impedance 
spectroscopy and standard biopsy techniques. Changes in the mean were assessed using the 
following effect-size scale: >0.2 small, >0.6, moderate, >1.2 large and compared with the 
threshold for the smallest worthwhile effect of the treatment.  
Results: Glycogen loading, both with and without creatine loading, resulted in 
substantial increases in estimates of lean body mass (mean ± SD; 3.0 ± 0.7 % and 2.0 ± 0.9 
%) and leg lean mass (3.1 ± 1.8 %and 2.6 ± 1.0 %) respectively. A substantial decrease in leg 
lean mass was observed following the glycogen depleting condition (-1.4 ± 1.6 %).   Total 
body water showed substantial increases following glycogen loading (2.3 ± 2.3 %), creatine 
loading (1.4 ± 1.9 %) and the combined treatment (2.3 ± 1.1 %).   
Conclusions: Changes in muscle metabolites and water content alter DXA estimates of 
lean mass during periods in which minimal change in muscle protein mass is likely.  This 
information needs to be considered in interpreting the results of DXA-derived estimates of 
body composition in athletes.  
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6.2 Introduction 
Dual x-ray absorptiometry (DXA) is recognised as a criterion technique for the 
measurement of body composition and has become a routine part of the preparation and 
monitoring of athletes (Nana et al., 2015).  Strategies which improve the precision of 
measurement can have real-life importance in sports nutrition; we have previously shown that 
the use of a standardised protocol which allowed the detection of small but worthwhile 
changes in total lean body mass and body fat that would have otherwise been missed if 
measured under non-standardised conditions (Nana et al., 2016).  Although the current 
recommendations for standardizing DXA scanning protocols aim to reduce the 
error/variability associated with gastrointestinal content from recent meals, general hydration 
status and fluid shifts associated with exercise (Nana et al., 2012a, 2013), we have proposed 
that alteration of intramuscular solutes (e.g., glycogen, creatine, carnosine) and their 
associated water binding may cause another source of biological variation.  Indeed, even with 
the implementation of a Best Practice Protocol, we sometimes observe within-athlete 
differences in lean body mass estimates of up to 2 kg over an acute time frame, which are 
unlikely to be explained by real changes in muscle mass.  
It has previously been shown that changes in cellular substrates achieved by common 
practices in sports nutrition can cause detectable changes in muscle size and mass.  For 
example, an investigation using Magnetic Resonance Imaging (MRI) showed increases in 
muscle cross-sectional area following a carbohydrate loading diet (Nygren et al., 2001).  
Similarly, a 10 day creatine loading protocol in untrained individuals was shown to increase 
body mass and DXA estimates of lean mass (Safdar et al., 2008).  A recent study reported an 
increase in the DXA estimate of lean mass in healthy males following the intake of a  high 
carbohydrate in the three days prior to a DXA scan (Rouillier et al., 2015).  However, how the 
variety of changes in muscle solutes and water content commonly experienced by athletes 
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interact to alter estimates of muscle mass has not been considered. Therefore, it is of interest 
to undertake a systematic investigation of the variability in DXA measurements of body 
composition that can be attributed to acute changes in muscle creatine, glycogen and their 
effect on total body water.  We undertook such an investigation, within a larger study of 
creatine and glycogen loading, with the aim of further refining Best Practice Protocols for 
body composition assessment by DXA and/or allowing better interpretation of the results.  
We hypothesized that activities that increased muscle solutes and water would create an 
artefact in measurement of body composition by increasing the estimate of lean mass, while 
depletion would be associated with a decrease in the estimate of lean mass.  
6.3 Methods 
Participants: 
Eighteen competitive male cyclists (age 31.4 ± 5.6 y; body mass (BM) 78.2 ± 8.8 kg; 
height 182.7 ± 7.2 cm; VO2max 65.2 ± 7.1 ml/kg/min) participated in this study which was 
approved by the human research ethics committees of the Australian Institute of Sport 
(20140612) and the Australian Catholic University (2014 254N).  Participants were informed 
of protocols and risks of the study before providing written informed consent.  
Study Design: 
This study, which was part of a larger investigation of creatine and glycogen loading 
on cycling performance, employed a parallel group design to investigate the effect of creatine 
loading, followed by a within-group cross-over application of carbohydrate loading. 
All participants underwent baseline measurements on day 0, followed by tests in the 
Glycogen Depleted state on day 1.  Following Day 1 measurements, participants were 
randomized into either the creatine loading or placebo group and returned for two subsequent 
testing days one week apart (day 7 and day 14) (see Figure 6.1). 
 92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Overview of study design. Pla, placebo; Cr, creatine; CHO, carbohydrate; TT, time trial 
 
 
 
 
 
 
Figure 6.1. Overview of study design. Pla, placebo; Cr, creatine; CHO, carbohydrate; TT, time trial. 
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Creatine and Glycogen Loading: 
Creatine loading was achieved by intake of 20 g/d of creatine monohydrate (Musashi 
Creatine Monohydrate, Vitaco, NSW, Australia) for five days using a split dose regimen (4 x 
5 g/d, consumed at the same time as a carbohydrate-containing meal or snack) followed by 
creatine maintenance (3 g/d) (Harris et al., 1992).  Normalised glycogen stores were achieved 
by consuming a pre-packaged diet providing a carbohydrate intake (6 g/kg/d) for 48 h as well 
as imposing a standardised training protocol including a rest day prior to the DXA scan. 
Meanwhile, glycogen loading was achieved by providing a pre-packaged diet providing 12 
g/kg/d of carbohydrate for the same standardised time period (Burke et al., 2011).  Hydration 
status was standardised by implementing a standardised fluid intake for the 24 h period prior 
to the DXA scans.  Glycogen depletion was achieved by undertaking a cycling protocol in the 
laboratory lasting ~ 3 h 30 min, with consumption of a pre-packaged low carbohydrate diet 
following completion of the protocol until the next morning’s DXA scan.  
The achievement of these protocols provided scenarios to reflect normal-creatine 
normal-glycogen (n = 18; Baseline), normal-creatine glycogen-depleted (n = 18; Glycogen-
Depleted), creatine-loaded glycogen-loaded (n=9; Creatine-Glycogen-Loaded), normal-
creatine glycogen-loaded (n = 9; Glycogen-Loaded), and creatine-loaded normal-glycogen (n 
= 9; Creatine-Loaded). 
 
Dietary Standardization: 
An individualised two day menu was constructed for each participant using 
FoodWorks Professional Edition, Version 7.0 (Xyris Software, Brisbane, Australia) based on 
their body mass and food preferences.  Prior to the baseline trial, subjects received a 
moderate-carbohydrate diet providing 6 g/kg BM/d carbohydrate; 1.5 g/kg BM/d protein; 1.5 
g/kg BM/d fat, with a total energy goal of ~215 kJ/kg/BM per day.  The participants were 
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then randomised to receive either a repeat of the moderate-carbohydrate diet (6g.kg-1BM/d) 
or a carbohydrate-loading diet (12 g/kg BM/d) in the two days prior to the Glycogen Loaded 
and Glycogen Normal trials (Day 7 and Day14) in a cross-over allocation.  These dietary 
treatments were implemented using a placebo-controlled design, whereby the overall menu 
for the day was kept constant, but key items were provided either as a low-kilojoule/low 
carbohydrate option or an indistinguishable carbohydrate-enriched/high kilojoule.   Protein 
and fat intake each remained constant at 1.5 g/kg BM/d in these diets, but energy intake was 
increased in the carbohydrate-loading diet (~320 kJ/kg/d).  Participants refrained from any 
intake of alcohol during the dietary standardisation period.  Caffeine and fluid intake was 
allowed ad lib two days prior to the baseline trial and up to two standard serves (e.g. 1 cup of 
coffee or 1 can caffeinated soft drink) the day before the experimental trial.  Participants 
recorded their caffeine and fluid intake and this was repeated during the dietary 
standardisation period of subsequent trials.  Following the glycogen depleting exercise (Day 
0), participants were fed a pre-packaged standardised low carbohydrate diet (<1 g/kg BM) for 
the reminder of the day to minimise resynthesis of muscle glycogen stores. Subjects were 
provided with all foods and most of their fluids in a standardised menu in portion controlled 
packages, and were given verbal and written instructions on how to follow the diet.  
Checklists were used to record each menu item as it was consumed, and to note any 
deviations from the menu.  An analysis of all the actual diets consumed by participants was 
undertaken on completion of the study using the same software. 
 
Muscle Biopsy:  
Each participant underwent four biopsies over the course of the study, with each being 
collected from the same leg from an incision that was as least 2 cm from the previously 
biopsied site.  All biopsies were conducted by medical practitioners using a 5 mm Bergstrom 
needle modified with suction (Evans et al., 1982). The site was anesthetised using 1% 
95 
 
xylocaine prior to an incision being made through the dermal layer and facia on the 
quadriceps.  Muscle tissue was immediately frozen in liquid nitrogen and stored at -80°C for 
later analysis.  
 
Biochemical Analysis: 
Muscle creatine and glycogen concentrations were measured as described previously 
(Churchley et al., 2007; Harris et al., 1974). Glycogen concentrations were determined via 
enzymatic analysis with fluorometric detection (Jasco FP-750 spectroﬂuorometer, Easton, 
MD) at excitation 365 nm/emission 455 nm. Concentrations were expressed as millimoles of 
glycogen per kilograms of dry weight (mmol/kg d.w). Muscle tissue was analyzed in 
duplicate for free creatine, creatine phosphate, and adenosine triphosphate (ATP) using 
fluorometric techniques. Total creatine was measured as a sum of free creatine and creatine 
phosphate (Harris et al., 1992). 
 
DXA and Total Body Water Protocol: 
For each of the four different conditions, participants reported to the laboratory in the 
morning after an overnight fast and undertook a total body DXA scan as per a standardised 
protocol (Nana et al., 2015).  Body composition was assessed using a whole body scan on a 
narrowed fan-beam DXA (Lunar Prodigy, GE Healthcare, Madison, WI) with analysis 
performed using GE Encore 12.30 software (GE, Madison, WI).  The DXA technical error of 
measurement (TEM) was ~ 0.1% for total mass, 0.4% for total lean, 1.9% for total fat and 
0.7% for total bone mineral content (Nana et al., 2012a).  Following 15 min of rest, total body 
water and fluid compartments were assessed using Bioelectrical Impedance Spectroscopy 
(BIS) (IMP SFB7, ImpediMed Limited, Queensland, Australia) and analysed using BioImp 
Analysis 5.4.0 Software (ImpediMed Limited, Queensland, Australia) according to the 
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protocol described by Moon et al. (Moon et al., 2008). The BIS has a TEM of 0.81 L. 
Hydration status was monitored by measurement of urine specific gravity (UG-a, Atago 
Refractomer, Japan) from a sample collected upon waking. 
 
Statistical Analysis: 
We used a mixed linear model (Proc Mixed in version 9.4 of the statistical Analysis 
System; SAS Institute, Cary, NC) to estimate the effect of the treatments on muscle glycogen 
concentration, muscle creatine concentration, the mass of each component of body and leg 
composition, and the mass of intracellular, extracellular and total body fluids. Treatment was 
a fixed effect in the model (nominal, with six levels), while random effects were the athlete 
identity and its interaction with dummy variables to estimate error additional to the residual 
(individual responses) to glycogen depletion, glycogen loading, creatine loading, and 
combined glycogen and creatine loading.  All dependent variables were log transformed for 
analysis.  The smallest important change was determined as per Nana et al. (Nana et al., 
2012b).  By using the default approach of standardization with an appropriate between-subject 
standard deviation, here the baseline standard deviation.  The magnitudes of changes the 
resulting effects were assessed using the following scale:, <0.2 trivial, >0.2 small, >0.6 
moderate, >1.2 large (Hopkins et al., 2009).  Small or larger changes were considered 
substantial when the threshold for the small effect was reached (≥0.2).  Uncertainty in the 
changes is shown as expressed by 90% confidence limits when the upper and lower 
confidence limits represented substantial increases and decreases, respectively.  Owing to the 
considerable number of effects investigated, the effects were assessed as clear or unclear 
using 99% confidence limits.  All other effects were deemed clear, and shown with the 
probabilities that the true effect was a substantial decrease, a trivial change, or a substantial 
increase. 
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6.4 Results 
Baseline values and percentage changes with the different treatments are presented in 
a series of tables: total body composition (Table 6.1), leg regional body composition (Table 
6.2), body water (Table 6.3) and muscle glycogen concentrations (Table 6.4).  
 
Body mass (Table 6.1):  There was a substantial increase in body mass in the 
combined Creatine–Glycogen Loaded treatment compared to baseline, the observed effect 
being small.  Changes in the separate Glycogen Loaded and Creatine Loaded treatments on 
body mass were clearly not substantial.  Additionally, there was no substantial change in body 
mass following the Glycogen Depleted condition.  
 
Lean Mass (Table 6.1 and 6.2): There were  substantial increases in lean body mass 
following the Creatine-Glycogen-Loaded and the sole Glycogen-Loaded treatments compared 
with baseline measurements, with the observed effects being small.  Similar results were 
observed for leg lean mass with a small but substantial increase with both treatments. The was 
no substantial decrease in lean body mass following the  Glycogen-Depleted condition but 
there was a  substantial decrease in leg lean mass. The effects of the Creatine-Loading 
condition on lean body mass and leg lean mass were likely trivial. 
 
Fat mass and Bone mass (Table 6.1 and 6.2): Compared to baseline measurements, 
changes in total fat mass and leg fat mass in Glycogen-Depleted and Glycogen-Loaded 
conditions were not substantial and produced trivial effect sizes relative to the smallest 
important effect. The effects of Creatine-Loading and the combined Creatine-Glycogen-
Loading conditions on total body fat mass and leg fat mass were also not-substantial.  
Changes in total bone mass and leg bone mass for all treatment conditions were not 
substantial.  
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Table 6.1. Baseline values, smallest important change, and percent changes from baseline following 
various treatments for total body composition. Also shown are magnitude-based inferences for the 
mean changes with each treatment. 
  Change (%) from baseline (mean; ±CL) 
Measure 
Baseline 
(mean ± SD) SIE 
Glycogen 
Depleted 
Glycogen 
Loaded 
Creatine 
Loaded 
Creatine-
Glycogen 
Loaded 
Body mass 77 ± 9 kg 2.3 -1.3; ±0.3  2.1; ±0.7  1.2; ±0.5  2.8; ±0.5 ** 
DXA whole body mass    
Total 78 ± 8 kg 2.2 -1.3; ±0.3  2.3; ±0.6 * 1.3; ±0.6  3.0; ±0.5 *** 
Lean 84 ± 6 %BM 1.5 -1.3; ±0.3  2.1; ±0.5 ** 1.3; ±0.5 3.0; ±0.4 *** 
Fat 12 ± 6 %BM 8.6 -2.0; ±1.5  4.5; ±3.4  3.3; ±5.7  5.2; ±3.9  
Bone 4.2 ± 0.3 %BM 1.8 -0.2; ±0.5  0.4; ±1.1  0.0; ±0.5  -0.2; ±0.5  
%BM, percent of baseline body mass; CL, 90% confidence limits;  
SIE, smallest important effect. This is 0.2 of the between subject SD and the percent change a variable 
has to meet to be considered a substantial change;  indicates substantial increase; , indicates 
substantial  decrease;   
Asterisk/s indicates how clear the change is at the 99% confidence level, *possible clear change, 
**likely clear change, ***very or likely clear change. 
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Table 6.2. Baseline values, smallest important change, and percent changes from baseline following 
various treatments for regional leg composition. Also shown are magnitude-based inferences for the 
mean changes with each treatment. 
  Change (%) from baseline (mean; ±CL) 
Measure 
Baseline 
(mean ± SD) SIE 
Glycogen 
Depleted 
Glycogen 
Loaded 
Creatine 
Loaded 
Creatine-
Glycogen 
Loaded 
Total 35.3 ± 2.0 %BM 1.1 -1.4; ±0.6 ** 2.9; ±0.8 *** 1.1; ±1.2 * 2.9; ±1.3 *** 
Lean 29.4 ± 2.3 %BM 1.5 -1.4; ±0.7 * 2.6; ±0.8 *** 1.2; ±1.0  3.1; ±1.2 *** 
Fat 4.3 ± 2.5 %BM 8.5 -2.5; ±1.7  6.2; ±1.8  2.4; ±6.1  3.2; ±4.1  
Bone 1.65 ± 0.15 %BM 2.0 0.0; ±0.3  0.7; ±0.5  -0.2; ±0.7  -0.2; ±0.5  
%BM, percent of baseline body mass; CL, 90% confidence limits;  
SIE, smallest important effect. This is 0.2 of the between subject SD and the percent change a variable 
has to meet to be considered a substantial change;  indicates substantial increase; , indicates 
substantial  decrease;   
Asterisk/s indicates how clear the change is at the 99% confidence level, *possible clear change, 
**likely clear change, ***very or likely clear change. 
 
Body water (Table 6.3):  There were likely substantial effects of Glycogen-Depletion 
and Glycogen-Loading treatments on total body water. There was a likely decrease in 
extracellular fluid in the Glycogen-Depletion treatment.  An increase in total body water and 
intracellular fluid with the combined Creatine-Glycogen-Loaded condition was very likely, 
with a possible increase in extracellular fluid.  The Creatine-Loading condition was associated 
with a possible likely increase in total body water and intracellular fluid, but no clear effect on 
extracellular fluid.  
Muscle glycogen (Table 6.4):  The effects of Glycogen-Depletion, Glycogen-Loading 
and the combined Creatine-Glycogen loading treatments on muscle glycogen concentration 
were clear.  There was no clear effect of the Creatine-Loading treatment on muscle glycogen 
concentrations.    
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Table 6.3. Baseline values, smallest important change, and percent changes from baseline following 
various treatments for total body water and water compartments. Also shown are magnitude-based 
inferences for the mean changes with each treatment. 
  Change (%) from baseline (mean; ±CL) 
Measure 
Baseline 
(mean ± SD) SIE 
Glycogen 
Depleted 
Glycogen 
Loaded 
Creatine 
Loaded 
Creatine-
Glycogen 
Loaded 
Total 
body 61.2 ± 3.8 %BM 1.3 -2.0; ±1.1 ** 2.3; ±1.3 ** 1.3; ±1.7 * 2.5; ±1.0 *** 
Intra-
cellular 36.1 ± 3.0 %BM 1.4 -1.3; ±1.6 * 2.2; ±1.9 * 1.4; ±2.0 * 6.8; ±4.5 *** 
Extra-
cellular 25.3 ± 1.4 %BM 1.0 
-3.5; ±1.2 
*** 2.2; ±1.5 ** 0.3; ±1.8 1.4; ±1.9 * 
%BM, percent of baseline body mass; CL, 90% confidence limits;  
SIE, smallest important effect. This is 0.2 of the between subject SD and the percent change a variable 
has to meet to be considered a substantial change;  indicates substantial increase; , indicates 
substantial  decrease;   
Asterisk/s indicates how clear the change is at the 99% confidence level, *possible clear change, 
**likely clear change, ***very or likely clear change. 
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Table 6.4. Baseline values, smallest important change, and percent changes from baseline following 
various treatments for muscle glycogen and total creatine. Also shown are magnitude-based inferences 
for the mean changes with each treatment. 
  Change from baseline (mean; ± CL) 
Measure 
Baseline 
(mean ± SD) SIE 
Glycogen 
Depleted 
Glycogen 
Loaded 
Creatine 
Loaded 
Creatine-
Glycogen 
Loaded 
Muscle 
Glycogen 
580 ± 140 
mmol/kg d.w. 1.9 -57; ±7.3 *** 22; ±12.6 *** -2; ±15.4 20; ±15.9 *** 
Muscle 
Creatine 136 ± 17 µmol/g 2.2 0; ±6.2 -2; ±8.5 6; ±10.1 6; ±4.6 ** 
%BM, percent of baseline body mass; CL, 90% confidence limits;  
SIE, smallest important effect. This is 0.2 of the between subject SD and the percent change a variable 
has to meet to be considered a substantial change;  indicates substantial increase; , indicates 
substantial  decrease;   
Asterisk/s indicates how clear the change is at the 99% confidence level, *possible clear change, 
**likely clear change, ***very or likely clear change. 
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6.5 Discussion 
This study is the first to systematically investigate the effect of glycogen loading, 
creatine loading and their interaction on DXA estimates of body composition.  Estimates of 
lean body mass were substantially higher with glycogen loading translating to a mean 1.3 kg 
increase in lean body mass and 1.7 kg increase in leg lean mass following our glycogen 
loading treatment and a 1.9 kg increase in lean body mass and 2.0 kg increase in leg lean mass 
following a combined creatine glycogen loading treatment.  On the other hand, glycogen 
depleting exercise resulted in a mean decrease of 1.0 kg and 0.8kg of lean body mass and leg 
lean mass which was deemed very likely trivial. The changes in the DXA estimates of lean 
body mass and leg lean mass were reflected by the changes in total body water and 
intracellular fluid. Our findings of increased total body water, and more specifically 
intracellular fluid, with glycogen loading were expected.  However, we have demonstrated, 
for the first time that this creates an artefact in DXA-derived measurements of body 
composition in well trained athletes.  
It is well accepted that water is bound to the glycogen molecule in the cellular 
environment.  Indeed, a ratio of three grams of water to one gram of muscle glycogen is 
commonly stated, based primarily on a single rat study from the 1940s which determined that 
1 g of liver glycogen was associated with 2.7 g of water over a range of concentrations 
(McBride et al., 1941). Olsson and colleagues assessed body water by tritium trace in dilution 
in males before and after glycogen loading, reporting that each gram of glycogen was stored 
with 3-4 g of water (Olsson & Saltin, 1970). They observed a mean increase in body mass of 
2.4 kg, of which 2.2 L was attributed to the increase in total body water. (Olsson & Saltin, 
1970).  However, Sherman et al. completed studies of rat skeletal muscle and failed to find a 
consistent relationship between glycogen and water content over a range of glycogen 
concentrations (Sherman et al., 1982). More recently, Fernández-Elías and colleagues 
reported different ratios of muscle glycogen to water following post-exercise glycogen 
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repletion under different fluid intakes.  A ratio of 1:3 was found when only 400 ml of water 
was consumed, while a ratio of 1:17 was determined when participants replaced the fluid lost 
during exercise (Fernandez-Elias et al., 2015).  Although anecdotes and studies have noted 
that glycogen loading is associated with a gain in total body mass (Brotherhood & Swanson, 
1979), and that changes in glycogen can confound the results of weight loss programs in the 
general community (Kreitzman et al., 1992), few studies have investigated how changes in 
glycogen loading (and consequently body water) would affect interpretations of body 
composition in athlete populations.  
An increase in body mass is considered a direct side effect of the creatine 
supplementation during the initial loading phase (Hultman et al., 1996; Juhn & Tarnopolsky, 
1998; Volek & Kraemer, 1996).  The mass increase is often attributed to water retention, as 
five days is considered too short a period to detect real changes in myofibrillar protein content 
(Hultman et al., 1996; Juhn & Tarnopolsky, 1998; Powers et al., 2003; Volek & Kraemer, 
1996). Since creatine is an osmotic particle, increases in its concentration in muscle could 
induce cellular swelling leading to fluid retention (Bemben et al., 2001; Francaux & 
Poortmans, 1999). Indeed, acute decreases in urinary output (Hultman et al., 1996) and 
increases in total body and intracellular water have both been reported following creatine 
loading protocols. Furthermore, creatine supplementation of 20-25 g per day for 5-7 days has 
been associated with increases of 1.0 to 2.0 kg (Kinugasa et al., 2004; van Loon et al., 2003; 
Volek & Kraemer, 1996) in body mass and 1.3 to 2.3 L in total body water (Deminice et al., 
2016; Powers et al., 2003; Safdar et al., 2008).  However, not all studies have found a 
concurrent increase in the intracellular water compartment (Powers et al., 2003).   
To our knowledge, only a handful of studies has have investigated the effect of 
carbohydrate loading or creatine loading on body composition or muscle size (Balon et al., 
1992; Nygren et al., 2001; Rouillier et al., 2015), and we are the first to investigate the 
interaction of these two strategies. Another novel aspect of our study was the assessment of 
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total body water as an adjunct to the measurement of body composition; to our knowledge, no 
other study has reported on the effect of glycogen loading on lean body mass and total body 
water. Our findings support those of Nygren et al. (Nygren et al., 2001) and Rouillier et al. 
(Rouillier et al., 2015), with substantial increases in muscle glycogen, lean body mass and 
total body water observed following 48 h of glycogen loading.  Nygren et al. (Nygren et al., 
2001) reported an increase in the vastus lateralis cross sectional area by MRI following four 
days of carbohydrate loading in healthy males. The increase in muscle cross sectional area 
was attributed to the increase in glycogen (281 to 634 mmol/kg d.w.) along with the binding 
of the water (Nygren et al., 2001).  However, neither body water nor measures of body 
composition were assessed in this investigation.  Meanwhile Balon and colleagues found no 
increase in muscle girth following a three day high carbohydrate diet (80% carbohydrate) 
compared with a low carbohydrate diet (10% carbohydrate) with concurrent resistance 
training (Balon et al., 1992).  
A recent study investigating three days of increased carbohydrate intake on DXA 
estimates of body composition reported a mean 0.9 kg increase in lean body mass and 1.4 kg 
increase in appendicular lean mass (arms and legs) (Rouillier et al., 2015). Although the 
authors attributed the increase in appendicular lean mass to increased glycogen storage, no 
biopsies were conducted to verify changes in muscle glycogen content (Rouillier et al., 2015). 
Furthermore, dietary intake was not prescribed and although carbohydrate intake achieved the 
stated goal of exceeding 75% of total energy intake, this amounted to a total daily intake of 8 
g/kg, compared to 12 g/kg in our study.  Some concerns regarding the standardization of the 
methodology of the DXA scans are also noted: although not clearly stated, the DXA scans 
were conducted following an overnight rest and fast (Bone & Burke, 2016) but it is unknown 
whether carbohydrate intake was standardized prior to the baseline scan.  
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Several studies have investigated the effect of creatine supplementation on body 
composition, however they are often for longer supplementation periods and taken 
concurrently with resistance training (Bemben et al., 2001; Earnest et al., 1995; Francaux & 
Poortmans, 1999; Kutz & Gunter, 2003; Ziegenfuss et al., 2002).  Currently only one other 
study has assessed the sole effect of short term creatine supplementation on body water and 
body composition (Safdar et al., 2008). Safdar et al. (2008) reported increases in lean body 
mass by DXA following a 10 day creatine supplementation period in untrained individuals.  
Furthermore, measurement of total body water by BIS revealed an increase in intracellular 
fluid compartment, although the magnitude of this increase was not provided (Safdar et al., 
2008). Our creatine loading treatment resulted in only trivial changes in muscle creatine 
content and lean mass, and showed only possible increases in total body water and 
intracellular fluid.  Due to our study design, the assessment of all these parameters occurred 
on either Day 7 or Day 14 of the supplementation protocol, where participants had changed to 
a reduced creatine dosage (3 g/d), believed to maintain elevated creatine stores (Preen et al., 
2003), for two or nine days respectively.  However, since van Loon et al. (van Loon et al., 
2003) recently reported that this “maintenance” dose is not always sufficient for maintaining 
creatine levels, it is possible that a reduction in creatine content occurred over the longer 
maintenance period, obscuring any earlier effects.  
We note some other real and apparent limitations of this study.  Due to the 
requirements of the larger study, we were unable to add further measurements such as an 
assessment of body composition and body water under a Creatine-Loaded-Glycogen-Depleted 
condition.  Furthermore, we anticipate the criticism that the Glycogen-Depleted condition was 
monitored 15-18 h after the completion of the glycogen-depleting task.  However, as we 
conducted our scans using a standardised protocol based on Nana et al. (Nana et al., 2016) 
which require fasted and rested conditions to standardize gut contents and hydration status, 
we needed to undertake these measurements on the morning following the exercise session.  
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However, we attempted to minimize glycogen resynthesis during the recovery period by 
providing participants with a diet providing < 1 g/kg carbohydrate.  This was successful in 
maintaining glycogen content below pre-exercise levels, and indeed may mirror the real-life 
practices of athletes who “sleep low” (restrict carbohydrate intake) after quality training 
sessions to prolong the adaptive response to exercise by delaying muscle glycogen storage 
(Marquet et al., 2016).  We acknowledge that BIS is an indirect measurement of total body 
water, however, the use of the criterion dilution methods did not fit within the constraints of 
the larger study. Additionally, BIS has been recently validated against criterion methods in 
athletes and was considered appropriate in this setting (Kerr et al., 2015; Matias et al., 2016).   
 
In summary, the results from this study provide further evidence of daily variability in 
the DXA assessments of body composition of athletes due to factors frequently experienced in 
sport.  Recent work by our centre has developed techniques to standardize DXA assessment 
protocols (Nana et al., 2012a, 2013; Nana et al., 2016), showing that the implementation of 
overnight fasted and rested conditions can reduce variability to allow greater sensitivity in the 
detection of real and interesting changes in body composition (Nana et al., 2016).  The present 
study expands on this work and indicates that when DXA is used for longitudinal monitoring 
of physique, scans should be undertaken with consideration of recent practices of training and 
diet that might be expected to manipulate muscle glycogen stores.  Where standardization of 
these practices is impractical, the interpretation of the results of DXA assessments of body 
composition should take into account the likely artefacts with respect to lean mass.  Future 
studies should also investigate the effect of other sources of changes in intramuscular fluid 
and substrate such as muscle damage or carnitine supplementation, alongside those caused by 
exercise or dietary manipulation.   
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Preface to Chapter Seven 
The previous study in Chapter 6 highlighted how manipulations of muscle glycogen 
concentration (whether depleted or loaded) had a likely substantial influence on lean mass 
estimates by DXA.  The following chapter is Study 4 of this thesis and investigates the 
validity and reliability of ultrasound technology for the use of estimating and tracking changes 
in muscle glycogen. If valid, this technique would assist practitioners in the interpretations of 
REE relative to FFM and possibly allow for a “correction” for this artefact in the DXA 
estimate of lean mass if the ultrasound detects a change muscle glycogen concentrations.  
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7.0 Study Four: Ultrasound Technology Fails To Provide Indirect 
Estimate of Muscle Glycogen Concentration 
 
The following chapter is comprised of the following manuscript under preparation to 
be submitted to Nutrients: 
 
Bone, JL. Ross, ML, Hopkins, WG, Tomcik, KA, Jeacocke, NA, Burke, LM. 
Ultrasound Technology Fails To Provide Indirect Estimate of Muscle Glycogen 
Concentration 
 
This study was funded by a grant from the Australian Catholic University Research 
Fund awarded to Prof Louise M Burke. 
 
  
109 
 
7.1 Abstract 
Quantification of muscle glycogen traditionally requires muscle biopsies or nuclear 
magnetic resonance. These procedures limit opportunities to conduct research in the field or 
with elite athletes. We undertook a validation study of measurement of muscle glycogen with 
new ultrasound technology in 12 highly-trained male cyclists. Muscle water and solutes were 
manipulated via glycogen depletion (~3.5 h of cycling) and combinations of carbohydrate 
loading (12 g/d per kg body mass for 48 h) and creatine loading (20 g/d for 5 d; 3 g/d for 9 d). 
Glycogen was measured in biopsies from the vastus lateralis on one leg and with ultrasound 
on the non-biopsied leg. Ultrasound images were captured at the midpoint of the vastus 
lateralis and contralateral to the biopsy site, then uploaded to proprietary software 
(MuscleSound® 2015), which provided an ultrasound glycogen score.  Changes in mean 
glycogen concentration in the glycogen-loaded and -depleted conditions were tracked clearly 
by biopsy, but not by ultrasound. Scatterplots showed poor relationships between biopsy and 
ultrasound score, and the error in glycogen concentration predicted by ultrasound score was 
either unclear or ranged in uncertainty from very large to extremely large when evaluated by 
standardization after removal of the contribution of error of measurement in glycogen 
concentration. Mixed modelling showed similar errors in prediction of changes in glycogen 
concentration by changes in ultrasound score.  We conclude that the ultrasound-based 
technique failed to predict muscle glycogen under conditions where muscle solutes and water 
vary across more extreme ranges experienced by athletes than original validation conditions.  
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7.2 Introduction 
Determination of muscle glycogen content is of interest in sports nutrition research 
and practice due to the important role of this compound as a fuel source in athletic 
performance and a regulator of muscle metabolism and adaptation (Philp et al., 2012).  
Typically, in research settings, muscle glycogen concentrations are determined via direct but 
invasive techniques (muscle biopsy) or by specialized techniques (nuclear magnetic 
resonance) that are expensive and not commonly available. More recently, a commercial 
application of ultrasound technology has been promoted as a practical and portable technique 
to measure muscle glycogen, suitable for both laboratory and field use (Hill & Millan, 2014; 
Nieman et al., 2015).  The MuscleSound® methodology uses high-frequency ultrasound 
technology and image analysis from patented cloud-based software to estimate muscle 
glycogen content based on the associated muscle water content, through the image grey scale 
(Hill & Millan, 2014; McBride et al., 1941; Nieman et al., 2015).   Changes in the brightness 
(echo intensity) of the image indicate greater amounts of fluid and therefore glycogen in the 
muscle while a darker image represents less fluid and glycogen (Nieman et al., 2015).  If this 
technique can be shown to provide accurate measurements of muscle glycogen, it would have 
valuable applications in sports nutrition practice and research, particularly in field conditions 
and among elite athletes where the traditional techniques of glycogen measurement are not 
suitable. 
Previous validation studies comparing direct and MuscleSound® estimates of muscle 
glycogen from the quadriceps of well-trained cyclists prior to and after a prolonged cycling 
bout reported significant correlations between values for pre-exercise, post-exercise and 
change scores in muscle glycogen between the two measurement techniques (Hill & Millan, 
2014; Nieman et al., 2015).  We undertook a further independent validation study of the 
MuscleSound® system within a larger investigation of the manipulation of muscle glycogen 
and creatine content in well-trained athlete.  This provided a novel opportunity to assess if 
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changes in intramuscular fluid and solutes from a range of strategies affect the precision and 
reliability of MuscleSound® assessments of muscle glycogen. We hypothesised that 
MuscleSound® estimates of muscle glycogen would not be valid when manipulations of 
intramuscular solutes and fluids were more extreme and were not related directly to changes 
in muscle glycogen.   
 
7.3 Methods 
Participants:  
Twelve competitive male cyclists participated in this study which was approved by the 
human research ethics committees of the Australian Institute of Sport (20140612) and the 
Australian Catholic University (2014 254N).  Participants were informed of protocols and 
risks of the study before providing written informed consent.  Participants’ characteristics are 
presented in Table 7.1.  These subjects represent a sub-group of a larger cohort who 
undertook the main project under which this study was performed (Bone et al., 2017). 
 
Table 7.1. Descriptive characteristics of the 12 study participants.  Data are mean ± SD. 
Age (y) 32.6 ± 5.1 
Body mass (kg) 79.2 ± 9.5 
Height (cm) 183.4 ± 5.0 
VO2max (L/min) 5.1 ± 0.6 
Maximum power output (W) 639 ± 115 
 VO2max: maximum oxygen consumption 
 
Study Design: 
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This study, which was part of a larger investigation of creatine and glycogen loading, 
employed a parallel group design to investigate the effect of creatine loading, followed by a 
within-group cross-over application of carbohydrate loading on muscle substrate and water 
content and performance (see Figure 6.1). Participants came in for four separate biopsy and 
ultrasound measurements; baseline (Day 0, 6g carbohydrate /kg BM/d for 48 h), Glycogen 
Depleted (Day1) and either Glycogen Loaded or Glycogen Normal (6 g carbohydrate /kg 
BM/d for 48 h) with or without creatine supplementation (Days 7 and 14).  Manipulations of 
creatine and glycogen stores were achieved by implementing “Best Practice Protocols” of 
creatine loading (20 g/d for 5 d loading; 3g/d maintenance) (Harris et al., 1992) and glycogen 
loading (12 g carbohydrate /kg BM/d for 48 h) (Burke et al., 2011) through a standardised 
pre-packaged diet.  Furthermore, a supervised cycling protocol of ~ 3.5 h, including a series 
of higher intensity efforts, was undertaken to deplete muscle glycogen stores with 
consumption of a low carbohydrate diet (<1g CHO / kg BM) to prevent repletion of glycogen 
stores before a further assessment of muscle glycogen content the following morning.  This 
provided situations where muscle glycogen was measured under baseline normalised 
conditions, depleted condition, and also glycogen loaded with or without creatine loading 
(Bone et al., 2017). 
 
Muscle Biopsy:  
Four biopsies were conducted over the course of the study, with each being collected 
from the same leg from an incision that was as least 2 cm from the previously biopsied site.  
All biopsies were conducted by medical practitioners.  The skin and fascia at the site was 
anesthetised using 1% xylocaine.   An incision was then made through the dermal layer and 
facia on the quadriceps before a modified 5 mm Bergstrom needle, with suction, was used to 
collect the sample (Evans et al., 1982).  Muscle tissue was immediately frozen in liquid 
nitrogen and stored at -80°C for later analysis.  
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Biochemical Analysis: 
Creatine and glycogen concentrations in the muscle samples were measured as 
previously described (Churchley et al., 2007; Harris et al., 1974). Glycogen concentrations 
were determined via enzymatic analysis with fluorometric detection (Jasco FP-750 
spectroﬂuorometer, Easton, MD) at excitation 365 nm/emission 455 nm. Concentrations were 
expressed as millimoles of glycogen per kilograms of dry weight (mmol/kg d.w) (Churchley 
et al., 2007). Samples for creatine concentration were analyzed in duplicate for free creatine, 
creatine phosphate, and adenosine triphosphate using fluorometric techniques. Total creatine 
was measured as a sum of free creatine and creatine phosphate (Harris et al., 1974).  
Error of measurement of glycogen concentration was estimated from individual values 
provided by the authors of a previous study (unpublished data), in which 10 athletes similar to 
those in the present study were biopsied twice for measurement of glycogen concentration in 
a high glycogen and low glycogen condition using the same biochemical methods. Each 
biopsy had been divided into two samples and analyzed separately. To obtain an estimate of 
error of measurement appropriate for the present study, we treated the data for the high and 
low glycogen conditions as if they came from separate subjects.  We then performed a one-
way reliability analyses with the first split sample, a separate one-way analysis for the second 
sample, then averaged the error of measurement (via an average of the variances) from the 
two analyses. The analyses were performed with a published spreadsheet using the cells for 
log-transformation (Hopkins, 2015); the resulting error of measurement was 22%. For 
purposes of parametric bootstrapping (see below), the error was assumed to have 20 degrees 
of freedom. 
 
Ultrasound Imaging & Processing: 
Two of the researchers involved with this study were trained to capture ultrasound 
images on the vastus lateralis using a portable ultrasound machine. They practised this 
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technique to achieve acceptable reliability with repeat images and were assigned to the study 
roster such that each participant was scanned by a single technician over the duration of their 
study involvement.  Thereafter, on each occasion that a muscle biopsy was performed, 
ultrasound images were captured on the contra-lateral leg using the same machine and by the 
same technician (Terason t3000, TeraTech Corporation, MA, USA). Five ultrasound images 
were captured at each time-point, at two different sites of the vastus lateralis. One site, which 
stayed constant over the four treatment days, was located at the midpoint of the thigh (Mid) 
between the anatomical landmarks of the distal ischemic bone and the anterior, superior 
patella.  The second site tracked the location of the specific incision on the biopsied leg 
(Contra). The ultrasound procedures were performed according to MuscleSound® guidelines 
with images captured on the transverse plane at a depth of 4 cm and a gain of 45 with the 
muscle relaxed.  The transducer head was manipulated to achieve a bright fascia which 
defined the muscle boundary for the region of interest.  Images were then uploaded to the 
MuscleSound® software  (v.2015, MuscleSound, LLC, Denver, CO) which provided a 
glycogen score (0-100) in arbitrary units (a.u.) (Nieman et al., 2015).  Scores were provided in 
bands of 5 a.u. with a typical error of ± 5 a.u. Ultrasound scores for US-Contra and US-mid 
were obtained by averaging the score of the five images captured at each site.  
 
Muscle Fuel Scores 
The ultrasound images were re-analysed using MuscleSounds updated algorithm (v 
2017).  The output from this analysis is termed the “Muscle Fuel Score” to differentiate it 
from glycogen score from the original analysis.  Briefly, the “Muscle Fuel Score” is an 
estimated fuel level determined placing an image in context of the maximum (100) and 
minimum (0) percent obtained for a specific participant.  The maximum and minimum values 
are determined from bank of images captured for that participant.  
Statistical Analysis: 
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Complex statistical models were used to determine the correlation and error of 
prediction for the ultrasound’s ability to predict single muscle glycogen concentrations and 
changes in muscle glycogen concentration against the criterion biopsy method.  
Specifically, scatterplots of glycogen concentration vs ultrasound score showed weak 
relationships that were best quantified with a simple linear model. Log transformation before 
analysis was deemed appropriate for glycogen concentration, since its values are positive and 
expected to show more uniformity of error when the error is expressed in percent rather than 
absolute units. The ultrasound score and Muscle Fuel Estimate were therefore also log-
transformed. The analyses were performed with the Statistical Analysis System (version 9.4, 
SAS Institute, Cary, NC). 
The utility of the ultrasound score and Muscle Fuel Estimate to measure glycogen 
concentration in single measurements of individuals was investigated with a novel analysis, in 
which the magnitude of the error in glycogen concentration predicted by the linear 
relationship was assessed by standardization.  The prediction error includes error of 
measurement in glycogen concentration (see above), which was removed by subtracting the 
square of the error of measurement from the square of the prediction error and taking the 
square root. The appropriate between-subject standard deviation (SD) for standardization of 
this net prediction error was the SD of the predicted values of glycogen concentration, which 
represents the typical differences between subjects free of prediction and measurement error. 
This SD was derived by multiplying the between-athlete SD of the ultrasound score by the 
slope of the glycogen-ultrasound relationship.  The standardized net prediction error was then 
derived by dividing the net error by the SD of the predicted values.  Thresholds for trivial, 
small, moderate, large very large and extremely large values of the standardized error were 
<0.1, 0.1, 0.3, 0.6, 1.0 and 2.0 respectively, which are half the usual thresholds for 
interpreting magnitudes of differences in means (Smith & Hopkins, 2011). Confidence limits 
(at the 90% level) for the net prediction error and the standardized error were derived by a 
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combination of usual and parametric bootstrapping: the analysis was repeated for 3000 
bootstrap samples, but for each sample a value of error of measurement of glycogen 
concentration was generated with a value chosen randomly from the chi-squared sampling 
distribution (by dividing the randomly-chosen value by the degrees of freedom for the error of 
measurement, taking the square root, then multiplying by the error of measurement). The 
slope of the linear relationship between glycogen concentration and ultrasound score (in 
percent per percent units) and the correlation between the variables were also derived via the 
usual linear modelling procedures applied to the original sample, but their magnitudes were 
not interpreted.  
This analysis was performed first with the data for two conditions (baseline and 
glycogen-depleted) by treating the repeated measurements as if they came from different 
athletes.  In this way the resulting range in glycogen concentration would be similar to that 
expected in athletes sampled before or after a hard training bout or endurance competition.  
The analysis was repeated for four conditions (Baseline, Glycogen Depleted, Glycogen 
Loaded) and for all six conditions (Baseline, Glycogen Depleted, Placebo, Creatine Loaded, 
Glycogen Loaded, Glycogen-Creatine Loaded). All analyses were also performed separately 
for biopsies sampled from the two sites (Contra and Mid).   
A similar novel analysis was performed to investigate the utility of the ultrasound 
score and Muscle Fuel Estimate to measure changes in glycogen concentration within 
individuals for the same three combinations of conditions and biopsies from the two sites.  A 
mixed linear model was used to predict glycogen concentration, with the ultrasound 
score/Muscle fuel estimate as a simple linear fixed effect and athlete identity as a random 
effect. This model effectively fits a straight line to the data, with the same slope but a different 
intercept for each athlete. To display graphically what this analysis achieves, each subject's 
values for glycogen concentration and ultrasound score were rescaled to a mean of zero and 
then plotted on one set of axes. The line of best fit for this scatterplot is effectively the line 
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provided by the fixed effect in the mixed model.  The SD of the residuals in the mixed model 
is the error in changes in glycogen concentration predicted by changes in ultrasound score or 
changes in the Muscle Fuel Estimate. As above, the net prediction error was obtained by 
removing error of measurement in glycogen concentration, and the magnitude of the error was 
standardized with the SD of glycogen concentration predicted by multiplying the slope of the 
relationship by the between-athlete SD in ultrasound scores and Muscle Fuel Estimate.  The 
SD of ultrasound scores and the Muscle Fuel Estimates was the overall SD of all athletes from 
all treatments, to represent the typical differences between athletes in a randomly chosen 
sample from randomly chosen treatments. Bootstrapping was performed by generating 
random samples of athlete identities, to retain the repeated-measures structure of the data. 
 
7.4 Results 
Baseline muscle biopsy concentrations, ultrasound scores and the mean percent 
change from baseline for each measurement under the different treatment conditions are 
presented in Table 7.2.  The glycogen depleting exercise had the largest effect on changing 
muscle glycogen with a mean decrease of 330.6 mmol/kg d.w. from baseline.  There were 
moderate substantial increases of 104.4 and 156.6 mmol/kg d.w. in muscle glycogen 
following glycogen loading with and without creatine loading respectively. There was no 
effect of creatine loading on muscle glycogen concentrations. 
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Table 7.2. Muscle glycogen concentrations and ultrasound scores at baseline and percent changes from baseline 
for all treatments. Data are mean ± SD.  Also shown are magnitude-based inferences for the changes from 
baseline. 
 
 
Changes from baseline (%) 
Measure 
Baseline 
(n=12) 
Smallest 
important 
(n=12) 
Glycogen 
depleted 
(n=11) 
Normal 
glycogen 
(n=7) 
Glycogen 
loaded 
(n=6) 
Creatine 
loaded 
(n=5) 
Glycogen-
Creatine 
loaded 
(n=5) 
Muscle 
glycogen 
580 ± 140 
mmol/kg d.w. 
1.9 -57 ± 42 *** -7 ± 26 18 ± 25 *** 7 ± 43 27 ± 35 *** 
Ultrasound 
contra 
55 ± 10 
units 
3.9 
-4 ± 15 * -3 ± 11 3 ± 18 
4 ± 6 00 10 ± 9 ** 
Ultrasound 
mid 
56 ± 9 
units 
4.2 
-9 ± 17 ** -1 ± 11 3 ± 14 
4 ± 6 00 7 ± 10 * 
Contra, images captured at the site contralateral to the biopsy; mid, images captured at the midpoint of the thigh. 
, *possible, **likely, ***very or most likely clear substantial increase () or decrease (). 
00likely, 000very or most likely clear trivial change. 
 
Changes in muscle glycogen concentration measured by the ultrasound technique were 
less clear. The Contra and Mid sites showed small but substantial increases of 5.5 a.u. and 3.9 
a.u. in ultrasound scores respectively following the combined Glycogen-Creatine Loading 
condition.  No change in ultrasound scores were observed following the Creatine Loading 
condition.  The Glycogen Depleted condition resulted in small but substantial decreases of 2.2 
a.u. and 5.0 a.u. for images captured at the Contra and Mid sites respectively. No substantial 
increases in ultrasound score were observed following the Glycogen Loaded condition. The 
changes in the Muscle Fuel Estimate across the various conditions are not provided as they 
were not able to be determined by the statistical model, meaning that errors or effect sizes 
could not be calculated.. The Muscle Fuel Estimate values provided could not estimate errors 
or effects.   
The scatterplot for predicting single muscle glycogen measurements from ultrasound 
showed a moderate relationship for the Baseline and Glycogen Depleted conditions at the mid 
ultrasound site (Figure 7.1). When all conditions were assessed the relationship ranged from 
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moderate to poor across both ultrasound sites (Table 7.3). The error in predicting muscle 
glycogen from ultrasound varied from unclear to extremely large at (Table 7.3).   
 
Table 7.3. Linear relationships for prediction of single glycogen concentrations and changes in glycogen 
concentration by ultrasound scores derived with data from different conditions for different biopsy sites. Data in 
parentheses are 90% confidence limits. 
  Biopsy 
site 
  Error of the estimated 
 Data analysed Correlation Slope (%/%) Percent units Standardizede Magnitude 
Prediction of single concentrations 
 Two conditionsa Contra 0.17 
(-0.20, 0.49) 
0.42 
(-0.49, 1.32) 
71 
(45, 89) 
5.6 
(-22, 26) 
Unclear 
  Mid 0.32 
(-0.05, 0.59) 
0.73 
(0.06, 1.59) 
68 
(41, 85) 
2.9 
(1.0, 12) 
Very large to 
extremely large 
 Four conditionsb Contra 0.10 
(-0.18, 0.37) 
0.23 
(-0.35, 0.73) 
62 
(39, 79) 
9.0 
(-42, 44) 
Unclear 
  Mid 0.20 
(-0.08, 0.46) 
0.43 
(-0.14, 1.04) 
61 
(31, 77) 
4.5 
(-19, 26) 
Unclear 
 Six conditionsc Contra 0.17 
(-0.08, 0.40) 
0.40 
(-0.07, 0.88) 
56 
(35, 73) 
5.3 
(-12, 28) 
Unclear 
  Mid 0.26 
(0.02, 0.48) 
0.57 
(0.06, 1.12) 
54 
(33, 70) 
3.3 
(1.3, 14) 
Very large to 
extremely large 
Prediction of changes in concentration 
 Two conditionsa Contra 0.22 
(-0.14, 0.53) 
0.42 
(-0.22, 1.46) 
71 
(50, 89) 
5.6 
(-21, 25) 
Unclear 
        
  Mid 0.42 
(0.08, 0.67) 
0.73 
(0.23, 1.87) 
68 
(45, 87) 
2.9 
(1.2, 9.8) 
Very large to 
extremely large 
 Four conditionsb Contra 0.24 
(-0.04, 0.49) 
0.24 
(-0.32, 1.26) 
62 
(44, 72) 
8.7 
(-30, 31) 
Unclear 
  Mid 0.46 
(0.20, 0.65) 
0.48 
(-0.02, 1.59) 
59 
(39, 70) 
4.0 
(-8.1, 21) 
Unclear 
 Six conditionsc Contra 0.31 
(0.07, 0.51) 
0.40 
(0.09, 1.38) 
56 
(40, 67) 
5.3 
(2.0, 18) 
Extremely large 
  Mid 0.48 
(0.26, 0.65) 
0.57 
(0.21, 1.65) 
54 
(37, 65) 
3.3 
(1.3, 8.5) 
Very large to 
extremely large 
aBaseline, glycogen depleted. 
bBaseline, glycogen depleted, placebo, glycogen-loaded. 
cBaseline, glycogen depleted, placebo, glycogen -loaded, creatine-loaded, glycogen – creatine loaded. 
dFree of error of measurement in glycogen concentration. 
eThresholds for small, moderate, large, very large, and extremely large errors: 0.1, 0.3, 0.6, 1.0, and 2.0 respectively. 
Contra,  images captured at the site contralateral to the biopsy; mid, images captured at the midpoint of the thigh 
120 
 
Figure 7.1. Cross-sectional relationship between biopsy muscle glycogen and ultrasound 
score measured at the mid-thigh site on the contralateral leg. Data shown are combined from 
the baseline and depleted conditions.  Axis are log scales. 
 
 
Figure 7.2 shows a moderate relationship between the observed changes in biopsy 
derived muscle glycogen compared with the ultrasound score for all non creatine treatment 
conditions at the Mid ultrasound site.  The magnitude of the error for predicting changes in 
muscle glycogen from the ultrasound showed similar magnitude of errors as the single 
measurements across all sites (Table 7.3).    
The inclusion of the Creatine Loaded and Glycogen–Creatine Loaded conditions into 
the linear and mixed models did not change the relationship between the biopsy measurement 
and the ultrasound score (Figure 7.3).  The magnitude of the prediction errors also remained 
the same (Table 7.3).  
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Figure 7.2 Comparison of change in glycogen status between measured glycogen 
concentration and ultrasound score from the mid-thigh on the contralateral leg for baseline, 
glycogen depleted, placebo and glycogen loaded treatment conditions. Participants’ means 
have been rescaled to means of zero. Axis are log scales. 
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Figure 7.3. Comparison of the change in glycogen status between biopsy glycogen 
concentration and ultrasound score from the mid-thigh site on the contralateral leg for all 
treatment conditions. Participants’ means have been rescaled to means of zero. Axis are log 
scales. 
 
The correlation between the updated Muscle Fuel Estimate and the biopsy glycogen 
was greater for both sites for the four and six conditions compared to original ultrasound 
scores (Table 7.4).  However, the error in the prediction remained either Unclear or ranged 
from Very Large to Extremely Large.  (Table 7.4).  The error in the prediction also remained 
either unclear or very large to extremely large when the updated muscle fuel estimate 
predicted the change in muscle glycogen levels between the conditions.  The scatterplots 
showing the relationships have been provided in the supplementary data appendix (Chapter 
12).  
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Table 7.4. Linear relationships for prediction of single glycogen concentrations and changes in muscle fuel 
estimates derived with data from different conditions for different biopsy sites. Data in parentheses are 90% 
confidence limits. 
 Biopsy 
site 
   Error of the estimated 
Data analyzed Magnitude Correlation Slope (%/%) 
Percent 
Units Standardized
e Magnitude 
Prediction of single concentrations 
Two conditionsa 
Contra Unclear 0.16 (-0.20, 0.48) 
0.30 
(-0.37, 0.96( 
71.5 
(42, 89) 
5.8 
(-21.7, 25.9) Unclear 
Mid 
Very large to 
extremely 
large 
0.22 
(-0.14, 0.53) 
0.21 
(-0.13, 0.55) 
70.3 
(42, 88) 
4.2 
(-4.6, 19.8) Unclear 
Four conditionsb 
Contra Unclear 0.24 (-0.04, 0.49) 
0.43  
(-0.08, 0.93) 
59.8 
(35, 77) 
3.7 
(-13.5, 19.5) Unclear 
Mid Unclear 0.31 (0.03, 0.54) 
0.31 
(0.15, 0.54) 
58 
(33, 75) 
2.8 
(1.4, 6.8) 
Very large 
to 
extremely 
large 
Six conditionsc 
Contra Unclear 0.28 (0.03, 0.48) 
0.48 
(0.06, 0.90) 
53.8 
(32, 71) 
3.2 
(-4.5, 15.8) Unclear 
Mid 
Very large to 
extremely 
large 
0.36 
(0.12, 0.55) 
0.35 
(0.12, 0.58) 
51.5 
(29, 58) 
2.4 
(1.2, 4.7) 
Very large 
to 
extremely 
large 
Prediction in changes in concentration 
Two conditionsa 
Contra Unclear 0.26 (-0.11, 0.56) 
0.30 
(-0.37, 0.96) 
71.5 
(47, 89) 
5.8 
(-22.5, 29.3) Unclear 
Mid 
Very large to 
extremely 
large 
0.38  
0.02, 0.64) 
0.21 
(-0.13, 0.55) 
70.3 
(46, 89) 
4.2 
(1.5, 17.2) 
Very large 
to 
extremely 
large 
Four conditionsb 
Contra Unclear 0.31 (0.03, 0.54) 
0.43 
(-0.06, 0.93) 
59.4 
(40, 72) 
3.7 
(-5.6, 15.9) Unclear 
Mid Unclear 0.43 (0.17, 0.61) 
0.32 
(0.05, 0.59) 
56.3 
(34, 70) 
2.7 
(1.2, 5.8) 
Very large 
to 
extremely 
large 
Six conditionsc 
Contra Extremely large 
0.34 
(0.10, 0.54) 
0.48 
(0.06, 0.90) 
53.8 
(37, 66) 
3.2 
(1.4, 12.1) 
Very large 
to 
extremely 
large 
Mid 
Very large to 
extremely 
large 
0.47 
(0.25, 0.64) 
0.36  
0.13, 0.59) 
50.8 
(31, 64) 
2.3 
(1.1, 3.9) 
Very large 
to 
extremely 
large 
aBaseline, glycogen depleted. 
bBaseline, glycogen depleted, placebo, glycogen-loaded. 
cBaseline, glycogen depleted, placebo, glycogen -loaded, creatine-loaded, glycogen – creatine loaded. 
dFree of error of measurement in glycogen concentration. 
eThresholds for small, moderate, large, very large, and extremely large errors: 0.1, 0.3, 0.6, 1.0, and 2.0 respectively. 
Contra, images captured at the site contralateral to the biopsy; mid, images captured at the midpoint of the thigh 
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7.5 Discussion  
This is the first independent study to investigate the validity of ultrasound technology 
(MuscleSound®) to assess muscle glycogen content with the added novelty of undertaking the 
investigation over a large range of variations in muscle solute and water content.  We found 
poor correlation between the criterion (biopsy derived) assessments of muscle glycogen and  
the ultrasound derived estimates, both for absolute glycogen concentrations and for changes 
due to glycogen loading or exercise depletion.  Our results confirmed the hypothesis that large 
changes in muscle glycogen and/or change in muscle water or solutes unrelated to muscle 
glycogen would challenge the ability of MuscleSound® to track muscle glycogen over the 
ranges that occur in sports nutrition practice.  The poor correlations seen in our study may 
reflect the failure of the presently available algorithms, derived from studies of exercise-
associated glycogen depletion, to have relevance to the wider manipulation of the muscle 
content of glycogen, water and creatine achieved in the present study.  It may also reflect 
some limitations of the present study design or execution.  However, the principle that muscle 
glycogen concentrations can be estimated from changes in the grey scale of ultrasound images 
as a surrogate for muscle water content is also challenged, particularly when muscle water 
content is changed by practices that are unrelated to glycogen stores. 
The ultrasound technique for assessment of muscle glycogen investigated in this study 
is a commercially available product that involves the capture of a high-frequency ultrasound 
image which is then processed using proprietary cloud-based software to produce a glycogen 
score in arbitrary units (a.u.) (Hill & Millan, 2014; Nieman et al., 2015). The image greyscale 
produced on an ultrasound scan is based on the intensity of the ultrasound “echo” or reflection 
of an ultrasound beam, with the beam being both produced and detected by the transducer 
forming the ultrasound image (Aldrich, 2007).  Ultrasound beams are reflected at the 
boundary between two materials with different acoustic impedances with strong reflections 
showing as white on the ultrasound image and weaker echoes being grey (Aldrich, 2007).  
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The boundary between soft tissue and water has an echo or reflection of 0.2%, while the 
boundary between muscle and fat is 1.08%. The boundary between soft tissue and air reflects 
99% of the beam (Aldrich, 2007).  Proprietary information within the MuscleSound® software 
aligns a darker image with greater glycogen stores using the principal that greater glycogen 
and its associated water content in the muscle fibre should reflect the lower echo intensity 
between soft tissue and water (Aldrich, 2007; Nieman et al., 2015).  Conversely, in instances 
when glycogen is low and there is less fluid, the echo intensity is greater due to increased 
visibility of other tissue boundaries resulting in a brighter image (Aldrich, 2007; Nieman et 
al., 2015). 
This process of identifying glycogen based on its bound fluid assumes that the 
relationship between muscle glycogen and bound water is constant.  Although it is well 
accepted that fluid is stored when glycogen is formed, the persistence of the ratio over a range 
of glycogen concentrations has been questioned (McBride et al., 1941; Sherman et al., 1982).  
A previous investigation using rat livers described a ratio or 1:2.7 for grams of glycogen to 
water when there is no change to non-glycogen solids (McBride et al., 1941). Meanwhile, 
Sherman et al. (Sherman et al., 1982) reported no gram to gram ratio could be calculated 
between glycogen and water in rat skeletal muscle.  A human study that measured total body 
water and muscle glycogen following carbohydrate loading found a glycogen to water ratio 
ranging from 1:3 to 1:5 (Olsson & Saltin, 1970).  Furthermore, a study in which cyclists were 
deliberately dehydrated by ~5% BM or 8% body water during 15 h of refuelling after cycling 
exercise found a lower muscle water content associated with glycogen storage compared with 
a trial involving euhydrated recovery (Neufer et al., 1991). Most recently, Shiose et al. 
(Shiose et al., 2016) assessed total body water by deuterium dilution and reported a ratio of 
~1:4 following 72 h of carbohydrate loading. Thus, it is unlikely that a tight ratio between 
muscle water and glycogen actually exists, with uncertainty in the ratio being attributed to 
differences in non-glycogen solids, such as fat, protein or connective tissue (McBride et al., 
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1941; Sherman et al., 1982) as well as alterations in body water content that are commonly 
seen in sport (Neufer et al., 1991).   
Our findings contradict two previous validation studies (Hill & Millan, 2014; Nieman 
et al., 2015) that found strong correlations between values for pre-exercise, post-exercise and 
change scores in muscle glycogen between biopsy-derived and MuscleSound® measurement 
techniques (Hill & Millan, 2014; Nieman et al., 2015).  Nieman et al (Nieman et al., 2015) 
reported a significant (0.92) correlation between these two measurement techniques for the 
change in muscle glycogen in the vastus lateralis following a 75 km cycling ergometer 
protocol lasting 2.8 h.  We estimated the absolute decrease in muscle glycogen seen in that 
investigation study (~ 307 mmol/kg dry weight (d.w.) (based on a conversion factor of 4.28 
between wet and dry weight measurements (Hawley et al., 1997) ), was slightly smaller than 
the change seen in the current study (330 mmol/l kg d.w.).  Significant correlations between 
the two measurements techniques for pre (0.92, p<0.001) and post (0.90, p<0.001) exercise 
glycogen concentrations were also reported by Nieman and colleagues. Although the absolute 
pre- and post-exercise muscle glycogen concentrations were not provided, they were 
estimated from graphical representations to be ~397 and 90 mmol/kg d.w., respectively 
(Nieman et al., 2015). 
Meanwhile, in the second study, Hill et al. reported a correlation of 0.81 (p<0.0001) 
between change scores of biopsy-derived and ultrasound measures of glycogen concentration 
of the rectus femoris following 90 min of laboratory-based cycling (Hill & Millan, 2014).  
They reported pre and post exercise muscle glycogen values of 418 and 268 mmol/kg d.w, 
with significant correlations of 0.93 (p<0.0001) and 0.94 (p<0.0001) between techniques for 
each respective time point.  Their glycogen loading protocol instructed participants to 
consume a diet providing a carbohydrate intake of 8 g/kg BM/d for three days prior to the 
exercise session (Hill & Millan, 2014), achieving a mean pre-exercise glycogen concentration  
that was ~ 150 mmol/kg d.w. less than our baseline values.  Furthermore,  the pre- to post-
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exercise decrease of 149 mmol/kg d.w. was smaller than that seen in both the current study 
and that of Nieman and colleages (Nieman et al., 2015), and corresponded to a 20 a.u. 
decrease in the ultrasound glycogen score (Hill & Millan, 2014).  Hill and Millan (Hill & 
Millan, 2014) stated that the attenuated glycogen depletion was because of the high fitness 
levels of their athletes; however, we note also the shorter duration of the cycling bout of 1.5 h. 
The contradictory results of our studies might be attributed to a number of factors.  
Our study manipulated absolute values of muscle glycogen over a wider range than seen in 
the previous studies (from ~155 mmol/kg d.w. following exercise depletion to 843mmol/kg 
d.w. following glycogen loading) as well as incorporating another dietary strategy known to 
alter muscle solute and water content.  The MuscleSound® technique appeared to poorly track 
the decrease in muscle glycogen with exercise depletion, showing mean changes of -2.2 and -
5.0 a.u for contra and mid legs respectively.  Indeed, since the unit of scale for the 
MuscleSound® ultrasound score was 5 a.u., this technique appeared to offer a blunt technique 
to monitor the decrease in muscle glycogen content achieved in this study.  Furthermore, the 
change in muscle glycogen from “normalised” to “loading” was clearly evident from the 
direct (biopsy-derived) measures of glycogen, but failed to show a substantial change in 
MuscleSound® scores.  Only in the glycogen loading trial with prior creatine supplementation 
trial, did the MuscleSound® technique show a trivial and likely possible increase in the 
ultrasound score.   
It is well documented that creatine supplementation acutely increases body mass (~1 
kg) with the change being attributed mostly to water weight (Dalbo et al., 2008; Deminice et 
al., 2016; Powers et al., 2003).  Indeed, as an osmotic solute, creatine pulls water into the 
muscle cell increasing intracellular fluid, and subsequently, total body water (Dalbo et al., 
2008).  Results from a separate part of this study observed that our creatine loading protocol 
increased muscle creatine by 6%; this is a smaller relative change than the 22% changes in 
muscle glycogen due to carbohydrate loading seen in the same study (Bone et al., 2017). 
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Changes in total body water and intracellular water of 1.3 and 1.4% (Creatine Loaded), and 
2.3 and 2.2% (Glycogen Loaded) were also detected (Bone et al., 2017).  As such, based on 
the theory underpinning the use of ultrasound to track muscle glycogen changes, creatine 
loading should also cause the echo intensity to decrease and produce a darker image (Aldrich, 
2007; Nieman et al., 2015).  Therefore, such changes in non-glycogen solutes and their effect 
on muscle water might need to be separately included in the glycogen score algorithm to 
allow it to become a valid surrogate measure of muscle glycogen in a greater number of 
scenarios.  Accumulation of additional data, such as that collected in the present study might 
assist in the evolution of a more robust algorithm that is able to account for a greater range of 
perturbations in muscle solute and water content as achieved in this study and seen in 
everyday sports nutrition practice.  
As in all studies, there is a requirement to consider limitations in the study design, 
methodology and researcher expertise in explaining results that are incongruent with the 
current literature.  Therefore the possibility that our protocols failed to achieved the desired 
manipulation of muscle glycogen need to be addressed.  The close supervision of the exercise 
task to achieve glycogen depletion, and the provision of tailored pre-packaged meals to 
achieve the various levels of glycogen repletion is regarded as best practice in achieving 
dietary control (Jeacocke & Burke, 2010).  Indeed, the data reported in this paper were 
collected using standard techniques by individuals who were familiar with the protocols 
required.  Furthermore, the results from these protocols fit the expected changes of 
water/glycogen increase with glycogen loading, and water/glycogen decrease with prolonged 
exercise.  We acknowledge that, due to the design of the larger study, the biopsy capturing 
exercise-derived glycogen depletion was not taken directly after exercise, but was instead 
taken the following morning. However, we minimised the potential for glycogen storage by 
providing participants with a low carbohydrate diet (<1 g/kg body mass) for the intervening 
period, and the biopsy derived measurement of vastus lateralis glycogen showed values that 
129 
 
were substantially lower than pre-exercise concentrations.  Nevertheless, there is the 
possibility that other changes occurred in the muscle during this recovery period that were not 
present in the previous studies; for example the hepatic resynthesis of glucose and glycogen 
from the lactate produced during exercise (Hermansen & Vaage, 1977).    
In addition, we note the limitations of deriving correlations between two measured 
variables to provide a validation of one of these measures.  Although it is a criterion method, 
biopsy derived measures of glycogen concentration can be variable as noted by the technical 
error of measurement of 22%.  Incorporating the biopsy variability into the statistical analysis 
standardized the data and reduced the error in the prediction of muscle glycogen from the 
MuscleSound score. Furthermore, the confidence limits for the single measurements are 
trustworthy only to the extent that the sample of values is reasonably representative of the 
values that would be obtained if single measurements were taken from a random sample of 
athletes. The confidence limits for the analysis of changes in glycogen concentration are more 
trustworthy, because the repeated measurements have been properly accounted for. 
Finally, we note the possibility that despite the training and practice undertaken by our 
research team, that we did not master the techniques needed to optimise the use of the 
MuscleSound® technology. However, we note that the protocol has been developed for 
practical application in the sports environment in which a range of nutrition, medical or 
fitness practitioners might undertake the ultrasound images under field conditions.  Therefore, 
we undertook a greater degree of standardization of the training of technicians and the 
protocol of image capture than might be expected in the real life conditions to which the 
MuscleSound® technology is at least partly directed. 
 
In conclusion, we acknowledge the exciting potential and value of having a relatively 
inexpensive, portable and non-invasive method to measure muscle glycogen in sports 
nutrition research and practice.  However, our study failed to find accurate estimations of 
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muscle glycogen concentrations, in absolute concentrations or to note change to either 
increase or deplete muscle stores, when an ultrasound-based technique (MuscleSound®) was 
compared to biopsy derived measures of glycogen. This may be both a problem of the 
underlying principles of the technique as well as the failure of currently available algorithms 
to cover a larger range of changes in muscle glycogen, or other manipulations of muscle 
solutes and water, than are often seen in sports nutrition practice.  It may also be a fault of the 
current study design and execution, although we followed similar principles to other 
investigators who have undertaken such validation studies. 
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Preface to Chapter 8  
The results of Chapter 7 (Study 4) indicate that estimates of muscle glycogen 
concentration by ultrasound are not valid.  However, in Chapter 6 (Study 3), changes in TBW 
mirrored the changes observed in muscle glycogen concentration and DXA-derived 
measurements of LM.  Therefore, it may be possible to uses changes in TBW as a tool to 
indicate when DXA artefacts of LM caused by changes in muscle glycogen and fluid have 
occurred.  
It may be possible to “correct” for this artefact by applying a transformation factor, to 
DXA-derived measurements of LM in known situations where exercise or dietary intake has 
likely to have caused a change in intramuscular glycogen and water.  
The real-life implications of the error in body composition assessment induced by 
manipulations of intra-cellular glycogen and fluid on the interpretation of relative REE have 
yet to be explored.  One such scenario in which this could occur is in the athlete who has 
adopted a ketogenic low carbohydrate high fat (LCHF) diet.  A large study on the effects of 
LCHF diet on the endurance performance of male race walkers provided a convenience 
sample to explore these concerns.  Thus, the following chapter uses the results and outcomes 
from the previous chapters of this thesis to investigate not only if adaptation to a ketogenic 
LCHF diet affects REE but also whether the artefact in DXA estimates of LM due to 
glycogen and fluid affects the interpretation of results of REE in elite male athletes.  
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8.0 Study Five: Measurement of resting energy expenditure 
following a low carbohydrate high fat diet is affected by artefacts 
in DXA measurement of lean mass  
 
This chapter is comprised of the following manuscript under preparation to be 
submitted to PLoS One: 
 
Bone, JL, Ross, ML, Welvaert, M, Burke, LM 
 Measurement of resting energy expenditure following a low carbohydrate high fat 
diet is affected by artefacts in DXA measurement of lean mass. 
 
 
This study was funded by a grant from the Australian Catholic University Research 
Fund awarded to Prof Louise M Burke. 
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8.1 Abstract 
Background: 
Variations in muscle glycogen concentration caused by exercise and/or changes in 
dietary intake can influence dual energy x-ray absorptiometry (DXA) estimates of lean mass 
(LM) and the related measure of fat free mass (FFM).  Since resting energy expenditure 
(REE) is typically assessed relative to FFM, artefacts in measurements of LM could 
potentially affect the interpretation of such assessments. Low carbohydrate high fat diets 
(LCHF) which are associated with chronic reductions in muscle glycogen have remerged as a 
putative performance aid for endurance and ultra-endurance sports.  The aim of this study was 
to investigate if adaptation to such a diet affects REE in elite athletes, and whether artefacts in 
DXA-derived measures of FFM interfere with the investigation of this issue.  
Methods: 
Nineteen elite male race walkers completed a 21 d dietary intervention in conjunction 
with intensified training.  Athletes were grouped into either LCHF intervention (n=9) or an 
energy-matched control (CHO) diet (n=10) for the duration of the study.  Body composition 
by DXA, total body water (TBW) and REE were measured at Baseline and Post-Intervention.  
Estimates of FFM were corrected with a transformation factor in individuals who showed 
meaningful changes in TBW consistent with glycogen depletion.  Linear mixed modelling 
was used to assess if there were changes in REE at baseline and post-intervention, both with 
and without the correction factor for FFM.  
Results: 
There were significant decreases in mean FFM (-1.4; 95% CI -2.0, -0.80 kg) and TBW 
(-2.9; -3.9, 0.5 L) between baseline and non-corrected post intervention values in the LCHF 
group. No changes were observed in FFM when corrected for loss of muscle glycogen and 
fluid.  There was no change in REE in the CHO group using both the corrected and 
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uncorrected FFM values.  In the LCHF group, there was a significant decrease in REE 
compared to baseline with the corrected values; however, this was not apparent when baseline 
values were compared with uncorrected post-intervention values.  
Conclusion: 
A reduction in relative REE was observed following a 21 d adaptation to a LCHF diet 
in elite racewalkers while REE remained stable in a control group of athlete. This effect was 
only detected when a correction factor was applied to DXA estimates of FFM which were 
affected by an artefact associated with reduced glycogen stores. Failure to account for this 
artefact would have implications for the detection and management of suppressed metabolic 
rate and low energy availability in such a scenario.  
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8.2 Introduction 
Low energy availability (LEA), defined as a failure of energy intake to cover the 
energy cost of supporting a wide range of body functions once the energy cost of exercise is 
taken into account, is associated with impairment of health and athletic performance 
(Mountjoy et al., 2014). The causes of this energy mismatch in athletes include disordered 
eating, overzealous weight loss programs, and inadequate knowledge or ability to consume 
sufficient food to cover the cost of a high volume training/competition regimen. LEA is 
associated with, and can be identified via a reduction in metabolic rate, as long as there is 
confidence in the reliability of measurement of resting energy expenditure (REE) and the 
absence of artefacts that could alter the interpretation of results. Considering LEA and REE 
are assessed relative to fat free mass (FFM), acute changes in muscle glycogen and associated 
water storage, achieved through exercise and glycogen loading, is one such artefact that 
impacts estimates of lean mass (LM) by dual x-ray absorptiometry (DXA) (Bone et al., 2017) 
and subsequently effects interpretation of LEA and/or relative-REE. This DXA artefact has 
also been observed in healthy untrained populations (Rouillier et al., 2015; Toomey et al., 
2017). Another scenario where this DXA artefact effects LEA or relative-REE may occur 
would be in athletes who follow a ketogenic low carbohydrate high fat (LCHF) diet. The re-
emergence of claims that a low carbohydrate high fat (LCHF) diet can enhance 
endurance/ultra-endurance performance (Noakes et al., 2014; Phinney, 2004; Volek et al., 
2016) has brought it back into consideration in sports nutrition practice. Notwithstanding 
evidence to refute these claims in terms of endurance performance {Burke, 2016 #531}, there 
is a need to explore its effects on other health issues and body function. Whether such extreme 
changes in macronutrient intake within a controlled energy intake have an effect on REE is 
one such issue.  
Measuring REE in subjects who follow a LCHF diet presents a potential 
methodological challenge as well as a physiological interest.  Indeed, there is reason to expect 
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that chronic intake of a LCHF, which results in a decrease in muscle glycogen stores (Phinney 
et al., 1983) similar to the decrease observed through acute glycogen depletion (Bone et al., 
2017), may cause an artefact in the estimation of the lean mass (LM) component of FFM. A 
reduction in the estimates of FFM due to the artefact of reduced muscle glycogen and fluid 
could potentially interfere with the interpretation of relative REE, and identification of LEA 
in populations who follow a ketogenic LCHF diet.  Accordingly, the aim of the present study 
was to measure REE in athletes in response to a 21 day adaptation to a LCHF diet and 
intensified training program, using standardised practices that have been shown to enhance 
the reliability of REE assessment.  To assist in the interpretation of results, we intended to 
incorporate the results of our previous work which identified the magnitude of the artefact 
caused by the reduction of muscle glycogen and associated muscle water. 
 
8.3 Methods 
Participants:   
A convenience sample of 19 elite male race walkers provided written informed 
consent prior to study commencement. This study was approved by the Australian Institute of 
Sport Human Resource Ethics Committee.  Participant characteristics are presented in Table 
8.1   
 
Table 8.1. Participant descriptive characteristics presented as mean ± standard deviation 
(SD).  
 All (n=19) LCHF (n=9) CHO (n=10) 
Age (y) 26.9 28.8 25.5 
Height (cm) 179.7 180.6 179.0 
Body mass (kg) 68.3 68.4 68.2 
LCHF: Low carbohydrate high fat diet group; CHO: carbohydrate diet group (control) 
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Study design:  
This study implemented a non-randomised parallel group design to investigate the 
effect of dietary interventions during a four week training camp.  There were nine participants 
in the intervention group and eleven controls.  All participants underwent the same training 
schedule and physical testing.   
 
Dietary intervention: 
The two groups followed a 21 d dietary intervention in which all meals and snacks 
were provided to participants and consumed under supervision. The ketogenic LCHF diet 
followed by the intervention group was modelled on the dietary principles of Volek & 
Phinney (2012), with fat providing 75-80% of energy intake, carbohydrate intake being 
restricted to <50 g/d, and protein intake being limited to 2.2 g/kg BM (~16% of energy).  The 
control group followed an energy- and protein-matched diet in which 65% of energy was 
provided by carbohydrate.  Details of the logistics of achieving and monitoring the diets are 
provided elsewhere (Mirtschin et al. in review). 
 
Indirect calorimetry protocol 
Resting metabolic rate was measured using indirect calorimetry using an outpatient 
protocol (Bone & Burke, 2017).  All measures were completed between 5:30-8:30am 
following an overnight 8 h fast and overnight rest from exercise.  Upon arrival, participants 
lay supine for a 25 min rest period. Ten minutes into the rest, participants familiarised 
themselves with breathing through a mouthpiece.  At the end of the rest period, participants 
put on a nose clip, a Douglas Bag was connected, and expirate was collected for 10 min 
periods in duplicate.  
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Determining REE 
The gas fractions for oxygen and carbon dioxide were determined using Ametek 
oxygen and carbon dioxide analysers (Ametek Inc, PA, USA).  The Haldane transformation 
(Haldane, 1918) was used to determine oxygen consumption and carbon dioxide production.  
Laboratory temperature, pressure and humidity were recorded.  Volume was measured using a 
350 L Tissot spirometer (Warren Collins, Braintree, MA, USA).  The Weir equation (Weir, 
1949) was used to convert gas fractions to energy expenditure in kJ/min and extrapolated to 
24 h to provide REE. The mean REE from the duplicate bags was calculated and divided by 
FFM to get relative REE (kJ/kg FFM/d).   
 
Body composition: 
Body composition was assessed via DXA on the same morning as the REE 
measurement, following standardised protocols of subject presentation and placement on the 
scanning bed (Nana et al., 2012a).  All scans were conducted on a GE Lunar iDXA (Madison, 
WI) and one technician operated the DXA and analysed all images using encore software 
(V16, GE, Madison, WI) (Nana et al., 2015).  The technical error of measurement for the 
DXA was 0.1% for total mass, 0.4% for lean mass, 1.6% for fat mass and 0.4% for bone 
mass. 
 
Total body water and hydration status: 
Total body water (TBW) was measured using bioelectrical impedance spectroscopy 
(BIS) (IMP SFB7, ImpediMed Limited, Queensland, Australia) and analysed using BioImp 
Analysis 5.4.0 Software (ImpediMed Limited, Queensland, Australia) as previously described 
(Bone et al., 2017). Briefly, participants lay supine for 15 min prior to triplicate measures 
being recorded.  The mean of the measures were calculated and used for analysis.  Hydration 
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status was monitored  on the morning of the DXA scan by measurement of urine specific 
gravity (USG) from a first void mid-stream urine sample collected upon waking (UG-a, Atago 
Refractometer, Japan).   
 
Data analysis  
Changes in TBW were used as a proxy for increases or decreases in muscle glycogen 
stores, based on previous work from our group in which we showed acute diet/exercise 
induced manipulations in muscle glycogen content was associated with changes in TBW and 
artefacts in DXA-derived estimates of LM (Bone et al., 2017).  A transformation factor to 
correct for this DXA artefact was calculated using these data.  Specifically, we noted that the 
proportion of the decrease in body mass attributed to LM following glycogen depletion was 
0.80 (95% CI; 0.63, 0.99) whereas, the proportion of the increase in body mass attributed to 
LM was 0.71 (0.42, 1.01).  The threshold where a change in LM was detected as meaningful 
corresponded to a decrease in TBW of 0.91 L and an increase of 1.07 L respectively.  
 
The transformation factor was applied to Post-Intervention values based on the changes in 
TBW and BM compared to Baseline.  A “negative” transformation factor to correct for the 
“decrease" of FFM due to muscle glycogen depletion was applied to all individuals who had a 
decrease in TBW greater than 0.91 L.  Participants who had increases in TBW greater than 
1.07 L had the “positive” transformation factor applied to correct for “increases” in FFM due 
to increased muscle glycogen. For the “negative” transformation the difference in BM was 
multiplied by 0.8 and added to the Post-Intervention DXA estimated FFM.  For the “positive” 
transformation the difference in body mass was multiplied by 0.71 and subtracted that from 
the Post-Intervention DXA estimated FFM. No transformation factor was applied to 
participants whose change in TBW did not meet these thresholds. All data were pooled in 
their respective intervention groups and labelled Post-Intervention-Correctedthreshold (Post-
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ICthreshold).This was then compared to Baseline and original Post-Intervention values for REE 
and FFM.  To minimise bias, an additional group where the "positive” transformation factor 
was applied to all participants in the CHO group and the ‘negative transformation factor’ was 
applied to all participants in the LCHF group was included (Post-Intervention-Correctedall or 
Post-ICall). The Post-ICall FFM and REE were then compared to Baseline, Post-Intervention 
and Post- ICthreshold values.  
 
Statistics 
Normality for all data was visually assessed by Q-Q plots of the variable residuals and 
no significant deviations were detected.  Linear mixed models, using an unstructured 
covariance matrix, were used to assess if there were difference between groups (diet), within 
groups over time (Baseline to Post-Intervention) and the diet-time interaction on all variables 
for FM, TBW, RER, FFM, absolute REE (kJ/d) and relative REE (kJ/kg FFM/d).  Relative 
REE and FFM had additional comparisons against Post-ICthreshold and Post-ICall values.  Data 
presented are estimated means and 95% confidence intervals (CI) unless otherwise stated. All 
analysis was completed using SPSS (Version 23 for Windows, SPSS Inc, Chicago, IL) 
 
8.4 Results 
Baseline and post intervention FM, TBW, USG, RER and absolute REE are presented 
in Table 8.2. With the exception of RER, there was no significant difference in any of these 
variables between the groups at baseline.  There was no change in USG across time in either 
of the groups. Similarly, there was no difference in TBW in the CHO group over time. 
However, TBW was significantly lower by 2.2 L (95% CI -3.92, -0.47) in the LCHF group 
Post-Intervention compared to Baseline.  RER was significantly lower in the LCHF group 
following the dietary intervention compared to baseline and against the CHO group.  FM was 
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reduced by a small but significant amount in both groups over the 21 d. There were no 
significant effects of adaptation to either dietary intervention on absolute REE (kJ/d).    
Table 8.2. Fat mass, total body water (TBW), urinary specific gravity (USG), respiratory 
exchange ratio (RER) and resting energy expenditure (REE) pre and post 21 day adaptation to 
LCHF or high CHO availability diets (estimated mean; 95% confidence interval). 
 CHO LCHF 
Baseline Post-Intervention Baseline Post-Intervention 
TBW (L) 43.1 (39.8, 46.3) 43.1(40.1, 46.0) 42.7 (39.3, 46.2) 40.5 (37.4, 43.6) ‡ 
USG (g/dL) 1.021 (1.018, 1.025) 1.020 (1.015, 1.024) 1.022 (1.018, 1.026) 1.023 (1.018, 1.026) 
RER 0.88 (0.86, 0.91) 0.89 (0.87, 0.92) 0.83 (0.80, 0.86)* 0.80 (0.77, 0.82) †‡ 
FM (kg) 8.4 (7.3, 9.5) 7.3 (6.5, 8.1) ‡ 8.3 (7.2, 9.5) 7.3 (6.3, 8.2) ‡ 
REE (kJ / d) 7450 (6897, 8003) 7349 (6855, 7842) 7488 (6905, 8071) 7233 (6712, 7753) 
*p<0.05 between groups at baseline; † p<0.05 between groups post-intervention ‡ p<0.05 
compared to baseline. 
 
Table 8.3 shows the post intervention values for FFM before and after applying the 
transformation factor within each group.  There was no effect of dietary adaptation on FFM in 
the control group.  This did not change when the correction factor was applied to those 
individuals who met the threshold for correction (Post-ICthreshold) or when transformation was 
applied to the whole CHO group (Post-ICall). In the LCHF group, FFM was significantly 
lower by 1.4 kg (95% CI -2.0, -0.80) following the intervention and prior to applying the 
transformation factor.  When the transformation factor was applied to all participants or to 
only those participants whose TBW change met the threshold, the difference was no longer 
significant compared to baseline.   
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Table 8.3. Fat free mass (FFM) pre and post 21 day adaptation to LCHF or high CHO 
availability diets (estimated mean; 95% confidence interval). 
 CHO LCHF 
Baseline 60.84 (57.25, 64.43) 60.76 (57.0, 64.5) 
Post-Intervention 60.84 (57.33, 64.35) ‡ 59.35 (55.65, 63.05) ‡ 
Post-ICthreshold  60.64 (56.95, 64.34) 61.20 (57.30, 65.09) 
Post-ICall 60.89 (57.42, 64.35) 61.48 (57.82, 65.13) 
Post-ICthreshold: Post-Intervention-Correctedthreshold; Post-ICall: Post-Intervention-Correctedall or 
Post-ICall; ‡ p<0.05 compared to baseline LCHF  
 
Relative REEs for the LCHF and CHO groups are presented in Figure 8.1. There was 
no difference in relative REE at Baseline between the LCHF and CHO groups (123.4and 
123.2 kJ/kg FFM/d respectively, p=0.955).  There was no change in relative REE across the 
dietary adaptation periods in either group, based on uncorrected values.   
Eight participants in the LCHF group and five participants in the CHO group had a 
change in TBW that met the threshold to apply the transformation factor to the post 
intervention value (Post-ICthreshold). When this was applied in the LCHF group the estimated 
mean relative REE decreased to 118.4 kJ kg FFM/d.  When the correction factor was applied 
to all participants in LCHF (Post-ICall) the estimated mean decreased to 117.9 kJ/kg FFM/d.  
Both Post-ICthreshold and Post-ICall were significantly different from Baseline in the LCHF 
group (-4.9 kJ/kg FFM/d; 95% CI -0.8, -9.1; and -5.5 kJ/kg FFM/d; -1.0, -10.0 respectively).  
In the CHO group, there was no difference between Baseline and Post-intervention relative 
REE when the transformation factor was applied to selected participants or all participants. 
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Figure 8.1. Relative REE (kJ/kg FFM/d) at Baseline, Post-Intervention, Post-Intervention-
Correctedthreshold (Post-ICthreshold) and Post-Intervention-Correctedall (Post-ICall) pre and post 21 
day adaptation to LCHF or high CHO availability diets.  Data presented are raw means and 
standard deviations. Post-ICthreshold; only values that met the threshold were transformed in 
each group.  Post-ICall, all values were transformed in each group. ‡ p<0.05 compared to 
baseline LCHF. 
 
8.5 Discussion 
The findings from this investigation indicate that the artefact in the DXA-derived 
measurement of LM associated with depletion of muscle glycogen and water is important as it 
appears to alter the interpretation of a measurement of REE relative to FFM. This study is the 
first to show that a seemingly small error in the measurement of body composition by DXA 
can have a substantial carryover effect when this information is used to interpret nutritional 
status relative to biologically active tissue.  In this case, the failure to correct for the artefact in 
FFM would lead to the failure to detect a reduction in relative-REE associated with a dietary 
change to a ketogenic LCHF diet.  This could lead to the failure to recognise to a potentially 
important side-effect of this diet at the population level, while at the individual level, it could 
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prevent the assessment of LEA and delay the implementation of strategies to correct this 
potentially harmful condition.  Both issues merit further investigation.  
 
Previous work from our centre showed that acute increases in muscle glycogen and 
TBW, achieved via 48 h of carbohydrate loading, were detected by the DXA as a gain of LM 
(Bone et al., 2017).  In contrast, decreases in muscle glycogen and TBW were detected by the 
DXA as a loss of LM.  Depletion was achieved via a 120 km cycling protocol completed on 
the day prior to the “depleted” DXA measurement.  The period between the exercise session 
and the DXA scan allowed for the restoration of sweat losses incurred by the exercise (time 
and fluid intake), such that the decrease in TBW was achieved via changes in intramuscular 
water.  All DXA measurements in this study were completed in the morning following an 
overnight fast and rest. This protocol was based on prior research that indicated that 
dehydration and plasma volume shifts which occur as a result of exercise also create an 
artefact in DXA measures of LM (Nana et al., 2013); this is why Best Practice Protocols 
recommends overnight fasting and confirmation of euhydration via USG (Nana et al., 2015).  
Importantly, our work not only confirmed the presence of the artefact in measurements of LM 
associated with glycogen and bound water, but also developed a crude transformation factor 
to account for this.  
An example of applying the correction factor is presented in Table 8.4.  In this case, 
absolute REE decreased as did relative-REE however the Post-intervention score was above 
the 126 kJ/kg FFM/d threshold for LEA, so although a reduction has occurred it could be 
interpreted that there is minimal need for concern, nutrition support or intervention. 
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Table 8.4 Application of correction factor on an individual participant. 
Baseline 
REE 
(kJ/d) 
Baseline 
FFM 
Baseline 
REE (kJ/ kg 
FFM/d 
Post-
Intervention 
REE (kJ/d) 
Post Intervention 
 FFM (kg) REE (kJ/ kg 
FFM/d) 
7612 55.9 136.2 7101 
Uncorrected 54.8 129.5 
Corrected 56.6 125.5 
Change in TBW from Baseline exceeded 0.9 L. thereby difference in BM was multiplied by 0.8 and this result 
was added to Post-Intervention Bone and LM mass measures to calculate the corrected FFM.  
 
When the correction factor is not applied, the lack of change in relative REE fails to 
reflect the reduction in absolute REE and the physiological changes that may have potentially 
occurred (Bielohuby et al., 2011; Fraser et al., 2000; Mountjoy et al., 2014). These 
physiological changes could include alterations to  regulators of anabolism and energy, given 
there is evidence of reduced growth hormone and IGF-1 activity and decreased free 
triiodothyronine (fT3) in rats and clinical human populations (Bielohuby et al., 2011; Fraser 
et al., 2000).   Once the correction factor is applied,  relative REE is now below the threshold 
and in combination with the reduction in absolute REE would justify a path of further 
investigation of LEA (such as blood biochemistry markers), and potential  interventions. This 
example highlights the potential importance of the use of the correction factor; however, it 
should be noted that measurements of REE should be used as part of a spectrum of diagnostic 
markers, which include biochemistry and performance at training, to assess energy 
availability in athletes to best gauge the meaningfulness of the change (Mountjoy et al., 2014). 
 
The present study, embedded into a larger investigation of the effects of the ketogenic 
LCHF in endurance athletes, offered the dual opportunities of examining the effect of the diet 
on REE as well as investigating the real-world significance of the error in measuring LM by 
DXA when there is a chronic change in muscle glycogen and its bound water.  Due to the 
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involvement of elite athletes as participants, it was impractical to directly measure changes in 
muscle glycogen stores as a result of the 21 d of dietary interventions.  However, results of the 
larger study showed indirect evidence of changes in glycogen associated with diets of high 
CHO availability and restricted CHO intake, respectively.  Specially, we observed a small 
increase in rates of whole body CHO oxidation, as measured by indirect calorimetry, during a 
prolonged exercise session as a result of a diet providing high CHO availability (Burke et al, 
in review).  This is consistent with the literature which shows that increases in muscle 
glycogen stores are associated with high CHO oxidation rates (Hawley & Leckey, 2015).  
Therefore, the increases in TBW in some of the CHO group participants in the current study 
could be the result of an increase in muscle glycogen content above baseline values.  More 
importantly, there was a pronounced decrease in rates of CHO utilisation over a range of 
exercise intensities in the LCHF group (Burke et al, in review), providing indirect evidence of 
a significant reduction in muscle glycogen stores.  Indeed, a study of a 4 week intervention 
with a similar ketogenic LCHF diet in well-trained cyclists has also reported a 51% decrease 
in resting muscle glycogen stores.  This decrease in muscle glycogen is similar to the 57% 
decrease in muscle glycogen achieved by acute exercise-induced depletion in our recent study  
(Bone et al., 2017).     
The current study measured USG as a crude marker of extracellular hydration, and 
found no differences between baseline and post-intervention hydration status in either diet 
group. This provides indirect evidence that the reduction in TBW following adaptation to 
LCHF was associated with a reduction in intracellular water, particularly that bound to 
glycogen.  We note that there was a small loss of BM and FM over the course of the 21 d of 
dietary adaptation and intensified training.  However, the groups received an energy matched 
diet and showed equal FM losses over this period, so there is no rationale to expect a greater 
loss of “real” LM (e.g. muscle mass) over this period in the LCHF group.  Therefore, we feel 
justified in explaining this apparent change of ~ 1.4 kg in the DXA-derived measurements of 
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LM in the LCHF as an artefact, and accepting that “real” LM was maintained in this group. 
We also note that calculations of absolute REE from equations based on VO2, VCO2 and RER 
may be affected by the contribution of the oxidation of ketone bodies on these measurements.  
Indeed, Frayn (Frayn, 1983), calculates that in the storage and utilisation of beta-hydroxy-
butyrate 4.5 mol of O2 are consumed and 4 mol of CO2 produced resulting in an RER of 0.89.  
However, we are unable to apply correction factors to the current calculations to allow for the 
contribution of ketone bodies to fasting metabolism  
To the authors’ knowledge, there are no other investigations of the effect of a 
ketogenic LCHF diet on REE in athletes, however sparse literature involving mixed and 
overweight populations is available.  Of most relevance are the findings of Urbain et al. 
(2017), who reported a decrease in absolute REE of ~ 389 kJ /d in a healthy population, 
including both sedentary and very active people, after six weeks of adaptation to a ketogenic 
diet (>75% energy from fats).  Crude estimates of relative REE, derived from the information 
provided in the results section of this paper showed a decrease of 7.5 kJ/ kg FFM/d between 
baseline and post intervention values. These results, even uncorrected for potential errors in 
the measurement of FFM used in this study (air displacement plethysmography), are not 
dissimilar to the change seen in our study when the period of adaptation to the diets is taken 
into account.  In contrast, Alessandro et al. (2015) concluded there was no change in absolute 
REE in healthy overweight individuals following 20 d of adaptation to an energy restricted 
low carbohydrate (<30g /d) diet.  However, this finding was only reported qualitatively rather 
than providing quantitative data as evidence for this statement.   Meanwhile, results from 
overweight adults who have lost weight indicate that consuming a low carbohydrate diet (10% 
of energy from carbohydrate, 60% from fat) to maintain weight loss, attenuates the decrease 
in REE that occurs during weight loss (Ebbeling et al., 2012).  All of these studies involved 
free living subjects who were instructed on how to follow a ketogenic LCHF or low 
carbohydrate diet via the provision of menus or meal plans with permitted and non-permitted 
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foods.  Dietary compliance, monitored via food diaries/diet recalls or daily urinary ketones, 
was likely to be less than that achieved in the present study, where all food was provided to 
participants, and weighed food records were maintained (Jeacocke & Burke, 2010). 
The cause and outcomes of the apparent reduction in relative-REE with the ketogenic 
LCHF diet in the present study are currently unexplored and require further confirmation and 
investigation.  Possible causes include decreases in T3 a regulator of energy metabolism or 
decrease in anabolic activity due to reductions in IGF-1 or increases in cortisol resulting in 
decreased in testosterone (Fraser et al., 2000; Lane et al., 2010; Loucks & Heath, 1994; 
Loucks et al., 2011).  In an athlete population, a reduction in relative REE could be associated 
with LEA syndrome, with its range of impairments of health, body composition maintenance 
and training adaptations (Loucks et al., 2011; Melin et al., 2015; Mountjoy et al., 2014; 
Vanheest et al., 2014).  Given the significant effect of these issues on illness, injury and 
performance outcomes, more work is warranted.  If the finding can be confirmed, the 
secondary issue is the accuracy of diagnosis of the problem in athletes who chronically follow 
a LCHF diet or have reduced glycogen stores due to other causes (e.g. energy restriction).  In 
these populations, based on the current study, there is a likelihood that changes in relative 
REE over time or in comparison to a threshold for diagnosis of LEA could potentially be 
masked by the artefact in measurement of FFM, at least by DXA.  This should be factored 
into a practitioners’ interpretations of RMR assessments of such athletes, either by changing 
the thresholds used to denote problematic measures of REE or by applying a transformation 
factor, such as the one used in this study, to correct the estimates of REE. 
Several limitations of the methodology and application of the current study are 
acknowledged.  Due to the constraints of the larger investigation in which the present study 
was undertaken, muscle glycogen could not be measured by muscle biopsy at Baseline or 
Post-intervention to confirm the presence (and magnitude) of this potential source of error in 
measurements of LM.  Future investigations of both this error/artefact in calculation of 
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relative REE and the chronic effects of ketogenic LCHF on metabolic rate would benefit from 
including direct measurements of muscle glycogen before and after the dietary intervention 
using nuclear magnetic resonance, since undertaking muscle biopsies on elite athletes poses a 
practical and ethical challenge.  However, this solution is only likely to be applicable to 
further research on the topic, since it would be impractical for athlete servicing needs.  
Following the application of the correction factor, it appears as though FFM increased by 400 
g (PIthreshold) and 700g (PIAll) respectively after 21 d adaptation of the ketogenic LCHF diet. 
Although the increases were not statistically significant, it indicates that further work may be 
needed to refine and validate the correction factor, as well as to confirm the utility and value 
of including measurements of TBW with DXA-measurements of LM as a proxy measure of 
changes in muscle (and liver) concentrations. The lack of inclusion of female athletes is 
another limitation of the current investigation. However, conducting this study in females 
would bring challenges with regards to standardising measures of REE around the menstrual 
cycle.  Nevertheless, such work is encouraged. 
In conclusion, adaptation to a ketogenic LCHF diet produces an artefact in the DXA 
estimate of FFM due to decreases in glycogen concentration and water storage. This resulted 
in an apparent reduction in relative-REE, once the artefact was corrected with a crude 
transformation factor. This may have implications when relative-REE is used as one of a 
range of markers to detect or manage LEA in athletes.  However, as there was no statistical 
change in absolute REE, further work is required to determine the reproducibility of these 
results. Further refinement of the correction factor is warranted in scenarios where reduced 
glycogen concentration is suspected or confirmed.  
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9.0 Summary and future directions 
9.1 Summary 
The primary aim of this thesis was to investigate the reliability of protocols used to 
measure resting energy expenditure in athletes.  The body of work presented investigated and 
identified key variables that influence either the measurement or interpretation of REE in this 
population.  The findings from these studies have implications for how low energy 
availability is screened, managed and monitored when using REE as the diagnostic tool, 
within the high performance sports environment where the problem of Low Energy 
Availability is becoming increasingly recognised as a major risk factor for injury, impaired 
health, and sub-optimal performance.  This has obvious currency for systems such as 
Australia’s Winning Edge program, which seeks to achieve international sporting success via 
the adoption of standardised Best Practice Protocols for athlete preparation and support across 
a network of sports medicine/science providers.  However, it may also leave a legacy for 
improved care and education of sub-elite athletes and committed exercisers who exist outside 
such networks, but in whom similar problems may occur.  In this case, benefits may translate 
to better community health (reduced healthcare costs, fewer sick days etc.), and greater 
participation and enjoyment of sport and exercise programs.     
Low energy availability (LEA) is associated with, and can be identified via a reduction 
in REE, as long as there is confidence in the reliability of measurement and an absence of 
artefacts that could alter the interpretation of results. The first step in this project was to 
review the literature (Chapter 2) to clarify the terminology used to describe metabolic rate and 
to highlight the differences in the definitions and measurement/calculation of BMR, RMR, 
BEE and REE.  Factors or protocols likely to influence the measurement of REE were 
identified, with particular interest in those which had the lowest levels of investigation and/or 
the highest likelihood of causing variability or artefacts in outcomes. These were combined 
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with practical questions or challenges that had been previously encountered in the 
measurement of REE in the athlete daily training environment to identify the following 
factors that were considered of primary importance to investigate in the target population: 
 Daily variation in REE under normal living conditions 
 Effect of the testing environment and patient preparation (inpatient vs outpatient 
measurements) on measurement of REE 
 Effect of duration of the overnight fast on REE measurements 
 Effect of acute exercise (i.e. exercise on the day(s) prior to measurement) on REE 
measurements 
 Effect of common artefacts in measurement of body composition on calculations 
of REE 
 Effect of extreme macronutrient changes on REE measurements 
There are multiple consequences of using protocols with poor reliability and validity 
in the measurement of REE. When a single measurement is used to screen for LEA there is a 
risk of failing to diagnose a problem that needs management (false negative) as well as 
wasting resources on an athlete who has been incorrectly diagnosed (false positive).  When 
using REE to monitor changes over time, measurement errors could lead to a failure to 
observe a problem that is developing at an early stage or to identify activities or behaviours 
that are problematic.  Equally, it will interfere with the assessment of a planned intervention 
or therapeutic activity to manage LEA to determine if it has been effective in causing a 
change in REE.  This outcome could interfere with the clinical management of an individual 
athlete as well as a judgement of the efficacy or harm of the intervention per se.  
 
Chapter 4 (Study 1) addressed the first three variables by comparing the absolute 
values for REE, and the reliability of measurement of REE, under inpatient (bedside) or 
outpatient (laboratory) protocols. It could be argued that we effectively compared 
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measurements of BEE (inpatient) and REE (outpatient).  However, as an 8 h overnight fast 
was used for both conditions, both protocols were technically REE measurements as per the 
definitions provided in Chapter 2.  Ideally, the methodology of Study 1 would have included a 
comparison between an 8- and 12 h fast for both inpatient and outpatient protocols.  However, 
given the impractical nature of a 12 h fast in athletes in the daily training environment and the 
minimal thermic effect of a meal on metabolic rate after 8 h, this time frame was used as a 
compromise between athlete compliance and scientific rigor (Fullmer et al., 2015; Kinabo & 
Durnin, 1990).   
The results from Study 1 indicate that there is no difference in measurements of REE 
conducted with the use of inpatient or outpatient protocols. There was large variation in the 
REE results for Study 1, particularly for the outpatient protocol, suggesting that ideal practice 
for interpreting single or serial measures of REE would include the capture of multiple 
measures of an individual athlete to determine a baseline typical error.  However, it was also 
concluded that this is not always probable in a high performance environment and that the 
typical errors determined from Study 1 could be used when interpreting longitudinal measures 
of REE.  Furthermore, the outpatient protocol had a bigger typical error, meaning it has less 
sensitivity in detecting changes in REE and would require a bigger difference between 
measurements to be considered a real change. Therefore, although both protocols have good 
day to day reliability, they should not be used interchangeably for longitudinal monitoring of 
REE.    
Study 2 (Chapter 5) was designed to investigate if a standardised rest period from 
exercise is required prior to measurement of REE.    Previous studies in endurance athletes 
have reported that the acute effects of exercise on metabolic rate are no longer present after 
39- and 72 h (Herring et al., 1992; Tremblay et al., 1988). However, given that the majority of 
elite athletes undertake training at least once a day, six to seven days a week, enforcing a rest 
period up to 72 h may not always be feasible.  Therefore, Study 2 investigated the effect of 
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shorter recovery periods on metabolic rate, measuring REE following exercise at ~ 12 h 
intervals up to a total rest period of 48 h.  This provides additional information to the current 
literature in which REE was measured at 24 h intervals (Herring et al., 1992) or only at 
baseline and 72 h later (Tremblay et al., 1988).  To enhance the external validity of the 
methodological design, and to extend the results to a range of sports and training protocols, 
this study was purposefully not restricted to endurance athletes, nor were the training sessions 
prescribed in terms of mode, duration or intensity of exercise.   
The results from Study 2 indicate that the acute effect of exercise had subsided ~48 h 
after exercise.  However, the differences were within the typical error for REE when 
measured using the outpatient protocol and of lower magnitudes than what has been 
previously reported in the literature.  Possible explanations for the smaller magnitude of 
decrease in REE are: insufficient sample size; heterogeneous population and variability in the 
exercise stimulus between participants; and lack of a sufficient change in energy flux between 
training and rest days. The sample size is most likely the biggest factor in preventing a 
meaningful difference in REE from being detected across 12 h time points. However, as 
reported in Chapter 5, this study was hampered by the difficulty in recruiting well-trained 
individuals, let alone elite athletes; the resistance to refraining from exercise for up to 48 h 
proved to be surprisingly difficult to overcome.  Indeed, only 10 of the 16 participants who 
showed any interest in the study by completing the screening questionnaire actually went on 
to commence the study.  Possible explanations for the lack of interest in the study and/or 
willingness to refrain from training include: fear of not maximising adaptation during the 
training block; habituation to a daily training routine, and fear of disruption to energy balance 
goals.   
The lack of a clear change of energy flux in the current study may have also 
contributed to the REE results.  Typically, a high energy flux (high energy intake and 
expenditure) through the metabolic system contributes to the increase in REE following 
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exercise (Bullough et al., 1995) and a change to low energy flux (low energy intake and 
expenditure) may be part of the REE decay. Although there was a significant decrease in 
estimated total energy expenditure between training and rest days among the subjects who 
completed the current study, there was no difference in their total (self-reported) energy 
intake between the days.  Therefore, the energy intake on the training days may not have been 
high enough to elicit a state of increased REE via high energy flux.  This concept provides 
another reason for needing to study elite athletes who periodise energy intake on training days 
and non-training days and achieve distinct changes in energy flux.  However, the challenges 
of achieving compliance from high level athletes (and their coaches) to disturb their training 
programs and include significant rest periods remain a prominent barrier to overcome.  
 
The first two studies of this thesis aimed to standardise what happens either before or 
during REE assessment protocols.  Study 3 (Chapter 6) focused on the application of the 
results of these protocols by examining the reliability of the measurement of FFM which is 
included in the calculation and interpretation of REE assessments.  Previous work on the 
reliability and validity of DXA measurement of body composition has shown that acute 
activities such as a recent bout of exercise or intake of food or fluid increase the error in the 
DXA estimate of LM.  This occurs principally because changes in total body water (TBW) 
are perceived by DXA as a change in LM. Thus, the best practice protocol promoted for DXA 
assessments of body composition (Nana et al., 2015), and commonly used throughout 
Australian’s Winning Edge network involves the presentation of the athlete in an overnight 
fasted and rested state.  However, the effects of other and often longer-term changes in body 
water content on DXA-estimates of body composition remain unknown, although 
practitioners have been aware of apparent anomalies in body composition assessments which 
include unexpected increases and decreases of small but meaningful amount of LM between 
assessments.  Study 3 explored the hypothesis that changes in muscle solutes (e.g. glycogen 
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and creatine), and the fluid bound with them, might create an artefact in DXA measurements 
of LM.  This is important since athletes are likely to experience wide variations in their 
muscle glycogen concentrations due to training and or periodisation of their carbohydrate 
availability to enhance metabolic adaptations to training (Marquet et al., 2016).  Use of 
supplemental forms of creatine to increase muscle creatine content provides another potential 
source of change in muscle solute and water. 
Study 3 included the use of bioelectrical impedance spectroscopy (BIS) to measure 
changes in TBW with various manipulations of muscle solute.  This technique has been 
validated in male athletes (Kerr et al., 2015) and offered practical advantages over the gold 
standard technique of deuterium dilution due to its ease of use and low participant and 
researcher burden. A series of exercise and diet manipulations to increase or reduce muscle 
glycogen were implemented in the face of normal or loaded muscle creatine stores.  A 
glycogen depleted-creatine loaded measurement was the only combination that was not able 
to be achieved within the design of Study 3.  However, given that creatine loading alone had a 
trivial effect on LM estimates, it is reasonable to conclude that there would have been an 
unclear change on total body LM under this treatment condition.  
The results of Study 3 indicate that glycogen depletion produces a trivial decrease in 
DXA estimates of total LM, however the threshold for reaching a substantial change was 
1.4% and there was a 1.3% change observed under this condition.  Furthermore, a possible 
substantial decrease in leg LM was observed following the Glycogen-Depletion protocol. As 
anticipated, glycogen loading, alone and when combined with creatine supplementation, was 
associated with substantial increases in estimates of LM of 2.1 and 3.0% respectively. The 
changes in TBW mirrored the changes in estimates of LM with substantial increases 
following glycogen loading, creatine loading and glycogen and creatine loading, and exercise 
induced depletion resulting in a substantial decrease in TBW.   
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Study 3 indicated that DXA estimates of LM can be acutely influenced by changes in 
intramuscular fluid and substrates, when no real change in muscle protein content is likely to 
have occurred. Therefore, when interpreting the results of DXA measurements of body 
composition, it is important to consider whether recent changes in dietary intake or training 
have occurred, and whether this may have caused substantial changes in muscle 
glycogen/water content. Factoring such events into the interpretations may be important, both 
for identifying whether real changes in LM have occurred and for using absolute measures of 
components of body composition in assessments of nutritional status. 
Investigation of the potential for an accessible and non-invasive technique to estimate 
muscle glycogen at the time of a DXA scan was the catalyst behind Study 4 (Chapter 7).  The 
novel MuscleSound® method uses ultrasound and proprietary software to estimate muscle 
glycogen based on the premise that water bound to stored glycogen and released during 
exercise changes the brightness of the ultrasound image.  Although validation studies had 
been undertaken, using a cycling bout to achieve simple changes in glycogen stores, we 
identified that the design of Study 3 (Chapter 6) provided an excellent opportunity to compare 
the estimates of muscle glycogen from MuscleSound® against the biopsy criterion method, 
under a more extreme glycogen-depleting protocol as well as glycogen loading protocols that 
were not included in the previous validation studies.  The inclusion of creatine 
supplementation in the study design provided an additional challenge to the ability of the 
MuscleSound® to track changes in muscle glycogen when changes in intramuscular fluid were 
not directly related to glycogen.   
The results of Study 4 found that MuscleSound® estimates of glycogen did not 
correlate well with the clear changes in biopsy-derived muscle glycogen concentrations 
resulting from the depleting and loading protocols. Therefore, we determined, in contrast to 
the previously conducted validation studies, that the MuscleSound® technique does not have 
the precision to detect changes in muscle glycogen that are commonly seen in athletes.  
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Discrepancies between the results of Study 4 and the previous publications could be due to the 
greater extremes in muscle glycogen achieved by our depletion and loading protocols, as well 
as the separation of glycogen depletion and dehydration in the post-exercise measurements.  
Specifically, our protocol involved the collection of the “depletion” measurements on the 
morning after the glycogen depleting cycling task, to coincide with the DXA measurements of 
body composition according to our Best Practice Protocol.  However, a secondary, and useful, 
feature of this methodological piece was the opportunity to allow participants to rehydrate 
during the ensuing (~ 14-16 h) recovery period while minimising glycogen recovery via the 
provision of a diet providing minimal carbohydrate content.  This is in contrast to the 
conditions used in the other validation studies of the MuscleSound® technique whereby post-
exercise assessments were conducted in the likely co-existence of exercise-induced 
dehydration.   Although the results of Study 3 indicated that the MuscleSound® technique was 
unable to provide a valid and reliable estimate of total muscle glycogen content or changes in 
glycogen due to a variety of manipulations, we found changes in total body water measured 
by BIS reflected the changes observed in biopsy derived muscle glycogen.  Therefore, we 
noted that the concept of tracking TBW in otherwise euhydrated individuals as a proxy for 
changes in muscle glycogen content appears to be valid, and the BIS should be considered as 
a tool to monitor changes in muscle glycogen under these conditions. 
The final study of this thesis (Chapter 8) investigated the significance of the artefact in 
DXA estimates of LM due to changes in muscle glycogen and water content, when 
interpreting the assessment of relative REE in situations when a change in muscle glycogen is 
induced through extreme dietary practices. Indeed, Study 5 had two aims: to investigate 
whether adaptation to a ketogenic low carbohydrate high fat (LCHF) diet in elite male athletes 
is associated with a change in relative REE, and to test the significance of the small but robust 
clear in the DXA measurement of LM in glycogen-depleted individuals on the calculation and 
interpretation of relative REE. This is relevant due to the re-emergence of claims LCHF diet 
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can enhance endurance/ultra-endurance performance and appears to be practiced by some 
elite athletes. 
A limitation of Study 5 was that muscle biopsies were not taken at baseline and post-
intervention to confirm any changes in in muscle glycogen stores with either diet.  However, 
other researchers have reported that the decrease in resting muscle glycogen stores achieved 
by a 4 week adaptation to a LCHF diet (Phinney et al., 1983) is similar in magnitude to the 
acute depletion in muscle glycogen observed in our previous investigation of the DXA 
artefact in LM assessment (Study 3).  Based on the results of Study 3, estimates of TBW by 
BIS in rested and euhydrated individuals were deemed to be a suitable indicator of presence 
of a meaningful change in intramuscular water to which a correction factor could be applied 
to DXA estimates of LM to provide a more valid estimate of LM (either for over or under 
estimation).  It could also be argued that using a four compartment model of body 
composition when measuring and interpreting REE would be more appropriate. However, this 
requires extensive resources and time, and would not be practical in an athlete servicing 
scenario.  Therefore, we restricted our investigation to methodologies that would be more 
practical and accessible in a real world environment.  
The results from Study 5 indicate that it is important to correct estimates of FFM for 
the artefact in DXA measurement of LM in individuals with depleted muscle glycogen and 
bound water stores.  Indeed, we noted a mean LM “loss” of ~ 1.4 kg in the LCHF group 
following 3 weeks of a CHO-restricted diet that was likely to reflect changes in intramuscular 
solutes and water rather than a true change in muscle mass or other body tissues.  Although 
this may seem a small error, has the potential to alter the measurement and interpretation of 
relative REE – the measurement of energy expenditure at rest from the traditionally identified 
metabolically active tissues.  Specifically, we noted that there was no change in estimates of 
relative REE in either group as a result of the 3 week diet-exercise intervention.  However, 
when a transformation factor was used to correct estimates of FFM in the LCHF group, either 
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for all individuals or only those who showed a substantial change in TBW measured by BIS, 
the reduction in relative REE was now deemed to be statistically significant. To ensure that 
this finding was not biased by applying the correction factor to the individuals in the LCHF 
intervention group, a similar transformation was applied to the control group to account for 
increases in post-intervention LM that should be more correctly attributed to increases in 
muscle solutes/water.   
Study 5 provides an appropriate conclusion to this body of work by providing 
evidence of the importance of establishing good reliability and validity in measurements of 
body composition and energy expenditure in special populations such as elite athletes.  
Indeed, it leaves an interesting legacy in challenging further investigations of the effect of 
ketogenic LCHF diets on resting metabolism in athletes.  More importantly, it underscores the 
potential risks of undertaking measurements of nutritional status in athletes without adequate 
standardisation of measurement or insight into interpreting the results.  In the current case, 
poor measurement technique and lack of insight would have been associated with a type II 
error – failure to detect a real effect.  Given the significant issues associated with reduced 
metabolic rate and low energy availability in athletes, this is would be an unfortunate 
oversight.  
 
9.2 Limitations 
Although limitations of individual studies were addressed in the relevant chapters, 
some elements appeared as common themes throughout this thesis and should be addressed. 
9.2.1 Statistics 
Different statistical methods were used to analyse the results of Studies 1, 2 and 5 
compared with Studies 3 and 4.  With the exception of Study 4, the statistical methods used in 
each respective study were chosen to make them compatible with the current literature, and in 
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particular, the series of publications from our research group on this topic. The magnitude 
based inference approach has previously been used in studies investigating DXA reliability by 
our centre and it was considered appropriate to continue with this method.  Conversely, for 
Study 4 it was decided that the statistics used in the previous two validation studies did not 
provide sufficient clarification with regards to the errors of the prediction equation and 
therefore linear mix modelling was used. 
Consistency with our work regarding REE was attempted by ensuring that all studies 
on this topic (Studies 1, 2 and 5) used the same statistical model of null hypothesis testing, 
and the use of statistical significance based on p-values, with further insights gained from 
confidence limits. Furthermore, linear mixed modelling was used in the group of studies in 
which parallel group designs were used in the investigation of different treatments.  
It is important to note that all studies used parametric statistical analysis, with the 
differences primarily residing in the methods used to make inferences around the results. At 
no point was an interpretative method chosen because it provided a “better outcome”. 
 
9.2.2 Generalisability 
With the exception of Study 1, the studies in this thesis did not include female 
participants.  The rationale for the exclusion of female athletes in Studies 2-5 include the 
challenging logistics of controlling for the menstrual cycle and its likely effects on several 
main variables under investigation (e.g. changes in resting metabolism, shifts in body fluids).  
Although we were unable to control for the phase of the menstrual cycle in female subjects 
who participated in Study 1, the intervention period involved a very short time frame (2-3 
days) in which we did not anticipate changes to occur.  Therefore, the generalisability of the 
results of our studies to female athletes should be treated with caution and in conjunction with 
the available literature (if any) for those specific variables on that particular intervention.   
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Although the goal of this thesis was to produce best practice guidelines for the 
measurement of REE in high performance athletes, only two studies contained participants 
from this target population.  Study 1 contained a mixture of elite (national representatives) and 
sub-elite (state representative) athletes, while Study 5 involved elite and highly trained male 
race-walkers. Studies 3 and 4 recruited participants who were well trained as evidenced by 
their VO2max (65.2 ± 7.1 ml/kg/min), but came mainly from an endurance background.  
However, like the race-walkers they were endurance trained. Therefore, the applicability to 
the results in this collection of work to resistance and team-sport athletes requires further 
investigation.   
The correction factor in Study 5 was developed on endurance trained male athletes. 
Furthermore, it was developed on a cohort of 18 participants.  As a tool it is still relatively 
crude and potentially limited by the bluntness of the BIS ability to detect smaller change in 
TBW.  In addition, changes in muscle glycogen concentrations are not the only cause for 
changes in TBW; indeed a separate correction factor would be needed for female athletes at 
various stages across the menstrual cycle or for use with athletes who are following a low 
residue diet Thus further development of the correction factor is required before it is applied 
to other sporting populations.   
 
9.3 Future directions 
More investigations are required to address the gaps in the literature concerning REE 
protocols in female and non-endurance athlete groups. Furthermore, studies involving female 
athletes should address the potential differences in metabolic rate between and among athletes 
who have natural menstrual cycles, those who are on the contraceptive pill or other long term 
forms of contraception such as an inter-uterine device, and those who have menstrual 
disturbances.  It is possible that daily variability in measurements of REE, and the effects of 
acute exercise or extreme macronutrient changes on REE may differ from male athletes, as 
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well as between these groups.  Effects of absolute and fluctuating concentrations of 
reproductive hormone may also affect total body water and its impact on measures of DXA 
LM, thus requiring separate investigations of the utility of BIS to track changes of interest in 
TBW, as well as determine when and what correction factor should be applied to DXA 
estimates of LM.    
Further development of the correction factor and using changes in TBW to account for 
changes in muscle glycogen is required to determine its sensitivity, reliability and 
applicability to female athletes and other sports. Whether the correction factor is still valid in 
sports where extreme acute changes in body mass have occurred (such as when making 
weight for combat sports) is also of interest.  
  Future studies on the acute effect of exercise on measures of REE require robust 
strategies to recruit elite athletes and increase sample sizes. Such strategies could include the 
staging of camps with incentives for attendees to refrain from training for multiple days (such 
as education activities or medical screenings);  other options would be to measure REE during 
a taper, or following a major event after which it is likely that many athletes would take a 
scheduled break from training (e.g. a marathon).  
Finally, more evidence is required to support the energy flux concept and whether or 
not this theory is influenced by acute changes of the macronutrient content of the evening 
meal on the night prior to REE measurement. This is of particular relevance to current 
nutrition practices in which athletes may chronically follow a LCHF diet or integrate periods 
of training with low CHO availability before or after a session.   
 
9.4 Conclusion  
This thesis investigated three variables that influence the measurement or 
interpretation of REE in athletes, as well as studying the use of two novel techniques to help 
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correct for potential errors/artefacts in measurements.  The outcomes of the completed body 
of work include   
 Demonstration of the reliability of REE measurements following an 8 h overnight 
fasting protocol, with identification of a typical error to assist practitioners to 
determine when a real change in REE is likely to have occurred. 
 Suggestion that the acute effect of exercise on metabolic rate in a heterogeneous 
athlete population may take a period of 48 h of rest to return REE to baseline 
values. 
 Identification of an artefact in the DXA estimate of LM when there is 
manipulation of the muscle content of glycogen and creatine (and associated 
water).  
 Failure to validate the use of commercial ultrasound technology and proprietary 
software to provide a non-invasive assessment of muscle glycogen content or its 
changes.  
 Demonstration of the utility of using a transformation factor based on Bioelectrical 
Impedance Spectroscopy-derived changes in TBW to reduce the artefact in DXA-
estimates of LM in athletes who have major changes in muscle glycogen content.  
 Identification of a potential reduction in relative REE following adaptation to a 
ketogenic LCHF diet, which may have important implications in the consideration 
of Low Energy Availability in athletes  
 
Together, the body of work presented in this thesis provides evidence that can be used 
to update protocols for measuring and interpreting REE in and how they could affect the 
identification and management of low energy availability in athletes (Figure 9.1).   
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Figure 9.1. Contribution of thesis studies to RMR Best Practice Protocol in athletes.
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9.5 Personal Reflections 
This thesis aimed to marry scientific rigor with practical application within a high 
performance environment.  The process of completing a Confirmation of Candidature allows 
the development of the PhD road map with clear study questions, outcome goals, and 
consideration of resources, skill sets and timeframes.  However, the completion of the journey 
requires an ability to embrace good luck, unforeseen circumstances, and changes in direction.  
This series of doctoral studies included examples of both good and bad fortune.   Study 2 
provided the greatest need for resilience in the face of setbacks.  Recruitment and testing for 
this project was actually completed twice.  Round 1 produced a worrying number of 
anomalous measurements of REE within the data set, despite careful collection protocols, 
equipment checks and advice from experienced practitioners and technicians. Persistence in 
checking equipment eventually determined the source of the problem: the degrading of some 
of the O-rings on mouthpieces and connections to the metabolic cart. The hard lesson was that 
failure of the most random and minor pieces of equipment can necessitate the cancellation of 
a whole data set/study.  However, the positive outcome of this lesson was an appreciation of 
my developing expertise and increased confidence in my ability to identify and interpret the 
quality of data.  Study 2 was also originally intended to be a fully powered investigation of an 
elite population.  However, the difficulties in recruiting high calibre athletes (both round 1 
and 2) to fulfil the requirements and the acknowledgement that we would need to move away 
from our target population to obtain an adequate sample size, made me rethink the use of my 
time and resources and to reclassify it as a pilot study.   
The silver lining of redoing Study 2 meant that I had to extend my candidature which 
coincided with an opportunity to better use those resources in Study 5. A large dietary 
intervention and training study was being planned within the AIS Sports Nutrition Research 
group and it provided a perfect opportunity to test out how one element of my work 
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(identification of an artefact in DXA-estimates of LM) would affect interpretations of REE in 
a group of world class athletes when muscle glycogen was manipulated by a LCHF diet. This 
example was just one of many I encountered throughout my PhD, where being in an 
environment which undertakes both high performance research and athlete preparation 
provided an unforeseen opportunity to contribute to other multidisciplinary activities while 
cross-fertilising my own work. And although the final journey was somewhat different to the 
path that was originally planned, it meant discovering a persistence and confidence in my 
expertise, as well as an appreciation that serendipitous chances can lead to clinically 
impacting and meaningful outcomes.  
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Change in Muscle Fuel Estimate (%)
Change in muscle
glycogen (%)
Baseline Glycogen Depleted Placebo Glycogen Loaded
Figure S2: Comparison of change in glycogen status between measured glycogen concentration and
Muscle Fuel Estimate from the mid thigh on the contralateral leg for baseline, glycogen depleted,
placebo and glycogen loaded treatment conditions. Participants means rescaled to means of zero. Axis
are log scales.
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